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Preface  
This thesis highlights the work done in the period from Marts 2007 to June 2010 by undersigned 
in order to obtain the Ph. D. degree. The work was done under The International Doctoral School 
of Technology and Science at the Faculty of Engineering and Science, Aalborg University, 
Denmark. 
The thesis is divided into three parts. The first part describes the work with structural biology of 
antimicrobial peptides and detergents and how paramagnetic species can be used to study 
these. It furthermore gives an introduction to antimicrobial peptides, membrane and membrane 
mimicking systems and to nuclear magnetic resonance spectroscopy (NMR). Part two describes 
the work on the transmembrane part of the autotransporter adhesin involved in diffuse 
adherence (AIDA) and contains an introduction to outer membrane proteins and 
autotransporters. It furthermore contains an experimental section wherein materials and 
methods as well as results are presented. Part three contains four papers based on the thesis 
work with structural studies of peptides and all experimental data is presented in these papers. 
Two of these papers have been published in peer reviewed journals and one has been submitted 
to J Biomol NMR. Paper III summarizes the work carried out on the peptides maculatin and 
citropin and although it is not ready for publication in the current form it includes important 
observations relevant for the thesis. An elaborating discussion of the papers is found in part I. 
This thesis does not include the published paper concerning the beta-sheet aggregation of 
kisspeptin-10 as the NMR part by which I contributed generally fall out of scope with the thesis. 
Likewise with the paper concerning the glycosylation on the extracellular domain of the Ag43 
although this presents the modeling approach used to model AIDA.   
The work of this thesis were carried out in the NMR laboratory at Department of Biotechnology, 
Chemistry and Environmental Engineering, Aalborg University under the co-supervision of 
Professor Daniel E. Otzen (Interdisciplinary Nanoscience Center, Department of Molecular 
Biology, University of Aarhus) and the supervision of Associate Professor Reinhard Wimmer. The 
Ph. D. study was funded by BioNET, a Danish research network for experimental and theoretical 
biophysics supported by the VILLUM KANN RASMUSSEN FOUNDATION. 
I would like to acknowledge the following persons: 
Reinhard Wimmer for excellent and dedicated supervision and for always providing invaluable 
help during my project. 
Daniel E. Otzen for making this project possible and for always providing scientific inputs and 
inspiration.  
Associated Professor Peter Fojan for help with the molecular dynamics simulations and peptide 
synthesis as well as letting me borrow the CD-spectrometer.  
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Kirstine Lykke Christensen for her work with maculatin and citropin. 
Finn Lillelund Aachmann for his help with synthesizing the AIDA-β1 plasmid and recording of 
AIDA-β1 three dimensional spectra.  
Thomas Boesen for help with the crystal screens. 
The members of the biophysics groups at University of Aarhus for scientific discussions and for 
letting me borrow the laboratory equipment.  
And last but not least, a great thanks to my friends, family and especially Stine Rudkjøbing Raklev 
for their love and support during my time as PhD student.  
 
 
 
 
Aalborg University, June 9th 2010 
 
 
 
____________________________ 
Magnus Franzmann  
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Summary  
Experimental methods for determining the insertion depth and the orientation of membrane 
embedded peptides and proteins are of great relevance for determining their biological 
functions. To the large and increasing numbers of identified straight α-helical antimicrobial 
peptides these methods are of great importance for elucidating their antimicrobial behavior as 
their orientation relative to the surface of bacterial membrane are one of the defining 
characteristic of their mode of action. To investigate how members of this group of peptides 
interact with membranes the model peptides novicidin, novispirin, acylated variants of novicidin, 
citropin and maculatin are used as model systems. These peptides are all derived from natural 
occurring animal peptides and they all form amphipathic α-helices in the presence of 
membranes and membrane mimicking environments like detergent micelles and lipid bicelles, 
which is typically used for studying peptide interactions with membranes.  
By titrating dodecylphosphocholine (DPC) micelles with the contrast agent omniscan (Gd(DTPA-
BMA)) the paramagnetic relaxation enhancement (PRE) values for all unambiguous proton 
signals were obtained. It was found that by correlating these PRE values with distances between 
the micelle center and DPC protons calculated using molecular dynamics simulations a 
PRE/distance correlation could be derived. Similar titration experiments were conducted on all 
the model peptides in micelle solutions and because PRE values of DPC and the peptides are 
comparable, it was possible to calculate the peptide protons distances to the micelles center 
from the DPC PRE/distance correlation. In DPC micelle solutions all of the studied peptides were 
located at the surface of the micelles with the hydrophilic part of the peptides clearly facing the 
solvent and the hydrophobic part buried at the hydrocarbon chains of the detergents. In anionic 
bicelles systems, which resemble the negatively charged bacterial membranes better than DPC 
micelles, it was based on qualitative analysis of residue specific PRE values shown that citropin is 
positioned parallel to the surface as expected from previous published results.  
Maculatin  was in contrast expected to be positioned perpendicular to the planner surface of 
membranes, however, stability issues with samples containing maculatin embedded in anionic 
bicelles prevented us from recording nuclear magnetic resonance (NMR) experiments that could 
substantiate this. Maculatin dissolved in zwitterionic bicelles did not exhibit the same stability 
issues and PRE values could therefore be recorded which showed that maculatin in these bicelles 
are located parallel to the surface. Combined with previously published data indicating a charge 
dependent membrane insertion of maculatin we speculate based on our stability observations 
and PRE measurements that maculatin is indeed positioned parallel to the bicelle surface in 
zwitterionic bicelles whereas it is positioned perpendicular to the bicelles surface in anionic 
bicelles causing bicelles degradation and subsequent precipitation.  
NMR structure determination of proteins and peptides is mainly based on distances between 
protons derived from Nuclear Overhauser Effect (NOE) cross peak intensities. NOE cross peaks 
originating from two chemically nonequivalent, diastereotopic, protons can typically not be 
distinguished (stereospecific assigned). The distance is therefore calculated to a “pseudoatom” 
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located at the center between the protons that they represent and to prevent errors  the 
distance is increased with a correction distance causing an inevitable loss of information. In this 
thesis a novel method of stereospecific assigning protons is presented. By titrating a model 
peptide, plectasin, with a free floating water soluble contrast agent, omniscan, information 
concerning the relative orientation of protons towards the solvent was obtained. From an 
ensemble of structures calculated without added stereo assignments we computer simulated a 
water shell surrounding the peptide wherein omniscan could be located and from this 
information regarding the orientation of proton pairs could be obtained. This information was 
correlated with the information from the titration experiments whereby the peaks could be 
stereospecific assigned. Recalculating the structure showed a significantly improved RMSD. 
Finally, the transmembrane domain of the autotransporter protein adhesin involved in diffuse 
adherence (AIDA) was successfully refolded into different detergent micelles. Circular dichroism 
spectra revealed β-sheet secondary structure as expected based on previous publication. Heat 
modifiability test confirmed that the protein were correct folded, however, it was not possible to 
record NMR spectra with a resolution sufficient for recording three dimensional spectra usable 
for structural determination. 
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Resume  
Bestemmelse af pertuberingsdybden og orientering af membran interagerende peptider og pro-
teiner ved hjælp af eksperimentelle metoder er af stor betydning for en vurdering af deres 
biologiske funktioner.  
For det stigende antal identificerede α-helix antimikrobielle peptider er disse metoder 
nødvendige for at kunne belyse deres antimikrobielle egenskaber, da peptidernes orientering i 
forhold til overfladen af bakterielle membraner er af afgørende betydning for deres virkemåde.  
Som modelsystemer til brug for undersøgelsen af, hvordan medlemmer af denne gruppe 
peptider interagere med membraner er anvendt peptiderne novicidin, novispirin, acylerede 
varianter af novicidin, citropin og maculatin. Alle disse peptider er afledt af naturligt 
forekommende animalske peptider og de danner alle amfipatiske α-helix strukturer i membraner 
og membran lignende miljøer såsom detergent miceller og lipid biceller, der ofte bruges som 
modeller til at studere peptiders interaktioner med membraner. 
Paramagnetisk relaksation forstærknings (PRE) værdier for alle utvetydige proton signaler er 
målt ved at titrere dodecylphosphocholine (DPC) miceller med kontrastmidlet omniscan (Gd 
(DTPA-BMA)). Ved at sammenholde disse PRE værdier med afstande mellem micelle centrene og 
DPC protonerne, som er beregnet ved hjælp af computer simuleringer, har det været muligt at 
udlede en PRE/distance korrelation. Lignende omniscan titrerings eksperimenter er udført på 
alle modelpeptiderne i micelle opløsninger.  Da PRE værdier for DPC og peptider er 
sammenlignelige er det muligt at beregne afstanden mellem peptidernes protoner og DPC 
micelle centre ud fra de målte PRE-værdier ud fra afstands korrelation fra DPC.  
Det viste sig, at alle de undersøgte peptider er placeret ved overfladen af DPC micellerne med 
den hydrofile del af peptiderne stikkende ud fra micellerne og den hydrofobe del begravet ved 
DPC acylkæderne.  
I anioniske bicelle systemer, som i højere grad ligner negativt ladede bakterielle membraner end 
DPC miceller er det, baseret på kvalitative analyser af PRE værdier, vist at citropin er placeret 
parallelt med overfladen som forventet ud fra tidligere offentliggjorte resultater.  
Maculatin forventes i modsætning til citropin at være placeret vinkelret på den plane bicelle 
overflade, men problemer med stabiliteten af prøver indeholdende maculatin i anioniske bicelle 
opløsninger har forhindret optagelse af NMR spektre, der ville kunne dokumentere dette. 
Maculatin opløst i zwitterioniske bicelle opløsninger udviser imidlertid ikke samme stabilitets 
problemer og der kunne derfor måles PRE-værdier, som har vist, at maculatin i disse biceller 
ligger parallelt med overfladen. Sammenholdes stabilitet observationerne og målinger af PRE-
værdier med tidligere offentliggjorte data, der viser en ladnings afhængig membran pertubering 
for maculatin, er maculatin formodentlig placeret parallelt med bicelle overfladen i zwitterionic 
biceller, hvorimod maculatin er placeret vinkelret på bicelles overflade i anioniske biceller, 
hvilket forårsager at bicellerne nedbrydes og efterfølgende udfælder.  
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Struktur bestemmelse af proteiner og peptider ved kernemagnetisk resonans (NMR) er 
hovedsagelig baseret på afstande mellem protoner beregnet ud fra nuklear overhauser effekt 
(NOE) krydstop intensiteter. Oprindelsen af NOE krydstoppe fra to kemisk forskellige, 
diastereotopiske protoner kan typisk ikke skelnes (stereospecifikt tilordnes). Afstanden er i 
stedet for beregnet til et "pseudoatom" placeret midt mellem de protoner de repræsenterer. Da 
afstanden er forøget med en korrektions afstand, vil dette uundgåeligt forårsage et tab af 
information. I denne afhandling præsenteres en ny metode til stereospecifikt at tilordne proton 
signaler. Ved titrering af et modelpeptid, plectasin, med et vandopløselige kontraststof, 
omniscan, fås oplysninger om den relative orientering af protoner imod den omsluttende 
opløsning. Fra et ensemble af strukturer beregnet uden stereospecifikke tilordninger er der 
computer simuleret en vand skal omkring peptidet hvori omniscan kan antage alle placeringer og 
ud fra dette er den relative orientering af proton par imod vandet bestemt. Herefter er disse 
orienteringsdata sammenholdt med data fra titreringens eksperimenterne, hvorved 
krydstoppene kunne stereospecifikt tilordnes. En gentagelse af struktur beregningen, men med 
de stereospecifike tilordninger, viste en væsentligt forbedret RMSD værdi i forhold til 
beregninger uden.  
Det transmembrane domæne af autotransporter proteinet ”adhesin involved in diffuse 
adherence” (AIDA), er succesfuldt blevet udtrykt og refoldet i forskellige detergent miceller. 
Cirkulære dichroism spektre viste β-foldeblad sekundær struktur, hvilket kunne forventes på 
baggrund af tidligere publikation. Varme modificerbarheds test har bekræftet, at proteinet var 
korrekt foldet, men det har ikke været muligt at optage NMR spektre med en tilstrækkelig høj 
opløsning, så de kunne anvendes til en strukturel bestemmelse af proteinet. 
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Abbreviations 
Gd(DOTA)  gadolinium-tetraazacyclododecanetetraacetic acid 
AIDA  adhesin involved in diffuse adherence 
AMP  antimicrobial peptide 
CD  circular dichroism 
CL  cardiolipin 
CMC  critical micelle concentration 
COSY  correlation spectroscopy 
DHPC  dihexanoyl-sn-glycero-3-phosphocholine 
DMPC  1,2-dimyristoyl-sn-glycero-3-phosholine 
DMPG  1,2-dimyristoyl-sn-glycero-3-phosphoglycerol 
DOPE  discrete optimized potential energy 
DPC  dodecylphosphocholine 
DQF  double quantum filtered 
DTT  dithiothretiol 
FDA  food and drug administration 
Gd(DTPA-BMA) gadolinium-diethylenetriaminepentaacetic acid 
GRAS  generally recognized as safe 
GUV  giant unilamellar vesicles 
HSQC  heteronuclear single quantum correlation 
IPTG  isopropyl--D-thiogalactopyranoside 
LPS  lipopolysaccharides 
LUV  large unilamellar vesicles 
MIC  minimal inhibition concentration 
NMR   nuclear magnetic resonance 
NOE  nuclear overhauser effect 
NOESY  nuclear overhauser effect spectroscopy 
OMP  outer membrane protein 
oPOE  octyl polyoxyethylene 
PAGE  polyacrylamide gel electrophoresis 
PC  phosphatidylcholine 
PE  phosphatidylethanolamine 
PG  phosphatidylglycerol 
PI  phosphatidyllinositol 
PRE  paramagnetic relaxation enhancement 
PS  phosphatidylserine 
RDC  residual dipolar coupling 
RF  radio frequency 
SDS  sodium dodecyl sulfate 
SPH  sphingomyelin 
SUV  small unilamellar vesicles 
TOCSY  total correlation spectroscopy 
TROSY  transverse relaxation-optimized spectroscopy 
UV  ultraviolet 
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Part I 
Antimicrobial peptides 
Bacterial resistance 
The discovery of penicillin as an antibiotic agent by Alexander Flemming in 1928 provided for the 
first time humans with a tool to treat bacterial infections and thereby to survive a large number 
of life threatening diseases. It also provided the capability of performing surgery, organ 
transplantations and chemotherapy treatments without causing serious infectious complications 
and the introduction of antibiotics thereby revolutionized the entire medical sector. The 
industrial production of penicillin started in 1943 and the use of antibiotics quickly became 
widespread which between 1944 and 1972 lead to a dramatic increase of eight years to the 
average human lifespan what is unprecedented both before and after.[5] However, only four 
years after the mass production of penicillin started, the first studies of clinical bacterial 
resistance were reported[6] and since then the number of antibiotic resistant bacteria have been 
steadily increasing. According to the world health organization WHO up to 70% of hospital 
infections are resistant to all penicillins and cephalosporins (two types of commonly used 
antibiotics) and for many other infectious strains the percentage of resistant bacteria are close 
to 100%.[7] Even worse is the emergence of vancomycin resistant strains of Enterococcus bacteria 
in many hospitals around the world, as this antibiotic were thought to be the last line of defense 
against multiresistant bacteria. Because the pathogens are highly virulent and able to quickly 
adapt the resistance genes and thereby become resistant to newly developed antibiotics, the 
time period where the development costs can be returned are significantly reduced. The profits 
that can be made by the pharmaceutical companies are as a consequence also significantly 
reduced which is directly reflected in the number of new antibiotics that have been introduced 
to the marked in the last years. In the period between 1999 and 2008 there were only 
introduced nine new antibiotics[8] and there are no indications that this trend will change, 
causing leading scientist to proclaim that the antibiotic era is at an end.[9, 10] 
There exist several different ways by which the microorganisms exhibit resistance to antibiotics. 
Penicillin and other β-lactam antibiotics targets a number of different bacterial enzymes which 
are necessary for the growth and maintenance of the peptidoglycan layer, and one of the most 
frequently observed resistance mechanism is an alteration of the penicillin binding sites on these 
enzymes, which prevents an interference.[11] Other well studied mechanisms are enzymatic drug 
modifications as are seen with β-lactamases like penicillinase[12] and overexpression of efflux 
pumps that actively pumps out the antibiotics before it causes damage to the bacteria.[13] Since 
the 1960s there have only been developed two new structural classes of antibiotics and because 
virtually all new antibiotics therefore are modifications of already existing products the 
resistance genes can easily adapt to the new antibiotics which is one of the main reasons that 
multidrug resistant bacteria are spreading out of control.[9] The need for new antibiotics is 
crucial in order to retain the ability to treat infectious diseases on a large scale. The rapidly 
Introduction to antimicrobial 
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Antimicrobial peptides 
 
12  
 
growing number of identified antimicrobial peptides (AMPs) constitute a group of very 
promising candidates for alternative treatment and might be part of a solution against multidrug 
resistant bacteria as will be discussed in details in the following sections. 
Introduction to antimicrobial peptides 
Antimicrobial peptides are a large group of structurally and sequentially very diverse antibiotics 
consisting of relatively short chains of amino acid polypeptides. These peptides play an 
evolutionary conserved role in the innate immune system (non-adaptive immunity) where they 
act on a broad range of microorganisms, typically with a low specificity. This enables a quick 
response to pathogens compared to the adaptive immune system as the AMPs do not require 
mobilization or expression of specialized cells which is highly beneficial at continuously exposed 
parts of animal’s bodies such as the skin, the mouth and the intestine. AMPs have been shown 
to kill a wide range of bacteria including Gram-positive bacteria, Gram-negative bacteria and 
mycobacteria as well as some types of viruses, fungi and even cancer cells.[14] However, the 
specificity for these targets varies greatly within the different types of AMPs indicating that they 
act in various ways. Therefore most multicellular organisms secrete a mixture of different AMPs 
in order to protect them from the diverse threats.[15] Common for all AMPs are that they 
originate from larger precursors which experience post transcriptional modifications like 
proteolysis modifications, glycosidation, C-terminal amidation or isomerisation.[16] Furthermore, 
all known AMPs appear to fold into amphiphatic structures with separate clusters of charged 
and hydrophobic amino acids.[15] 
Classes of antimicrobial peptides 
The great diversity of peptide antibiotics makes it difficult to categorize them into defined 
groups, and as a consequence there have been various approaches in doing so. Mammal AMPs 
can be divided into two groups based on their evolutionary divergence where defensins differs 
from the large and structurally very diverse group of cathelicidins.[17, 18] The cathelicidin group 
has obtained its name from the 96 residue porcine peptide cathepsin L. inhibitor from which the 
molecules were first isolated[19] and they consist of a cathelin domain and a C-terminal AMP 
domain which will be described further. On a broader level the peptides are typically grouped by 
a combination of net charge, amino acid composition and the number of disulfide bridges that 
the peptides contain[14, 20]. On the following pages a short introduction to the different groups 
listed below: 
1) Linear cationic α-helical peptides 
2) Cationic peptides enriched for specific amino acids 
3) Anionic and cationic peptides that contain cysteine and form disulphide bonds 
4) Anionic peptides 
5) Anionic and cationic peptide fragments of larger proteins 
Linear cationic α-helical peptides 
One of the largest and most well studied groups of AMPs is the group of small cationic peptides 
which are highly abundant and widespread in nature where they are found in all types of 
Classes of antimicrobial peptides Antimicrobial peptides 
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organisms ranging from insects to higher mammals.[21] They act against most Gram-negative and 
Gram-positive bacteria but also some fungi and enveloped viruses. They are typically less than 
40 residues long, do not contain any cystein residues that can form disulfide bridges and do not 
appear to form any secondary structure in aqueous solutions. However, in the presence of lipids, 
detergents or even some small organic compounds like alcohols[17, 22], they adapt a linear α-
helical conformation which in several cases has a hinge or kink in the middle of the helix (see 
figure 2). The hydrophobic residues of the peptides are distributed in a manner so that they 
upon α-helix formation typically are located on one side of the peptides while the charged and 
hydrophilic residues are located on the other side, which makes them highly amphiphatic. This 
promotes an interaction with the lipid environment of the target cell membranes as the peptides 
thereby can be positioned between the lipid headgroups and their hydrophobic tails. 
A great effort has been put into determining the mechanisms by which the AMPs target the 
bacteria without affecting the host cells. For the linear cationic α-helical peptides the main 
driving force is generally accepted to be the highly negatively charged surface of the prokaryotic 
membranes that contains a relative large amount of anionic phosphatidylglycerol (PG) compared 
to the more neutrally charged surfaces of eukaryotic membranes. Upon binding to the bacterial 
membrane the peptides disrupts the membranes by either forming pores or by destabilizing the 
membrane leading to a collapse of the lipid structure and consequently cell death. Three general 
models have been proposed to describe these interactions; the barrel-stave model[23], the carpet 
model[24] and the toroidal pore model[25]. In the barrel-stave model the peptides bind to the 
target membrane as either monomers or as oligomers before assembling on the membrane 
surface. Subsequently the peptides transverse the membrane by pore formation which lead to a 
breakdown of the electrochemical potential, pH gradient and osmotic regulation across the cell 
membrane and thereby causes the cell to die. As the typical bacterial membrane is 
approximately 30 Å thick, the peptides must be at least 20 residues long in order to span the 
entire width of the bilayer.[26] In the barrel-stave model the hydrophobic part of the peptides are 
bound to the lipid core of the membranes while the hydrophilic part of the peptides are bound 
to the lipid headgroups as well as the water within the pore and the water surrounding the 
membrane. As these peptides can interact with the hydrophobic core of the membrane it is 
assumed that the formation of the transmembrane pores are mainly driven by hydrophobic 
interactions and that they therefore bind to the lipids independent of their charge. A cartoon 
illustration of the barrel-stave model can be seen in figure 1C. In the toroidal pore model the 
peptides assemble on the membrane surface of the target cell until a critical concentration is 
reached as is also seen for the barrel-stave model. However, the peptides acting by the toroidal 
pore model do not bind to the hydrophobic tails of the membrane lipids but rather induces a 
bend from the outer surface of the membranes to the inner surface thereby forming pores. The 
lipid head groups continuously lines the hydrophobic core along with the AMPs which are placed 
in the interface between the charged head groups and the lipid tails. This can be seen in figure 
1B. Because the peptides, acting by the toroidal pore model, mainly binds to this interface they 
are more sensitive to the lipid head group charge which causes them to be more specific 
towards the negatively charged bacteria surfaces. The carpet model is in many aspects similar to 
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the toroidal pore model. The peptides accumulate on surfaces of the bacteria covering the 
membrane like a carpet until a critical concentration is reached and the curvature of the 
membrane is disrupted in a detergent like manner displacing part of the membranes and 
thereby forming small lipid micelles as is illustrated in figure 1A. AMPs acting by the carpet 
model require a higher concentration of peptide compared to the barrel-stave and the toroidal 
pore models and in some cases the method has been shown to be peptide concentration 
dependent so that at low concentrations the peptides will form pores while at high peptide 
concentrations the peptides will break down the overall structure of the membrane.[24]  
 
Figur 1 Schematic model of three general models of membrane disruption by α-helical cationic peptides. 
Hydrophobic regions of the peptides are colored red whereas hydrophilic regions are colored blue. (A) The carpet 
model where peptides cluster on the surface of the membrane in a detergent like manner which leads to a collapse 
of the membrane structure and subsequent micelle formation. (B) The toroidal model where the peptides bend the 
surface of the membrane to form pores that are lined by the peptides bound to the head groups of the lipids. (C) 
The barrel-stave model where peptides forms pores in the membrane by binding to the lipid tails with hydrophobic 
part of the peptides whereas the hydrophilic part of the peptides lines the water filled inner of the pores. Taken 
from 
[20]
 
Cationic peptides enriched for specific amino acids 
Currently more than 80 cationic AMPs enriched for specific amino acids have been 
characterized. This is a relative small number compared to some of the other classes of AMPs 
according to the Antimicrobial Sequence Database.[27] The structural properties of the peptides 
are very diverse and vary from small α-helix to extended loops.  The amino acids by which the 
peptides are enriched also vary and are highly dependent on the organisms from which they 
originate and can therefore be divided into subgroups. Some of the most well studied are the 
large group of Pro and Pro/Gly enriched peptides such as pyrrhoccoricin, apidaecin and drosocin 
that have been shown to primarily be active against Gram-negative bacteria. They are thought to 
kill bacteria by entering cells and inhibiting the molecular chaperone DnaK and not by 
perforating the membranes as it is seen for the small cationic α-helical peptides.[28] In humans a 
group of AMPs enriched for histidins, known as Histatins, has been isolated and show to target 
fungi with a high specificity compared to bacteria.[29] Furthermore are groups of Cys/Pro, 
Arg/Pro, Glu or Trp enriched peptides found in mammals where some of them show a very 
Classes of antimicrobial peptides Antimicrobial peptides 
 
15  
 
broad specificity ranging from bacteria to enveloped viruses as it is seen for indolicidin which is a 
tryptophan enriched peptide.[27, 30] 
Anionic and cationic peptides that contain cysteine and form disulphide bonds 
The group of charged peptides that forms disulphide bonds was first recognized in 1956 by RC. 
Skarnes and coworkers where leukin from rabit leucocytes was isolated and later 
characterized.[31] The group was among the first peptides with antibiotic effect that were 
identified and has later become one of the most well studied groups with members from all 
classes of organisms ranging from animals, including humans, to plants and even fungi.[32, 33] The 
largest family within the group is the defensins which are small evolutionary conserved cysteine 
rich peptides with mainly β-sheet structures which are stabilized by three, or in rare cases four, 
disulfide bridges.[32, 34] There exist three subfamilies of defensins in vertebrates called α, β and θ 
where the latter is a distinct group of cyclic peptides that were identified by Tang et al. in 
1999[35] The α- and β-defensins both consist of a triple-stranded β-sheet that are folded into a 
characteristic defensin β-sheet fold, but the pairing of the cysteins and the length of amino acids 
between the disulfide bonds varies between the two subfamilies. Clusters of positively charged 
amino acids are located in most of the α- and β-defensins but the distribution and predominance 
between either arginine or lysine varies greatly depending both on the organisms but also by 
which tissue they are secreted which makes it difficult to categorize the peptides based on these 
properties.[36] 
The highest concentrations of defensins (>10 mg/ml) are found in tissues that are continuously 
exposed to microbial infections. α-defensins are mostly stored in granules which in leukocytes 
are fused to vacuoles containing the bacteria and thereby exposing the bacteria for a very high 
local concentration of peptide.[37] Likewise releases the paneth cells in the intestine granules 
containing high concentration of α-defensins into the small pits in the lumen of the 
gastrointestinal barrier.[38] In contrast are β-defensins in humans mainly secreted by epithelia of 
several organs, including skin.[39] The means of action against bacteria and other pathogens are 
less elucidated compared to the small cationic α-helix peptides described above, but it is widely 
accepted that they mainly act by disrupting the membranes of their target cells. Dye leakage 
experiments with vesicles clearly indicate that defensins forms pore in the bilayer and that the 
pores have a maximum width of 25 Å[40], however defensins have also been shown to interact 
with a wide variety of different components in the host cells and thereby trigger an immune 
response.[32] An example of this is the fungal defensin plectasin has been shown to interact with 
the bacterial cell-wall precursor Lipid II which causes an inhibition of cell-wall biosynthesis. [41] 
Furthermore have defensins been shown to induced a release of histamine through a rapid G 
protein-dependent response in rat peritoneal mast cells.[42] 
Small peptides located in invertebrates like insects, plants and fungi that contain six or eight 
cysteins bonded by disulfide bridges are also called defensins despite that they have different 
structural properties compared to the vertebrate defensins, and despite that there are not 
found any evolutionary linkage between the two types of defensins. The structure of insect and 
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plant defensins contains typically an N-terminal α-helix that is linked to a C-terminal β-sheet 
segment through disulfide bonds going from cystein 1-4, 2-5 and 3-6.[32]  
Besides the large family of defensins, the group of AMPs forming disulfide bridges is less defined 
although many of them form β-hairpin structures and are typically grouped by the number of 
disulfide bridges in the molecules.[15] The smallest of the single disulphide bridge AMPs can be 
represented by peptides like thanatin and brevinin whereas peptides with two disulphide 
bridges can be represented by the ~2 kDa hairpin structured peptides androctonin, protegrin 1 
and tachyplesin which are found in both vertebrates and invertebrates.[43] 
Anionic peptides 
Very few anionic AMPs have been characterized compared to their cationic counterparts which 
is presumably because they are less abundant in nature due to their negative charge that 
prevents them from binding to the negatively charged bacterial membrane surfaces. The first 
anionic AMPs were reported in the early 1980s and have now been isolated from plants, 
invertebrates and vertebrates where they among other places have been found in the airway 
epithelial and in sweat glands from where the peptides are secreted into the sweat and 
transported to the epidermal surface.[44, 45] In most cases the anionic peptides appear to act by 
forming amphiphatic α-helices and subsequently interacting with and disrupting the membranes 
of the target cells despite having a net charge between -1 and -7 that presumably repels the 
negative membrane surface.[46] However, it has been suggested that these interactions may be 
facilitated by the formation of cationic salt bridges with the bacterial membranes although this 
has not been thoroughly investigated. Many of the anionic peptides require metal ions like zink 
as a cofactor in order to fold properly, but these are also likely to play a role in the formation of 
the mentioned salt bridges as well as neutralize some of the negative charges.[45]  
Anionic and cationic peptide fragments of larger proteins 
The sequential and structural properties of the protein fragments which exhibit an antibiotic 
effect overlap with many of the other groups of peptides and are therefore more difficult to 
distinguish. They are either produced by an enzymatic cleavage or by an autocatalytic reaction 
where a part of a larger protein without any related function obtains antimicrobial properties. 
For instance, a crude lysate of the bacterial strain Helicobacter pylori were searched for a 
cecropin motif but the search instead revealed that cleaved peptides from the N-terminus of the 
ribosomal protein RpL1 exhibits antimicrobial activity.[47] It has as a consequence been 
postulated that some of the Helicobacter pylori, which are located in the stomach and are 
resistant to the RpL1 derived peptides, undergo altruistic lysis that releases the AMPs into the 
gut and thereby suppresses faster growing bacteria.  
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Figur 2. Representative structures of the different groups of AMPs. (A) Structure of the linear cationic α-helical 
human peptide LL-37 PDB code: 2K6O
[48]
 (B) Structure of lactoferricin which is part of the larger protein lactoferrin 
PDB code: 1Z6V
[49]
 (C) Structure of the human α-defensin-5 PDB code: 1ZMP
[50]
 (D) Structure of insect defensin A 
PDB code: 1ICA
[51]
 (E) Structure of anionic human AMP dermcidin-1L PDB code: 2KSG
[52]
 (F) Structure of indolicidin 
which is high enriched for tryptophan PDB code: 1G89
[53]
 
Bacterial AMP resistance 
The selectivity for different types of bacteria and pathogens varies within the different groups of 
AMPs as described above. However, a number of common traits like positively charged 
membrane surface, low cholesterol content and distinctive electrochemical gradients appear to 
distinguish differences between the host cells and the bacteria. Although AMPs are naturally 
occurring and have existed alongside bacteria through evolution, bacterial resistance towards 
the peptides is not very widespread. This is likely caused by difficulties in changing the basic 
composition in the membranes without seriously affecting the viability of the bacteria. However, 
as will be described a number of instances have been reported where resistance against AMPs 
have been achieved through different mechanisms.  
The bacteria S. aureus can become resistant to defensins and protegrins by a mutation in the 
mprF gene which leads to a lysine modification of PG in the bacterial membrane. The lyso-PG 
modifications causes a significant reduction of the negative charge of the membrane surface 
which consequently reduces the electrochemical attraction of primarily cationic AMPs to the 
membrane. The mutated bacteria were therefore able to survive larger peptide concentrations 
compared to the bacteria with more anionic membranes.[54] S. aureus has furthermore 
developed resistance towards some AMPs by reducing the transmembrane potential Δψ.[55] For 
some defensins this appears to be one of the major factors for the antimicrobial activity whereas 
other highly cationic defensins are less susceptible to changes in the Δψ. Other Gram negative 
bacterial strains have obtained resistance to cationic AMPs through a different mechanism 
where polyanionic sodium alginate which is highly similar to exopolysaccharides in the secretion 
of P. auruginosa have been shown to inhibit the AMPs.[56] The very negative charged alginate 
presumably interferes with the positive peptides before they reach the bacterial membrane and 
thereby prevents the AMPs from killing the bacteria.  In Gram negative bacteria overexpression 
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of a group of genes regulates an aminoarabinose or 2-hydroxymyristate modification of lipid A 
which is one of the component of the bacterial membranes.[57] The modifications substitute a 
negative lipid A phosphate group with a free amino group and thereby changes the overall 
charge of the molecule and thereby the membrane hence reduces the AMPs affinity for the 
bacteria. Also H. influenza has been shown to reduce the membrane charge by incorporating a 
high content of phosphorylcholine bound to lipopolysaccharides (LPS).[58] As phosphorylcholine 
is rare in prokaryotic organisms but a major component in eucaryotic cell membranes the 
incorporation is presumably a method by which the bacteria further mimics the mammalian cells 
and thereby prevents getting targeted by the immune system and the AMPs. The 
phosphorylcholines importance for resistance is substantiated by its ability to decrease the 
susceptibility of different human AMPs expressed in the upper respiratory tract. [59] 
As it is seen for prokaryotic resistance to conventional antibiotics some bacteria are capable of 
expressing proteases that degrade the molecules and thereby protects the bacteria. This is 
likewise the case for AMPs where some salmonella bacteria strains have been shown to express 
the endopeptidase PgtE which is highly similar to the outer membrane protease family OmpT 
and protease VII from E. coli.[60] These proteases cleave peptides at the center of paired basic 
residues or at the carboxy side of paired basic amino acid residues,[61] and because many AMPs 
are typically highly cationic they are therefore potential targets for these proteases. These 
proteases is however not effective against all AMPs as the tertiary structure of e.g. defensins, 
protegrin or CAMPs apparently provides steric hinderers from the proteases.[60]  
Also efflux pumps are used by bacteria and fungi to obtain resistance against AMPs. This has 
been reported in several instances like the gonococcal MtrC-MtrD-MtrE efflux pump which not 
only protects the bacteria from antibiotics like penicillin but also from the human AMP LL-37.[62] 
Such efflux systems have furthermore been described in fungi where ABC type transporters have 
provided resistance to AMPs and other antifungal agents.[63] 
The use of AMPs and especially the use of analogs of human peptides like LL-37 have raised a 
serious concern that bacteria would develop resistance to these peptides which through cross 
resistance could lead to bacterial strains that are immune to humans natural defenses.[64] The 
likelihood of this happening will of course increase if breakthroughs in development of these 
peptides as therapeutics, in farming and as food preservatives provide basis for a large scale 
production. Although only few reports of AMPs resistance have been reported as described 
above, they exist and must therefore be taken very seriously because the consequences could 
potentially be catastrophic. 
AMPs as pharmaceuticals 
Despite cases of resistance against AMPs which were described in the previous section, it is 
generally considered more difficult for the bacteria to develop resistance against AMPs 
compared to conventional antibiotics. Also, there appears to be none or very limited cross 
resistance between the different peptides. This is for instance seen with treatment against P. 
aeruginosa which causes the majority of infectious diseases in cystic fibrosis patients. By growing 
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bacteria in media with sub minimal inhibition concentration (MIC) of AMPs (less-than-lethal) it 
was with over 11 subcultures not possible to induce resistance to the AMP PG-1.[65] Similar 
results were shown for a number of different peptides where it through 30 subcultures only 
were possible to induce a 2-4 fold increase in MIC to the AMPs.[66] Comparable studies with the 
broad spectrum antibiotics norfloxacin and gentamicin have in contrast showed an up to 190 
fold MIC increase.[65] Also attempts to induce resistance to the AMP pexiganan in both E. coli and 
Staphylococcus have been unsuccessful.[67] Because the microorganisms in most reported 
instances of AMP resistance are forced to change fundamental aspects of their membrane like 
reducing the overall charge, it appears that they weaken their natural defense against other 
factors. These include bile salts and some conventional antibiotics and this opens a door for 
combined treatment of infectious diseases with a cocktail of AMPs and conventional 
antibiotics.[68] Administered together this is likely to prevent or significantly reduce the 
occurrences of resistance and thereby to obtain more effective pharmaceuticals. This synergistic 
effect has been shown successful between colistin and rifampicilin in colistin resistant strains but 
until now there have not been any clinical trials of these different types of antibiotics used 
together.[68] Further encouraging results with AMPs are that they show great activity against a 
number of multidrug resistant bacterial strains like S. aureus and P. auruginosa, but also that 
they are capable of simultaneously act against a broad spectrum of pathogens in a very rapid 
manner.[66, 67]  
According to public databases the number of identified and characterized AMPs are rapidly 
growing and there does not appear to be any slowdown in the increasing rate.[27] Despite that, 
only a very limited number of candidates have gone into clinical trials and in recent years and 
even fewer of these therapeutic candidates have been approved for pharmaceutical use. One of 
the potential drug candidates Pexiganan is a synthetic analog of magainin 2 derived from the 
african clawed frog Xenopus laevis. It showed great in vitro activity against 3,108 bacterial clinical 
isolates including Gram-positive and Gram-negative microbes, and at the same time it was not 
possible to induce resistance to it in different bacterial strains.[67] However, in 1999 the American 
Food and Drug Administration (FDA) rejected an application for the use of Pexiganan as a 
therapeutic antimicrobial agent for the treatment of foot ulcers. The rejection was based on 
Pexiganans disability to outperform already existing products with the same antibiotic abilities. 
Subsequently Pexiganan has reentered clinical trials under new ownership in order to get 
approval, but presently this work has been ongoing for more than 10 years.  Also other 
promising drug candidates like Omiganan (an indolicidin), Iseganan (a protegrin) and Neuprex (a 
bactericidal increasing protein) have failed initial phase III clinical trials for treatment against 
their initially defined microbial targets. Like Pexiganan they have all reentered clinical trials with 
newly defined drug targets.[69] 
There are currently only a handful of commercial available AMP drugs on the marked. Two of 
them are Polymyxin B and Colistin (Polymyxin E) which are cyclic lipodecapeptide antibiotics that 
act by binding to the LPS in the outer membrane of bacteria and thereby destabilize it. They 
were first discovered in 1962 and were subsequently marketed as a therapeutic against Gram 
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negative bacteria.[70] In the 1970s both Polymyxin B and colistin showed to be neurotoxic and 
consequently both drugs were abandoned for use as pharmaceuticals. However, in recent years 
the rapidly growing resistance to conventional antibiotics has deemed it necessary to reinstate 
Polymyxin B and Colistin as last resort drugs against extreme multidrug resistant bacteria. 
Although significant efforts have been invested in reducing the cytotoxicity of Polymyxins there 
has not been developed any ‘second generation’ drugs. In 2003 the FDA approved the anionic 
AMP Daptomycin for treatment of complicated wounds infected by multi resistant bacterial 
strains, otherwise no new peptides have been approved for antimicrobial treatment in the 
resent years.[71] 
Despite the very limited commercial success with therapeutic AMPs so far there is still a great 
interest in developing new products from pharmaceutical companies due to the lack of 
alternatives and the continuously growing demand for new and effective broad spectrum 
antibiotics. Reasons for the lack of marketed products can be ascribed to various reasons 
although issues regarding toxicity and stability appear to be key obstacles to be addressed 
before a breakthrough can be achieved. Considerable efforts have been put into making AMPs 
less susceptible to protease degradation and one way of achieving this without losing the 
antibiotic effect could be conversion to D-enantiomers or peptoids.[72] Also, as mentioned above 
some peptide classes like defensins appear to be less affected by enzymatic degradation which 
may favor them with regards to some medical applications. Another way of reducing protease 
degradation is to make the peptides cyclic, which significantly increases their resistance and 
even in some cases increases their antimicrobial effect.[73] Cyclization can however have the very 
unfortunate effect that the peptides become more hemolytic compared to linear peptides which 
makes them unsuitable for pharmaceutical uses, however they might be interesting from other 
antibiotic perspectives.[73, 74] Many AMPs are hemolytic and especially peptides rich in 
tryptophan like omiganan and other indolicidins have this cytotoxic characteristic. Single amino 
acid mutations and introduction of arginine-trypthophan modules have been used in an effort to 
optimize the antimicrobial effect while reducing the cytotoxicity.[75, 76] Correlations between 
hemolytic effects and high hydrophobicity, high amphipathicity and high helicity have been 
shown using amino acids mutations. However, the amino acids compositions effect on hemolysis 
and cytotoxicity in general still remains to be further elucidated so that AMPs can be  designed.  
The high costs of producing AMPs compared to conventional antibiotics can be a limiting factor 
for therapeutic use of AMPs and alternatives to chemical synthesis are clearly needed. In 2005 
the Danish medical company Novozymes reported that they successfully expressed a fungal 
defensin AMP in a fungi expression system which is one way of reducing the cost of production, 
although this is not generally applicable for AMPs.[33] Another problem to overcome is the 
sensitivity to physiological salt concentration, divalent cations and mucins which are found in 
many of the target areas of the AMPs.[77] Although it is possible to modify existing AMPs to 
tolerate higher salt concentrations most peptides requires altering of fundamental properties 
like charge and hydrophobicity which is likely to influence the overall activity of the peptides. In 
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some cases it might be necessary to rethink the field of application of the AMPs and use them in 
areas with lower salt concentrations.[56] 
Other applications of AMPs  
Besides from the most obvious use of AMPs as therapeutics in the medical sector other 
industries are also using AMPs as antibiotics. The food industry has been using the bacteriocin 
AMP Nisin since it was first introduced in 1953 and was the first AMP to get the FDA notification 
Generally Recognized as Safe (GRAS).[78] Later a number of similar bacteriocins with increasing 
potential like lacticin 3147 have been marketed.[79] Nisin is a polycyclic 34 amino acid cationic 
peptide which has hydrophobic characteristics and contains a number of lanthionines and 
methyllanthionines. It is stabilized through a number of thioether linkages which are likely to 
increase its resistance against high temperature and low pH. It is fermented by lactic 
streptococci and is mainly used in dairy products where it acts against Gram-positive bacteria.[80] 
AMPs are also used as a disinfecting agent within the area of personal care where e.g. a 
synthetic cecropin is used to kill bacteria in contact lens solutions.[81] Although the industrial use 
of AMPs are still very limited compared to other antimicrobials a brief look through the public 
European patent database (ep.espacenet.com) reveals numerous patents granted for use in as 
different areas as cosmetics, hygiene products, sterilization products and feed products. It 
therefore seems probable that we within the coming years will see a much wider use of AMPs in 
household and industrial products.   
Biological membranes and membrane mimicking systems 
Phospholipids 
Phospholipids are a group of lipids and are some of the main components in all cellular 
membranes. The phospholipids are composed of four components: fatty acids, a phosphate 
group, an alcohol and a backbone which can consist of different molecular compositions and 
defines the type of the phospholipid (see figure 3). In biological systems the most abundant 
phospholipids have a glycerol backbone and are known as glycerophospholipids. Another 
biological relevant type contains a sphingosine backbone (sphingomyelin) which is only present 
in animal cell membranes and especially in the myelin sheath which surrounds nerve cell 
axons.[82] The phospholipid alcohol is covalently bound to the phosphate group and depending 
on the molecule the lipids obtain a number of different properties which are reflected in the 
several different variations of phospholipids that is seen in nature. In glycerophospholipids, the 
carboxyl group of each fatty acid is esterified to the hydroxyl groups on carbon-1 and carbon-2 
of the glycerol backbone, and the phosphate group is attached to carbon-3 by an ester link (see 
figure 3). 
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Mammalian cell membrane 
The basis for all living cells is their ability to compartmentalize and thereby to build and uphold 
the specialized environments that are necessary for the chemical processes within the cells. The 
cell wall which is also known as the plasma membrane was in 1972 described by Singer and 
Nicholson as a ‘fluid mosaic’ describing the plasma membrane of mammalian cells as a liquid 
surface wherein the membrane associated components like membrane proteins move around 
freely (see figure 4).[83] Later models have however described the membrane as more mosaic 
than fluid but the basic principles remains.[2] In mammalian cells the plasma membrane is 
typically 30 Å thick and consists mainly of various phospholipids that combined with cholesterol 
constitute approximately 50 % of the molecules.[84] The lipids are arranged in a bilayer with the 
hydrophilic head groups of the molecules facing the inner and outer perimeter of the membrane 
and the hydrophobic tails of the lipids facing each other thereby constituting the center of the 
bilayer (see figure 4). The major structural lipids in eukaryotic plasma membranes are 
sphingomyelin (SPH), phosphatidylcholine (PC), phosphatidyllinositol (PI), phosphatidylserine 
(PS), phosphatidylethanolamine (PE) and cardiolipin (CL). The composition of these lipids varies 
among the different organelles but the main constituent in all the membrane types 
(mitochondrial, endoplamatic reticulum, plasmamembrane, lysosomal membrane etc.) are PC 
followed by PE which are both zwitterionic molecules. This gives a relative neutrally charged 
membrane surface of the eukaryotic cells compared to the negatively charged prokaryotic 
surfaces which will be described in the next section.  
Bacterial cell membrane 
The plasma membrane of prokaryotes is like the eukaryotic cell membrane mainly composed of 
phospholipids and membrane proteins that enable the cells to uphold a differentiated chemical 
environment within the cells. Based on the physical properties of their cell membranes, bacteria 
can be divided into two groups known as Gram positive and Gram negative bacteria (see figure 
5). Gram positive bacteria distinguish themselves from Gram negative bacteria and eukaryotic 
Figur 3. Chemical structures of phospholipids. The phosphate is esterified at the position “A” by a compound 
bearing a hydroxyl group with some of the most abundant in the box. 
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cells by having a thick (20-40 nm) peptidoglycan layer surrounding the cell wall which provides a 
physical barrier that stabilizes and protects the bacteria from the environment.[85] This 
petidoglycan layer provides the basis for binding of a number of polymers including teichoic and 
teichuronic acids and is furthermore stainable with gram staining (crystal-violet dye) giving name 
to the group of bacteria.[86]  The method of gram staining were published by the Danish doctor 
Hans Christian Gram in 1884 as a technique for distinguishing bacteria with similar clinical 
symptoms but has later developed into the property that defines the overall characteristic of 
bacterial groups.[4] Gram negative bacteria are characteristic in that they have two lipid 
membranes enclosing the cytoplasmic in contrast to both Gram positive bacteria and eukaryotic 
cells. The two membranes are termed the outer- and inner-membrane and encompass the 
periplasmic space wherein a peptidoglycan layer much thinner (1-7 nm) than seen for Gram 
positive bacteria is placed.[85] A further distinguishing feature in Gram negative bacteria is the 
presence of a layer of LPS which covers the outer membrane of the bacteria.[87] The LPS layer is 
easily recognized by animal immune systems and will typically induce a strong immune response 
when introduced to these.[88] The enzymes responsible for the growth and maintenance of the 
LPS layer are furthermore the target for a number of different antibiotics like penicillin as 
mentioned in the Bacterial resistance section. 
 
 
The phospholipid composition of bacterial membranes differs from that of eukaryotic 
membranes and is generally more anionic. In E. coli which is a Gram negative bacteria strain, the 
most abundant phospholipid is PE, which constitutes 70-80% of the total phospholipid (both 
membranes), whereas PG (15-20%), PS (1%), and CL (<5%), a diphosphatidylglycerol, are found 
in smaller amounts.[89] The phospholipid composition of the outer membrane is slightly enriched 
in PE compared to the inner membrane.[90] Gram positive bacteria typically have a considerably 
higher concentration of PG as is seen for B. megaterium with the majority of its phospholipids 
being PG (48%) compared to PE (35%), CL (11%) and glucosaminyl PG (6%).[91] The relatively high 
concentration of PG in prokaryote cell membranes compared to in eukaryotic cells is the main 
reason for the bacterial membrane being more negatively charged. 
Phospholipids Plasma membrane 
SPH 16.0 
PC 39.3 
PI 7.7 
PS 9.0 
PE 23.3 
CL 1 
Cholesterol/Phospholipid 
(mol/mol) 
0.4 
 
 Figure 4. Lipid composition of plasma membrane from rat liver  sph (sphingomyelin), pc (phosphatidylcholine), pi 
(phosphatidyllinositol), ps (phosphatidylserine), pe (phosphatidylethanolamine), cl(cardiolipin) (adapted from 
[2]
) 
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Membrane mimicking systems  
Detergents 
Detergents are amphipathic molecules that are typically comprised of a hydrophobic portion, 
usually a long alkyl chain called the tail, attached to a hydrophilic functional group called the 
head group. They belong to a class of surface active agents (surfactants) that reduces the surface 
tension in hydrophobic/hydrophilic mixtures like oil/water by adsorbing to the interface.[92] The 
ability to detach lipids from surfaces has made detergent widely used in cleaning products but 
they are also extremely useful in protein science where they are used in a variety of applications 
like polyacrylamide gel electrophoresis (PAGE), membrane mimicking, membrane 
permeabilization, membrane dissolution, inclusion body solubilization, crystallization and many 
more. They are typically grouped by the overall charge of their head groups thus given four 
groups: anionic, cationic, zwitterionic and non-ionic. The structures of some commonly used 
detergents are shown in figure 6. 
Micelles  
Despite the detergents ability to solubilize in aqueous solutions at low concentrations the 
hydrophobic nature of the detergent tails are very energetically unfavorable for the molecules 
when they are dissolved in aqueous solutions. When increasing the detergent concentrations 
the molecules will driven by the hydrophobic effect start to self assemble and form non-covalent 
clusters in solution. The point at which the assembly commences occurs over a narrow 
Figur 5. Schematic representation of Gram negative (A) and Gram positive (B) bacterial membrane. The Gram 
negative membrane is composed of an outer and inner membrane separated by the periplasm wherein a small 
peptidoglycan is located. The Gram positive membrane consists of a single bilayer encapsuled by a thick 
peptidoglycan layer. Inspired by 
[2]
 and 
[4]
.  
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concentration range and is termed the critical micelle concentration (cmc). When increasing the 
concentration above the cmc all added detergent will go into micelles however the monomeric 
concentration of detergent will remain equal to the cmc.[93] The cmc varies depending on the 
detergent and can relatively easy be determined using a number of different methods like 
surface tension measurements light scattering or dye experiments[94],  although the latter 
method might have the unfortunate effect that the addition of dye slightly alters the cmc. When 
micelles are formed they are capable of absorbing more detergents as well as solubilizing 
hydrophobic and amphipathic molecules like proteins and lipids and thereby make mixed 
micelles. Initially the detergents will form spherical micelles, whose sizes depend on the 
properties of the used detergent, but when increasing the concentration more complex shapes 
like ellipsoidal, rod-like and doughnut shaped detergent aggregates will start to form.[95] 
Consequently the dynamical properties of the micelles will change as the tumbling rate of the 
micelles diminishes when transforming into larger aggregates. 
 
Bicelles 
Bicelles are non-covalently bound lipid aggregates consisting of a mixture of relative long chain 
lipids and either shorter chained lipids or short chain detergents.[96, 97] When mixed properly the 
long chain lipids in theory form soluble disc shaped planar bilayers where the hydrophobic lipid 
tails are shielded from the water by a rim of short chained lipids (see figure 7) thus stabilizing the 
macromolecular structure. The size of the bicelles is determined by the ratio of the long 
chain/short chain lipids (q) and the total phospholipid concentration (cL), however, they are 
typically mixed so the diameter is approximately a few hundred angstroms and the width is 
approximately 40 Å. Bicelles were initially described by Sanders and Prestegard for studying 
membrane associated biomolecules using solid state NMR[97, 98] but have later been adapted for 
studies of proteins and peptides in solution. Due to the diamagnetic properties of the lipids 
commonly used for making bicelles they spontaneously align with the lipid long axis 
Figur 6. Chemical structures of some common detergents obtained from Sigma Aldrich homepage 
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perpendicular to external magnetic fields greater than 1 T.[97] This property causes an incomplete 
averaging of anisotropic magnetic interactions which makes it possible to measure the relative 
orientation of parts of proteins and peptides as the residual dipolar couplings (RDCs) are 
dependent on the orientation against the external field and are no longer averaged out by 
isotropic tumbling.[99]  
 
Besides a widespread use in alignment media bicelles are also used as membrane mimicking 
systems because they provide a more native like lipid environment compared to micelles due to 
the more planar shape of the bilayers.[100] Furthermore, some of the micelle detergents affect 
the structure of membrane proteins whereas the much lower bicelle detergent concentration 
does not affect the protein structures to the same extent. Like with micelles it is easier to obtain 
homogeneous lipids/detergents in bicelles compared to lipid vesicles which combined with their 
smaller sizes makes them much more suitable for NMR studies.[101] 
Liposomes 
Liposomes are self-closed structures of lipid bilayers with an aqueous phase on both sides of the 
bilayer which are typically spherical and of varying sizes. Phospholipid liposomes were first 
described in the 1960s as multilamellar vesicles structures with several concentric bilayers with 
water filled gaps in between.[102] Because the lipid composition can be varied and thereby vary 
the thickness, charge and several other factors of the liposomes, it is possible to create 
liposomes which highly resemble the properties of biological membranes. Many different types 
of liposomes have been described and liposomes have been extensively used as membrane 
mimicking model systems and more recently also as drug delivery systems.[103] The most 
commonly used liposomes are unilamellar which as the name implies only contain a single 
bilayer encompassing its aqueous inside. They are typically grouped according to the diameter of 
the vesicles and named either small unilamellar vesicles (SUV), large unilamellar vesicles (LUV) or 
giant unilamellar vesicles (GUV). SUV refers to liposomes less than 100 nm but typically around 
40 nm which can easily be formed by sonicating larger multilamellar vesicles.[104] LUVs ranges in 
size from 200- 800 nm and can be prepared by pressing lipids through e.g. 200 nm pores which 
gives relative uniform sized liposomes.[105]  GUV size ranges from 5 – 200 μm and can be 
prepared using various methods depending on the desired size. Because the size of these 
liposomes is comparable with the size of many cells, many studies of membrane properties have 
been using GUVs.[106] This is further enhanced by the ability to study these liposomes using light 
Figur 7. Both micelles (left) and bicelles (right) are largely monodisperse and noncompartmentalized 
macromolecular structures consistent of either detergents, lipids or a mixtures of these.  
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microscope whereby a number of morphological changes like budding, healing, endocytosis and 
other cytomimetic processes can be observed.[107] As liposomes can be prepared with different 
aqueous solutions in and out, it is furthermore possible to measure even small disruptions of 
membrane by measuring dye leakage from liposomes where the encapsulate phase contains 
dye.[108]  
Nuclear Magnetic Resonance 
Introduction 
NMR is a very powerful technique for studying structural and dynamical properties of peptides 
and proteins, and it is currently the only method by which these can be studied in solution at 
atomic resolution. In the following a short introduction to the basic principles of NMR will be 
given.  
All atomic nuclei and electrons have an intrinsic property called spin which generates a magnetic 
field. The fields have an angular momentum associated with them and the values for these are 
according to the Schrödinger equation +½ or -½ (also denoted α and β respectively) for the most 
commonly studied nuclei (1H, 13C, 15N and 31P). When the nuclei are placed in a strong magnetic 
field (B0) the angular momentum axis coincides with the field direction of the magnetic moments 
which causes a energy difference between the α and β states. α has a z-component aligned with 
the external field and is therefore in a lower energy state than β which opposes the external 
field. This causes a population bias toward the lower energy states according to the Boltzmann 
distribution, and the energy difference (ΔE) between the two spin states is defined as: 
0E
2
h B
h

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where h is Planck’s constant,  is the frequency and  is the gyromagnetic ratio. Because the 
energy of a photon is E=h it is possible to change the spin angular momentum by applying a 
radio wave with the same energy as ΔE to the nuclei whereby the α and β states will resonate 
and the two populations equalize.[109] 
Modern NMR spectrometers can excite all nuclei in the range of interest at the same time by 
applying a radio frequency (RF)-pulse to the sample, which tilts the magnetization vector away 
from the equilibrium position along the external magnetic field. The excited magnetization 
oscillates in the xy-plane about the z-axis  creating an observable RF, and it is the frequency of 
this signal that is recorded as it returns to its equilibrium. This decay is known as free induction 
decay (FID) and is converted into a frequency spectrum using the Fourier transformation.[110]Due 
to a shielding effect by local nuclei and electrons for each nucleus, variations in the parts per 
million (ppm) scale occur in the magnetic field, and thereby in the frequencies. As a 
consequence do different structural environments give rise to different frequencies from each 
nucleus which can be observed in the NMR spectra. These variations are referred to as chemical 
(1) 
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shifts and the ppm unit is adapted due to its independence of the external field strength, which 
is very practical when spectra from spectrometers with different field strengths are to be 
compared.  
The magnetic field of neighboring non-equivalent nuclei affects each other by either through 
bond or through space couplings. Through bond connectivities (called scalar couplings or J-
couplings) arises through the transfer of magnetization between two nuclei mediated by the 
electrons participating in the bonds. They originate from either dipole interactions or Fermi 
contact interactions in cases where the electron occupies the s-orbital, and can be between 
either identical atom types (homonuclear) or different atom types (heteronuclear). The coupling 
constants are independent of the external magnetic field strength and the magnitude of them is 
typically dependent on the number of bonds separating the nuclei and the molecular geometry. 
They are denoted depending on the number on the number of bonds (e.g. 1J, 2J, 3J), and in 
protein samples couplings between nuclei separated by more than three bonds are rarely visible. 
To ease the interpretation of spectra the multiple peaks per nuclei originating from the J-
couplings are often merged into one by a decoupling pulse which refocuses the coupling.  
Local magnetic fields generated by nuclei affect one another through space without any 
contributions from the electron clouds which is known as dipolar coupling. However, in solution 
state NMR the tumbling of the molecules is isotropic and very fast on the NMR timescale which 
causes the time averaged dipolar coupling to become zero.  
Relaxation 
As mentioned above the magnetization of the nuclear spin (M) will return to its Boltzmann 
equilibrium position along the B0 axis (z-axis) after perturbation. This time dependent decay is 
caused by energy transfer between the nuclear spin and its surroundings given by the equation:  
 
where R1 is the longitudinal relaxation rate and Mz(0) is z-axis magnetization at time = 0.
[111] It is 
possible for the observable xy-magnetization to disappear without returning to the equilibrium 
along the z-axis. This is caused by the loss of phase coherence, meaning that the signals will be 
distributed equally in the xy-plane and thereby cancels out. The time dependency of this 
transverse relaxation is determined by the R2 rate constant and caused by interactions with 
neighboring spins in the sample, and is like longitudinal relaxation given by a first order 
equation: 
  
where Mxy(0) is either magnetization along the x- or along the y-axis at time = 0 and R2 is the 
transverse relaxation rate.[111] There are several mechanisms by which the nuclear spins are 
interacting with the surrounding nuclei and electrons and both intra- and inter-molecular 
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processes can lead to relaxation processes. The overall relaxation properties of nuclei can be 
defined as a combined contribution of several mechanisms: 
 
where R(DD) is the contribution from dipole-dipole interactions, R(SR) from spin rotation, R(CSA) 
from chemical shift anisotropy, R(SC) from scalar couplings, R(Q) from quadrupole interactions 
and R(e) from couplings with unpaired electrons.  
Dipolar relaxation 
For a two spin system there exists four energy levels with a total of 12 transitions (see figure 8).  
 
In systems without any paramagnetic spices or quadruple nuclei present the dominant 
relaxation mechanism for energy exchange for spin ½ nuclei is DD interactions. The DD 
relaxation is made up of two overall contributions called auto relaxation and cross relaxation 
which for two unlike spins I and S is given by the Solomon equations[112]: 
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where I and S are the auto relaxation rates and I  and S cross relaxations rates. When the 
proteins reorientate in the solution, the nuclei experience different local fields, and the 
relaxation rates are therefore dependent of the protein tumbling rates.[112]  The auto relaxation 
rates (R1 and R2) in a two spin systems (I and S) where we assume a fixed distance between the 
spins are given by[111]: 
 
R(observed)=R(DD)+R(SR)+R(CSA)+R(SC)+R(Q)+R(e)
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Figure 8. Energy levels of a two spins system consisting of I and S spin and transitions between them. Transitions 
involving a single spin flip require the energy at Larmor frequencies I or S. Transitions can also occur through 
double- and zero-quantum transitions. All transitions also exist with opposite signs.   
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where J(ω) is the spectral density functions, 0 is the permittivity of free space, . I and  S is the 
larmor frequencies of the spins and rIS is the distance between the spins. For an isotropic 
rotational diffusion of a rigid rotor or spherical top the spectral density functions are given by:  
2 2
2
( )
5 (1 )
c
c
J

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
 
where c is the correlation time which is the time for the molecule to rotate by one radian and 
therefore are dependent on molecular size, solvent viscosity and temperature.  is the larmor 
frequencies.  A rule of thumb is that c is in the order of picoseconds for small molecules and in 
the order of nano seconds for larger biological macromolecules in aqueous solutions. In all 
protein and peptide samples c>>1 which causes very low R1 rates compared to R2 rates and as 
a consequence transverse relaxation is the dominating relaxation mechanism when studying 
biological molecules. 
The dipolar interactions between nuclei causes a transfer of spin polarization from one spin 
population to another via cross relaxation which causes the Nuclear Overhauser effect (NOE). RF 
pulses with frequency ωS will equalize the αα and βα populations as well as the ββ and αβ 
populations (see figure 8). These levels will equalize through cross relaxation where (ωI + ωS) will 
populate level αα by transferring magnetization from ββ originating from βα and likewise will 
level (ωI – ωS) transfer magnetization to level βα via level αβ. The dipolar cross relaxation rate is 
given by: 
 
Because of the distance dependency of NOEs they can provide information regarding nuclei 
which are in close proximity of each other (typically only observable on distances less than 5 Å) 
and this information is of prime interest for structural studies of proteins as these nuclei may be 
far apart in the polypeptide chain.[113] 
Scalar and Quadrupole relaxation 
The scalar relaxation occur when nuclei interact through chemical bonds (J-couplings) and the 
spin I can feel the neighboring spin S in two forms. Scalar relaxation of the first kind can occur 
when values of JIS is changing due to reorientation of atoms in accordance with the Karplus 
relationship. Scalar relaxation of the second kind is for spin I dependent on the rapid relaxation 
of spin S which could be a result of chemical exchange where nuclei I and S is shifting between a 
bound and unbound state which can be seen for exchangeable protons like NH or could be cause 
by a binding to a quadrupolar nucleus.[111] The latter nuclei has a spin >½ and is characterized by 
a non-spherical distribution of electrical charges and it possesses an electric magnetic moment. 
The quadrupolar couplings are typically in the MHz range which consequently causes the nuclei 
to relax very quickly and the presence of quadrupolar nuclei will therefore typically dominate 
the overall relaxation rate if they are present.  
 
2 2 2 2
0 31
4 26
( 1)
R ( ) ( )
4
I I S
I S I S
IS
S S
J J
r
  
   

 
     
 
(9) 
(10) 
Relaxation Nuclear Magnetic Resonance 
 
31  
 
CSA relaxation and spin rotation relaxation 
Chemical shifts are defined by the magnetic shielding from the external field and chemical shift 
variations within molecules are caused by their different structural environments. These local 
fields are anisotropic and because of molecular motions the components of the local fields 
reorientates with respect to the axis of the external field which is a cause of relaxation.[111] The 
maximum CSA of a nucleus is determined by its maximum chemical shift range and CSA 
relaxation is consequently predominant for nuclei with large chemical shift ranges like 31P, 13C 
and 15N whereas CSA relaxation of protons are much less pronounced. After dipolar relaxation is 
CSA relaxation the second largest contributor to the overall relaxation properties of nuclei with 
large chemical shift ranges when quadrupolar and paramagnetic species are not present.[111]  
Spin rotation relaxation has the largest impact in small symmetric molecules and can therefore 
be neglected when considering larger biological molecules. Spin rotation interactions originate 
from rotating electronic charge distributions like methyl groups which generates a magnetic field 
which is proportional to the magnitude of the rotational angular momentum. By means that will 
not be elaborated here the generated magnetic field contributes to spin relaxation of 
neighboring nuclei.  
Paramagnetic Relaxation 
Paramagnetic species are characterized by having unpaired electrons which generate local 
magnetic field and is typically seen in free radicals or transition metal complexes. The relaxation 
mechanisms for paramagnetic relaxation are the same as for other relaxation mechanisms like 
nuclear dipolar relaxation and scalar relaxation except that the interaction is between a nucleus 
and an electron. The reason the other relaxation rates and R(e) are separated in eq. 4 is that 
although the mechanisms are the same the impact on neighboring spins is considerable 
different. Considering eq. 7 and 8 it is seen that the relaxation rates are dependent on both the 
gyromagnetic moment of the spins I and S and dependent on the spin angular momentum e.g. ½ 
for protons. Because the gyromagnetic ratio of electrons is much higher compared to that of 
nuclei (1.760 * 1011 s-1T-1 compared to 2.6752 * 108 s-1T-1) the relaxation rates in the presence of 
paramagnetic species are significantly increased which is known as paramagnetic relaxation 
enhancement (PRE). Furthermore does many widely used paramagnetic species like Gd3+, Mn2+ 
and Ni2+ have a spin angular moment different than ½ ( 572 2,  and 1 respectively) which also 
increases the relaxation rates.  
The initial way of describing paramagnetic relaxation was formulated by Solomon, Bloembergen 
and Morgan in the 1950s and 1960s.  Solomon first described the paramagnetic relaxation as a 
pure dipolar relaxation[112] and later J-couplings (scalar relaxation) and relaxation properties for 
higher spin numbers were added to the equations in collaboration with Bloembergen and 
Morgan.[114] The Solmon-Bloembergen-Morgen equations make a number of assumptions like 
assuming a fixed distance between spin I and spin S which limits the theory.  
For describing the relaxation properties of non fixated paramagnetic species like contrast agents 
it is necessary to divide the overall paramagnetic relaxation rate into three separate 
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contributions namely inner sphere, outer sphere and second sphere relaxation. Inner sphere 
represents the relaxation contribution for the nuclei directly bound to the paramagnetic species 
whereas outer sphere represents the relaxation occurring due to dipolar interaction between 
nuclei and electrons with unrestricted relative molecular motions, typically occurring with 
solubilized paramagnetic agent (see figure 9). 
 
Inner sphere relaxation is typically the most important contribution to the overall paramagnetic 
relaxation rate and the predominant amount of data recorded on soluble Gd3+ chelates have 
been analyzed using inner sphere theory (Solmon-Bloembergen-Morgen theory).[115] The 
longitudinal relaxation rates are given by: 
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where J is the electronic spin, r is the distance between the electron and 1H spin, gJ is the Lande 
factor, B is the Bohr magneton, R is the complex correlation time, A/ħ is the electron nuclear 
hyperfine coupling constant, T1e is the electron relaxation and M is the lifetime of the 
intermolecular adduct. It should be noted that the first part of the equation originates from 
dipolar relaxation whereas the latter part originates from scalar couplings.  
Outer sphere relaxation account for approximately 40 % of the relaxation of monoaquo Gd3+ 
complexes and  originates from dipolar modulations when spins diffuse within proximity of each 
other. The longitudinal relaxation is described as[1]: 
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Figur 9. Schematic representation of the three relaxation spheres surrounding paramagnetic Gd wherein relaxation 
of the spin S is defined by inner sphere (gray circle), second sphere (white circle) and outer sphere relaxation (area 
outside the circles) occurs. Inspired by
[1]
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where COS is a constant (5.8 * 10-13 s-2M-1) and the non-Lorentzian spectral density function 
contain the dependence on S. At the magnetic fields of interest it depends primarily on the 
distance of closest approach a (see figure 9), related to the molecular dimension and charge 
distribution of the complex, and on the relative diffusion coefficient of solute and solvent D.  
To fully describe the paramagnetic relaxation mechanisms the second sphere relaxation 
mechanism has been introduced. This relaxation mechanism contributes to the overall 
relaxation mechanism when the spin S is fixated at the paramagnetic electron for longer time 
than the diffusional correlation time d which is seen when chelated paramagnetic complexes is 
non-covalently bound to the nuclei through hydrogen bindings. The relaxation rate theory of 
second sphere relaxation are identical to that of inner sphere relaxation if the lifetime of the 
interactions is long compared to the time required for the affected nuclei and the chelated 
paramagnetic agent to diffuse past each other.[115] Because there is not covalent bonds between 
the spins the rate constant equations differ in that there is no relaxation through scalar 
couplings:  
 
Structural determination of proteins and peptides 
Homonuclear spectra 
As the name implies does homonuclear spectra transfer magnetization between nuclei of the 
same kind which almost exclusively is protons. Homonuclear spectra provided the basis for the 
first structural determination of proteins and peptides using NMR and are still widely used for 
this purpose. Three of the most common types of spectra will briefly be discussed in the 
following and the content of this section is based on the textbooks by Wüthrich et al.[110] and 
Cavanagh et al.[111] 
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Correlation spectroscopy (COSY) spectra is the simplest form of two dimensional NMR spectra 
with only two RF pulses separated by an evolution time wherein magnetization is transferred 
from one nuclei to a neighboring homolog nuclei through scalar bonds. It is possible to observe 
correlations through three bonds and the information provided can play a very important role 
for resonance assignments of small chemical molecules, peptides and even small proteins. 
Because the diagonal and cross peaks differ in phase by 90o it is not possible to phase the signals 
so that both are simultaneously absorptive which can cause problems with spectral overlap due 
to broad signals. However, by applying an extra RF pulse at the end of the pulse scheme it is 
possible to only select double quantum coherences whereby all peaks in the spectra have the 
same phase. Double quantum filtered (DQF) COSY spectra are consequently by far the most 
widely used type of COSY spectra. 
Total Correlation spectroscopy (TOCSY) transfers magnetization through scalar couplings. 
Isotropic mixing transfers magnetization between coupled spins which typically are separated by 
up to five bonds although in polypeptides it is only possible to seen connections within the 
amino acids of the spin. All peaks in TOCSY spectra are absorptive and in-phase in both 
dimensions in contrast to DQF-COSY spectra which give dispersive signals. The TOCSY spectra are 
extremely important for successful resonance assignment in non-isotope labeled polypeptides 
and is often used together with DQF-COSY spectra for initial identification of spin-systems.   
Nuclear Overhauser Effect spectroscopy (NOESY) spectra transfers magnetization through space 
via cross relaxation as described in the section dipolar relaxation. Because dipolar couplings are 
dependent on the inverse sixth power of the distance between the two spins it is possible to 
obtain information regarding which spins is within approximately 5Å of each other in space but 
not necessarily close to each other in the amino acid sequence of the polypeptide. This 
information is of the utmost importance when determining the secondary and especially the 
tertiary structure of proteins and peptides. 
Heteronuclear spectra 
For large proteins (typically >10 kDa) the amount of signals will in 2D homonuclear spectra 
typically reach a level where spectral overlap is inevitable which makes it impossible to assign all 
signals and consequently determine the structure. To overcome this problem it is possible to 
record heteronuclear spectra wherein magnetization is transferred between different types of 
nuclei, typically protons and nitrogen or carbon. These types of spectra increases the obtainable 
amount of information, makes it possible to add extra dimensions e.g. 3D, 4D and through 
advanced pulse sequences makes it possible to selectively record spectra with different types of 
couplings which all aides the process of assigning the signals. Because both the predominant 
isotopes of nitrogen and carbon are not spin ½ it is necessary to isotope label the proteins with 
the appropriate isotopes depending on the spectra one wants to record (13C and 15N in the case 
of carbon and nitrogen). Because the natural abundance of 13C is 1.1% it is however possible to 
record spectra on samples that are not enriched with the isotope although it takes considerable 
longer time.  
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Heteronuclear single quantum correlation (HSQC) spectra transfers magnetization from protons 
to typically 15N or 13C through scalar couplings and after an evolution time the magnetization is 
transferred back to the protons and a FID is recorded. HSQC spectra are widely used because 
they provide a great dispersion of the signals and because of the simplicity of the spectra due to 
the relative low amount of signals (one pr. amide group in 1H,15N-HSQC spectra of proteins).  
Structure determination strategies 
Although different approaches for structural determination of proteins and peptides exist, the 
general strategy were first developed by Kurt Wüthrich and coworkers[110]. For proteins and 
peptides the first step is the recording of correlation spectra from which sets of signals belonging 
to the same amino acids can be defined and the type of spin systems can be identified. Secondly 
the signals are assigned to specific residues in the predetermined primary sequence based on 
through space connections obtained from the NOESY spectra aided by knowledge about the spin 
systems obtained from the correlation spectra. Following the resonance assignment the 
remaining NOEs are assigned providing information about interresidual connections and atoms 
within close proximity of each other. NOEs are subsequently integrated and the volumes are 
converted into distance restraints which are used as input for structure calculation programs. 
Additional input can be obtained from chemical shift values as these contain information 
regarding the torsion angles in the backbone of proteins.[116] Also RDCs and psedo constact shifts 
can be used as restraints in structure calculations however these will not be discussed further in 
this thesis. The first set of calculated structures is used to evaluate the NOE assignments based 
on a error function defined by the structure calculation programs which typically is based on the 
calculated structures fulfillments of factors like torsion angles and steric overlap.[117] After 
cleanup of the NOEs a final set of structures are calculated and typically the 20 structures 
fulfilling the target function the best are selected and energy minimized.  
Pseudoatoms      
It is not possible from normal homo- or heteronuclear spectra to distinguish between chemically 
nonequivalent, diastereotopic proton signals bound to the same nucleus as it is seen for 
different carbon-hydride groups in amino acid side chains. Consequently is it not possible to 
stereospecific assign the signals hence use them for structure calculations even though they can 
provide important information for the structure calculations. To overcome this problem pseudo 
atoms have been introduced which are hypothetical atoms with no mass placed at the center 
between the non assignable protons.[118] When volumes of the integrated NOEs are converted to 
distances the distance is then calculated to the pseudo atoms instead of the protons. However, 
because the distance to the protons is only rarely the same as to the pseudo atoms it is 
necessary to correct the calculated distance with the maximum distance between the pseudo 
atom and the protons which is the largest possible error. Although this prevents violations in the 
structure calculation it also introduces an unwanted uncertainty as the introduced error in most 
cases is much lower than the pseudo atom correction accounts for. 
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It is therefore desirable to stereo specifically assign as many protons as possible which can be 
done using various computational and experimental methods. For some amino acid types (valine 
and leucine) it is possible to stereospecific assign the protons by using fractional 13C labeling 
combined with knowledge of the biosynthetical pathways.[119] Other labeling schemes rely on 
selectively deuterating glycine and leucine protons whereby stereospecific assignment can be 
made.[120] A completely different approach is to analyze the local conformation around 
methylene groups which can be done either manually[121] or systematically using grid searches in 
combination with preliminary structures[122] Furthermore, C,H and H,H dipolar couplings can be 
used for determining the stereospecificity of CH2 groups provided that additional structural 
information is known.[123] Software programs which have been developed by Peter Güntert and 
coworker are additional methods of determining the stereospecific assignments of amino acid 
sidechain protons which relies on scalar couplings in combination with NOEs (HABAS) or 
diastereotopic substituents based on distance restraints and calculated structures (GLOMSA).[124, 
125] 
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Discussion of papers 
Paper I, II and III 
This section elaborates on Paper I (Quantitative Use of Paramagnetic Relaxation Enhancements 
for Determining Orientations and Insertion Depths of Peptides in Micelles), Paper II (Divorcing 
folding from function: How acylation affects the membrane-perturbing properties of an 
antimicrobial peptide) and Paper III (Structural studies of amphibian antimicrobial peptides in 
micelle and bicelles phospholipid environments), which describes the results of the thesis work 
performed on peptides interaction with membrane mimicking detergents and lipids using 
solution NMR. The overall purpose of this study was to investigate how peptides and especially 
peptides with antimicrobial properties interact with membranes, and to achieve this we used 
the peptides novicidin, novispirin, acylated variants of novicidin, citropin and maculatin as model 
systems. Common for the peptides we used is that they all originate from naturally occurring 
AMPs where they act as first line of defense against microbes in epithelia of their respective host 
organisms. They are furthermore all members of the group of linear cationic α-helical peptide 
described previously hence the structural properties of the peptides are very similar. Their net 
charge at physiological conditions ranges from +2 and +3 for maculatin to +6 for novispirin, 
novicidin and they all have an amphipathic nature when structured.    
Novispirin, novicidin and acyl-novicidin are all derivatives of ovispirin which again is derived from 
the larger AMP SMAP-29 from sheep. Ovispirin has the very unfortunate property that it is highly 
cytotoxic to human epithelial cells and hemolytic for human erythrocytes which clearly limits its 
use as therapeutic in humans.[126] In a pursuit to reduce these characteristics, single amino acid 
mutations were carried out by Sawai et al. and the result of this work showed a promising 
reduction of hemolytic behavior without compromising the AMP effect of the peptide in the 
derived group called novispirins.[75] The efficiency of novispirin has been significantly improved 
through point mutations where the mutation of Gly18 to Phe18 has decreased the MIC against 
the gram positive bacteria L. monocytogenes and S. aureus from 0.125–128 μg/ml to 0.031–32 
μg/ml.[127] This novispirin derivative is known as novicidin and it retains the relative low 
hemolytic effect as observed from novispirins.  
In paper I we used the two model peptides novicidin and novispirin for studying interactions 
between members of the linear cationic α-helical peptide group and model mimicking 
dodecylphosphocholine (DPC) micelles. DPC titration experiments with the peptides using far 
ultraviolet (UV) circular dichroism (CD) were recorded prior to the recording of the NMR spectra 
(figure 10). These spectra revealed in agreement with previous studies[128] that neither of the 
peptides exhibited any secondary structure in buffer solutions or with DPC concentrations below 
cmc (1.1 mM). At DPC concentrations just exceeding cmc value the circular dichroism (CD) 
signals at 208 and 222 nm shifted towards negative values for both the novicidin and novispirin 
samples, clearly indicative of α-helix formation. NOESY spectra of the peptides in pure buffer 
solution showed very sharp signals for all amino acids which are typically seen for peptides with 
high flexibility (low c values), often seen in unstructured proteins and peptides. Furthermore 
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were water exchange peaks seen for all HN peaks reflecting the exposure of the amide protons 
toward the solvent. Upon addition of DPC the lines broadened and new cross peaks 
characteristic of α-helix occurred (e.g. i, i+3) whereas exchange peaks for a number of amino 
acids disappeared, all clear signs of micelle binding. The proton signals of both novispirin and 
novicidin dissolved in DPC micelles were manually assigned with the aid of standard sets of 
homo/hetero nuclear spectra, and the subsequently calculated structures revealed as expected 
two highly identical α-helices spanning the entire length of the peptides (see paper I, fig 2).  
Likewise the structure of c16-novicidin was determined in DPC micelle solutions from which it 
was seen that the N-terminal attached acyl chain(s) does not affect the structure of novicidin 
(see paper II, fig 8). Although the structures of novicidin, novispirin and acyl-novicidin were 
almost identical the antimicrobial effects of novicidin are considerable higher than that of 
novispirin as mentioned above.  
 
So far no one has been able to formulate the optimal characteristic for AMPs with respect to 
high antimicrobial activity and low cytotoxic effect – perhaps because they in some aspects 
contradict each other. However, the activity of the peptides are most likely made up of five 
different factors; charge, conformation, amphipathicity, hydrophobicity and polar angle (see 
figure 11)[3] 
 
Figur 11. Interrelationship between relevant factors influencing the activity of AMPs. Adapted from
[3]
     
Figure 10. Far-UV CD spectra of Novispirin and Novicidin in the presence of varying amounts of DPC. From the local 
minima induced at 208 and 222 nm it is clear that DPC induces α-helix formation in both peptides. 
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It has been suggested that the helicity of peptides plays a major role in the activity of the group 
of linear cationic α-helical peptides[20, 129] however it is clear from our structural determination of 
novispirin, novicidin and acyl-novicidin that the difference in AMP activity between these 
peptides is not caused by this factor. Exchanging a Gly to a Phe does not affect the charge of 
peptides and it is therefore in our case not this factor affecting the activity either. The remaining 
three factors are in the case of novispirin and novicidin overlapping as the mutation to the more 
hydrophobic Phe increases the hydrophobicity, changes the polar angle and makes the 
amphipathicity more pronounced. Pathak et al. suggest that increased amphipathicity has a 
larger positive impact on the AMP activity than the hydrophobicity.[130] As calcein release studies 
from GUV’s upon exposure to novicidin and acyl variant show (paper II, fig 3), increasing the 
hydrophobicity by attaching an acyl groups to the peptide actually deteriorates the activity of 
the peptides. This effect appears to be more pronounced with the longer and more hydrophobic 
c16 acyl chain than the c12 and especially the less hydrophobic c8 chain (paper II, fig 3). This is in 
contrast to previously published studies of acylated peptides which have shown that the 
aggressiveness of AMPs is correlated with the length of the attached carbon chain[131] and that 
the chain length correlates with the membrane permeabilizing ability so that the activity is 
increased by the added hydrophobicity.[132] By titrating micelle embedded novicidin and acyl 
novicidin with the paramagnetic probe gadolinium-diethylenetriaminepentaacetic acid 
(Gd(DTPA-BMA)) it was possible to qualitative asses that the acylated and more hydrophobic 
peptide variant was deeper inserted into the micelles than the wild type (paper II, fig 8). 
However, the acylation of novicidin increases the concentrations needed for vesicle disruption, 
and furthermore leads to a decreased preference for zwitterionic vesicles compared to partially 
anionic vesicles (see paper II, fig 3). There is no obvious explanation for this reduced membrane 
disrupting abilities, however it can be speculated that the acylated novicidin variants help 
retaining the overall composition of the membrane (paper II). The polar angle is a measurement 
of the relative proportion of polar versus nonpolar facets of an AMP conformed to an 
amphipathic α-helix. A smaller polar angle, and therefore a greater hydrophobic surface, is 
associate with an increased capacity to permeabilize membranes.[3] However, as both novispirin 
and novicidin have an α-helical amphipathic structure and therefore do not have any large 
sequentially combined hydrophobic areas, the introduction of a single hydrophobic amino acid 
does not change the over polar angle noticeable and this cannot account for the MIC difference 
between novispirin and novicidin either. 
For a better understanding of the peptides interaction with the model membranes we sought to 
develop a method by which we could obtain high resolution data without costly isotope labeling 
of the peptides which would allow for recording of RDCs (paper I). Prior to our work a method 
for estimating peptide orientation and immersion depth based on titrating micelle bound 
peptides with chelated paramagnetic Gd3+ was developed by Zangger and co-workers.[133] They 
expanded the use of Gd(DTPA-BMA), which were first used by Ottinger et al.[134] for studying 
proteins, to be used for obtaining PRE values of micelles embedded peptides. However, their 
method did only encompass perfectly straight helices and because the tilt angle and orientation 
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were fitted to the combined PRE values the method was vulnerable to PRE value errors from 
single amino acids.  
We adapted the use of Gd(DTPA-BMA) for measuring PRE values of micelle bound peptides from 
Respondek et al.[133] but our method differs to theirs in all other aspects. By determining the 
distances between the center of a micelle and the peptide atoms we were able to retrieve 
information concerning both the insertion depth and the relative orientation based on 
independent calculation for each atom.  However to get to this point we first had to calculate a 
correlation function between PRE values and distances (within the micelles)(paper I, fig 1). DPC 
micelles were titrated with Gd(DTPA-BMA) and all unambiguous signals were assigned and PRE 
values measured. Distances between the micelle center and the assigned DPC atoms were 
averaged from an ensemble of MD simulated micelles and plotted as a function of the PRE 
values from which we could fit the distance to a r-3 dependent curve(paper I, fig 1). With the 
calibration curve in hand we could, based on the assumption that the calibration curve were 
transferrable between DPC and peptides atoms, calculate distances between micelle centers and 
peptides atoms (paper I, fig 4 and paper III, fig 4). Subsequently, we applied the calculated 
distances between the peptide atoms and the center of the micelles as low weighted distance 
restraints to the structure calculation program CYANA[117] along with the previously NOE and 
torsion angle derived constraints and recalculated the structures of novispirin, novicidin, citropin 
and maculatin. The outcome contained not only the high resolution structures but also data 
regarding the exact placement of the peptides in the micelles (paper I, fig 5 and paper III fig 5). 
Direct comparison of novispirin and novicidin showed that the C-terminal part of novicidin was 
buried deeper in the micelles compared to that of novispirin, and because the C-terminal end of 
novicidin is more hydrophobic compared to novispirin due to the Gly to Phe substitution, the 
result is highly probable. It was furthermore seen that novicidin was rotated slightly around the 
helix axis compared to novispirin. The effect of this from a biological perspective (if any) is 
however not clear. 
The two amphibian AMPs maculatin and citropin did like novispirin and novicidin only fold in the 
presence of amphipathic molecules and their structure was consequently solved in DPC 
solutions revealing two α-helices. They were chosen as model systems because of the results 
from Ambroggio et al. that by using differently sized fluorophores elegantly showed that 
maculatin formed pores in GUVs whereas citropin destroys the overall structure of the bilayers 
through the AMP carpet mechanism.[135] We therefore speculated that we based on differences 
in PRE curves obtained from titration with Gd(DTPA-BMA) and a polylysine dendrimeric form of 
24 gadolinium-tetraazacyclododecanetetraacetic acid complexes (24Gd(DOTA)) in micelles and 
bicelles would be able to distinguish between peptides acting by pore formation and peptides 
acting by the carpet mechanism. Because the Gd(DTPA-BMA) titration of maculatin and citropin 
were conducted using the same DPC concentration and buffer conditions as in paper I the 
PRE/distance calibration curve was directly transferrable (paper III). The calculated distances 
between the micelle centers and citropin and maculatin atoms revealed that both peptides were 
placed at the surface of the micelles in the zwitterionic buffer/detergent interface (paper III, fig 
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5). Since the geometry and size of micelles are completely different than bilayers it is not 
surprising to find maculatin near the surface of the micelles.  We therefore wanted to conduct 
Gd(DTPA-BMA) titration experiments with the peptides dissolved in bicelles hoping that the 
more planner lipid bilayer would enhance the formation of membrane penetrating pores in the 
case of maculatin (paper III, fig 2) . The PRE curves of citropin were as expected highly 
comparable with almost identical maximal values in DPC micelles and anionic 
DMPG/DMPC/DHPC bicelles. Much to our regret we were not able to record any titration curves 
with maculatin dissolved in anionic bicelles due to low stability. We therefore conducted the 
titration experiments in zwitterionic DMPC/DHPC bicelles which did not exhibit the same signs of 
instability. The maximum PRE values for maculatin in DMPC/DHPC bicelles showed a great 
resemblance with the PRE values in DPC micelles when titrated with Gd(DTPA-BMA) implying 
that the peptide is positioned at the surface of the bicelles. The PRE values of maculatin in 
DMPC/DHPC bicelles titrated with 24Gd(DOTA) were much more ambiguous and left much room 
for speculations. However, when comparing the maximal PRE values with the values from the 
micelle titration similarities are seen which suggests that the peptides is located at the surface of 
the bicelles as well. Previous publications have reported different lipid binding properties of 
maculatin depending on the charge of the lipids where maculatin appears to be located near the 
surface of zwitterionic bilayers and more deeply buried in anionic bilayers.[136] Due to the 
stability differences between zwitterionic and anionic bicelles when maculatin is present it is 
clear that the peptide interacts differently with the two types of bicelles as they without 
maculatin present do not show any signs of instability. It furthermore seems perfectly logical 
that maculatin destroys the overall composition of bacteria-like membranes due to its very 
nature as an AMP. Therefore, to study peptides inserted perpendicular to the surface of the 
membrane on a timescale suitable for NMR studies it is crucial to find a peptide without any 
membrane disrupting properties.   
As seen from eq. 17 the transverse dipolar relaxation rate hence the PRE value depends on the 
rotation of the interacting nuclei/electrons (c), and consequently can PRE values not be 
uncritically compared between nuclei with different correlation times. When PRE is plotted as a 
function of R (paper III, fig 3) it reaches its maximum at 0.3 ns with lower relaxation rates for 
both faster and slower correlation times. Because the correlation times for DPC and the peptides 
are slower and faster than 0.3 ns respectively the relaxation rates are by coincidence very similar 
(63 s-1 for DPC compared to 62, 66 and 73 s-1 maculatin in bicelles, maculatin in micelles and 
citropin in micelles, respectively) despite the large deviation in R (see figure 3). Furthermore, 
because the calculated distances are dependent on the inverse third power of the relaxation 
rates the differences become negligible whereby the PRE values between DPC and the peptides 
can be directly compared. It is therefore in our case valid to use the PRE values obtained from 
DPC to produce a distance to PRE correlation curve usable for calculating distances between the 
solution (the paramagnetic agents) and micelle embedded peptides. 
Paper IV Discussion of papers 
 
42  
 
Paper IV 
This section elaborates on Paper IV (Stereospecific assignment of protein NMR resonances using 
paramagnetic environment relaxation enhancements), which describes the results of the thesis 
work regarding stereospecific assignment of protons in peptides and proteins. 
Only very few techniques can provide high resolution structural information of proteins and 
peptides. This limited group consists of X-ray crystallography, computational chemistry and NMR 
spectroscopy. Where X-ray crystallography has played a dominating role in structural 
determination of proteins and protein complexes, problems with crystallizing small peptides 
have made this technique inadequate for this type of studies. Although various methods like 
attachment to fusion proteins have made peptide crystallization possible it remains a 
troublesome way of determining peptide structures.[137] Computational studies of peptides are 
becoming more and more widespread and the ever growing available computer resources 
combined with increasingly sophisticated software makes these calculations valuable. However, 
simulation studies will always only be as good as the input and the results will presumably 
always suffer from a certain amount of mistrust caused by the lack of experimental evidence.  
Since the first structure determination techniques using NMR spectroscopy was pioneered by 
Wüthrich and coworkers in the 1980s one of the main assets of NMR has been the capability to 
study small proteins and peptides in solution.[113] Isotope labeling of proteins and advanced 
pulse schemes like TROSY have over the years significantly extended the size limit of proteins 
which are amenable to NMR solution structure analysis.[113] However, the predominant part of 
the structures determined by NMR are still peptides and small proteins.  
The overall purpose of our study was to make it possible to improve the resolution of calculated 
structures within the limits of the existing structural determination approaches. As a model 
peptide we chose a 40 amino acid residue defensin named plectasin whose structure has 
previously been published.[33] We assigned all ambiguous proton and carbon cross peaks from 
COSY, TOCSY, NOESY and 1H,13C-HSQC spectra based on the published resonances[33] and 
subsequently calculated the structure based on distance restraints obtained from NOEs and 
torsion angle constraints obtained from chemical shifts. The calculated structures of the peptide 
did highly resemble the previously published structure as expected (paper IV, fig 1). 
We then recorded an inversion recovery 1H,13C-HSQC spectra from which we could determine 
the T1 relaxation times of all ambiguous cross peaks. However due to spectral overlap in the low 
ppm range the number of proton signals with measurable relaxation times were primarily Hα and 
Hβ side chain atoms which typically have relative higher ppm values compared to Hγ and Hδ. As 
the T1 relaxation times can be obtained from a multitude of different types of spectra, problems 
with spectral overlap could to some degree be overcomed by recording different types of 
spectra. We titrated the protein sample with the chelated paramagnetic agent Gd(DTPA-
BMA)[134] and recorded a inversion recovery spectrum and measured the T1 relaxation times for 
each titration point. Because the increased relaxation rate induced by Gd3+ are dependent on 
the inverse third power of the distance to the affected atoms we could compare PRE values of 
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the peaks originating from stereo pairs relative to each other (paper IV, tab 1). The nuclei with 
the relative highest values must necessarily be closest to the solvent containing the 
paramagnetic agent as the dynamical properties of the protons are the same because they are 
bound to the same carbon. However it is not possible to compare the PRE values between the 
stereopairs as the dynamics in side chains and throughout the peptides can vary and PREs as 
elaborated above varies with c.  
To use the relaxation rate information in the structure calculations we had to correlate the data 
with the initially calculated structure ensemble. Unless stereo specific assignments are given to 
CYANA in the input file the program will base its calculation on distances to pseudoatoms placed 
between stereo proton pairs.  We assumed that Gd(DTPA-BMA) could take the same positions as 
water surrounding the peptide except from a 5.9 Å shell where steric hindrance of the chelate 
prevented the Gd3+ to enter. This is an assumption previously described by Zangger and 
coworkers.[138] By computer simulating water around the calculated ensemble of peptide 
structures we obtained information about which of the protons were placed relative closest to 
the solvent hence the paramagnetic agents. As the 20 calculated structures deviated slightly and 
the relative orientation of the protons therefore deviated in some instances we only selected 
stereo pairs with consensus in 90% or more of the structures. It was then straight forward to 
correlate the peaks with the largest change in relaxation rate with the protons closest to the 
solvent and provide this information as stereospecific assignments in CYANA. The resulting 
structure calculated yielded a structural ensemble with a much lower RMSD compared to the 
structure calculated without the input of the stereo assignments (paper IV, fig 1). This resolution 
improvement is in agreement with previous studies that likewise have reported lower RMSD 
values after employing stereospecific assignments.[122, 124, 139] The software programs HABAS and 
GLOMSA developed by Peter Güntert and coworkers provides stereo specific assignments based 
on scalar couplings, NOEs and distance restraints and does not require any additional input to 
the structure calculations programs than otherwise would be provided. They are therefore easy 
to implement in structure determination protocols and are consequently very extensively used. 
However, they are not capable of providing a complete assignment of the stereopairs and can 
therefore be supplemented by e.g. the method developed in paper IV.  
Our method differs to most other methods for stereo specific assignments in that it do not 
requires any time consuming advanced isotope labeling schemes which often will be out of 
proportions with the importance of structure calculations of small proteins and peptides. 
However, because the structure of many small proteins and peptides are determined by NMR 
there is still a need for developing methods that can complement and improve the calculated 
structures, although the main focus in the NMR community have shifted towards much larger 
systems.  
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Part II 
Structural studies of autotransporters 
Introduction 
Outer Membrane Proteins 
The cell membrane of Gram negative bacteria consist of two phospholipid bilayers divided by a 
periplasmic space containing a relative small peptideglycan layer (see section Bacterial cell 
membrane and figure 5). The two lipid membranes are termed the outer membrane and inner 
membrane. Besides from LPS there is a substantial amount of proteins in the outer membrane of 
bacteria and in E. coli approximately 50 % of the membrane mass is estimated to originate from 
proteins.[140] Studies have shown that from a quantitative perspective the outer membrane 
proteins (OMPs) in E. coli are largely made up of only four constituent; OmpA, OmpF, OmpC and 
OmpX.[141] However, a multitude of other proteins are expressed although to a much lesser 
extent.[142] The structure of the proteins in the outer and inner membrane differs considerably. 
Proteins in the inner membrane are typically membrane spanning in the form of hydrophobic α-
helices whereas integral OMPs are typically antiparallel β-strands that fold into cylindrical β-
strands. These OMPs are amphiphatic structures with hydrophilic interiors and hydrophobic 
residues facing the lipid tails of the phospholipids.[140] In contrast to the inner membrane the 
outer membrane are not energized by a proton gradient and ATP is not present in the periplamic 
space. Consequently are most transport across the outer membrane passive diffusion via the 
OMPs which allows for non-specific passage of typically small hydrophilic compounds (<600 
Da).[143]  
X-ray crystallography have played a dominating role in structural determination of proteins and 
protein complexes, however inherent problems with crystallizing lipid and detergent imbedded 
proteins have meant that this technique until now have been very inadequate for this type of 
studies. Crystallization studies of small nano-discs have show promising results although the use 
of these has been sparse and remain to prove themselves for a wider use.[144] Solid state NMR 
have long been proposed as a leading candidate for solving the structures of membrane protein, 
although considerable improvement must be made to spectral resolution before the method can 
really fulfill its potential.[145] For solution state NMR the dominating obstacle for structural 
determination of membrane proteins is the dramatic size increase when proteins become 
imbedded into membrane mimicking systems where even small micelles adds approximately 20 
kDa to the overall weight of the proteins. This causes the overall correlation time to go up 
whereby the relaxation rate goes up according to equation 7, 8 and 9. A number of different 
NMR methods have been developed for studying larger protein systems and membrane proteins 
which have effectively pushed the envelope of what can be studied. The most significant 
improvements have been achieved through the application of transverse relaxation-optimized 
spectroscopy (TROSY)[146], RDCs[147], spectrometer hardware improvements and more or less 
advanced isotope labeling schemes.[148] Despite these improvement and tremendous amount of 
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work, the structures of only 7 unique membrane β-barrels have been solved using NMR until 
now (http://www.drorlist.com/nmr/MPNMR.html).    
Autotransporters 
Autotransporters are a growing family of OMPs frequently found in pathogenic Gram-negative 
bacteria.[149] They consist of a signal peptide, a passenger domain and a C-terminal called the β-
domain.[150] The signal peptide direct the inner membrane transport of the pro-protein where 
the C-terminal β-domain is then inserted into the outer membrane. It adapts a -barrel structure 
through which the passenger domain can be transported to the extracellular space before it is 
cleaved of by an autocatalytic mechanism.[151] Thus all information necessary for secretion across 
the outer membrane is contained within a single polypeptide in contrast to other bacterial 
secretion systems. The β-domains are generally between 250 and 300 amino acid residues long, 
and are typically highly homologous in contrast to the passenger domains that varies greatly 
both with respect to sequence, structure and biological functions although all of them are 
implicated in virulence.[149] The structure of five different passenger domains have been solved 
using x-ray diffraction and they reveal different structural properties which is not surprising 
considering their functional diversity (see figure 12).[152] However, common for them is the 
presence of either β-helices or β-rolls which also has been predicted to be a general trait for 
autotransporters.[149] 
 
Figur 12. Crystal structures of autotransporter passenger domains on the top and β-barrel structures below. 
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Crystal structures of four autotransporters β-domains have been solved of which one is part of a 
full-length autotransporter (EstA).[140, 151, 153] All of them reveal a 12 stranded anti parallel β-
barrel structure with the strands tilted approximately 45o which are typically seen for OMPs (see 
figure 12).[152, 154] A unique feature which is seen in all of the autotransporter β-domain 
structures are the presence of an α-helix positioned within the barrel lumen to which it is 
connected through hydrogen bonds.[151] Because the α-helix remains within the barrel 
subsequent to cleavage it has been speculated that it acts as a plug preventing undesirable influx 
or efflux from the bacteria after separation from the passenger domain.[151] 
AIDA 
Adhesin involved in diffuse adherence (AIDA) is an afimbrial adhesion protein and a member of 
the autotransporter family. By presenting the passenger domain on the surface of certain 
pathogenic strains of E. Coli the bacteria become capable of adhering to the intestinal lining and 
thereby to colonize the gut. This can cause diarrhea that contributes significantly to the high 
mortality rate among infants in developing countries.[155] AIDA furthermore possesses a major 
role in the development of diarrhea in piglets and studies have shown that more than 25 % of 
porcine E. coli isolates contain the AIDA operon.[156] 
AIDA is synthesized as a pre-pro-protein consisting of 1286 amino acids divided into three 
domains as is seen for all autotransporter.[157] The 49 amino acid N-terminal signal peptides is 
cleaved from the remaining protein after transport to the periplasmic space. After insertion of 
the β-domain into the outer membrane and subsequent translocation of the passenger domain 
to the extracellular matrix, the passenger domain is cleaved from the barrel between residue 
846 and 847 most likely through an autocatalytic mechanisms.[158] 
The passenger domain consists of 31 sequential repeats of a 19 amino acids sequence[157] and 
based on sequential analysis the domain are predicted to form a β-helix which coincide both 
with the published structure of autotransporters (see figure 12) and with the biological function 
as an adhesion.[159] In several instances the passenger domain of AIDA have been replaced, 
thereby using the autotransporter secretion mechanism for displaying foreign protein on the cell 
surface of the bacteria.[160] 
The C-terminal β-domain consists of two subdomains termed the β1 (residues 847-949) and β2 
(residues 950-1286) and the two subdomains are defined as the part that can be proteolytic 
degraded (β1) and the membrane embedded part that is protected from degradation (β2).
[157] 
There exist no high resolution structure of the AIDA β-domain but it most likely fold into a β-
barrel structure based on both bioinformatic and experimental studies.[158, 161] The exact number 
of β-strands is however not known but calculations based on amphipathic properties of the 
protein predict roughly 14 β-strands which are in contrast to the previously published β-domain 
structures.[162]  
The smaller β1 act as a linker region between the barrel and the passenger domain and the 
tertiary structure (if any) is largely unknown. It has been predicted to form two β-strands at the 
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bilayer which presumably is part of the also predicted β-helix structure of the passenger 
domain.[158]  
Material and Methods 
Expression and purification 
The expression and purification of the β2-domain of AIDA were largely carried out as described 
previously.[163] E. coli BL21(DE3)pLysS transformed with the plasmid DT4 coding for the β2-
domain were grown on LB-agar plates and single colonies were transferred to 10 ml LB media 
containing 100 g/mL ampicillin and grown overnight a 37 oC with agitation. The overnight 
cultures were used to inoculated either 1 l LB, (>98%) 15N Spectra 9 or M9 minimal media (3 g/l 
KH2PO4, 7.5 g/l Na2HPO4  2H2O, 5 g/l NaCl, 10 ml 100x MEM vitamins (VWR, USA), 1 mM MgSO4, 
1,5 g/l 15N-(NH4)2SO4, (Spectra Stable Isotopes, USA), 4 g/l glucose) containing 0.1 g 
15N-Phe and 
0.1 g of each of the unlabeled variants of the remaining 19 natural amino acids. For growth in 
2H13C15N M9 minimal media with 13C-glucose and >99% D2O were used. The cells were adjusted 
to D2O by growing the overnight culture in LB media with 100 g/mL ampicillin and 25 % (v/v) 
D2O and then transferring 100 L to a second overnight culture containing 50 % D2O which were 
used to inoculate the 2H13C15N M9 minimal media. All media were grown at 37 oC until OD600 nm  
0.8 was reached and the culture was induced with IPTG to a final concentration of 1 mM. The 
cells subsequently grew for four hours before they were harvested at 6000 g for 10 min at 4 oC 
and flash frozen in liquid N2 before they were resuspended in 10 ml/l culture TEN buffer (50 mM 
Tris, 2 mM EDTA, 100 mM NaCl, pH 8). DNase (0.1 mg/mL) was added and the samples 
incubated for 45 min at room temp. One Complete Protease Inhibitor Cocktail Tablets (Roche 
Diagnostics, Germany) were added pr 50 ml of buffer and the cells were sonicated for 5 x 30 s on 
ice. Inclusion bodies were collected by centrifugation at 4000 g for 1 h at 4 oC and subsequently 
washed with TEN buffer (10 mL/L culture) containing 2% (w/w) Triton X-100 for 2 h at 37 oC. The 
inclusion bodies were then washed with TEN buffer, sedimented and washed again with TN 
buffer (50 mM Tris, 100 mM NaCl, pH 8).  
The inclusion bodies were solubilized in TN buffer containing 8 M urea and incubated for 2 h at 
37 oC then centrifuged at 32,000 g for 1 h. The dissolved protein was mixed 1:1 (v/v) with TN 
buffer containing either 10% (w/v) oPOE or 50 mM DPC or 10% (w/v) SDS sonicated 30 min? on 
ice. 1:10 (v/v) Ni-NTA beads were added and incubated for 2 h. The solution were applied to a 
Parmacia PD-10 gravity column and excess proteins were washed off with TN buffer containing 
either 0.5% (w/v) oPOE, 2.5 mM DPC, 0.5 % (w/v) SDS depending on the detergent wherein the 
protein was folded. AIDA-β2 was eluted from the column with 0.5 M imidazole in TN buffer 
containing either 0.5% (w/v) oPOE, 2.5 mM DPC, 0.5 % (w/v) SDS again depending on the 
detergent wherein the protein was folded. For NMR samples the protein was concentrated on a 
Amicon Ultra (Milipore, USA)(MWCO 30 kDa) spin filter while the buffer was exchanged to 10 
mM sodium phosphate, 5% D2O, 0.05% NaN3, pH 6. 
The gene coding for the 1 subunit from AIDA has been synthesized de novo (GenScript, 
Piscataway, USA), and subsequently re-designed by Finn L. Aachmann (NTNU, Trondheim, 
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Norway) The N-terminal threonine was mutated to alanine for optimal cleavage from the fusion 
protein during purification. The synthetic gene was inserted into the pTYB11 (from IMPACT-CN 
system, New England BioLabs) vector using the restriction sites SapI and EcoRI, hereafter 
purified via gel electrophoresis and ligated with T4 ligase at 289K over night resulting in the 
plasmid pFA11. The construct pFA11 was verified by restriction mapping. This plasmid was 
transformed into the E. coli production strain ER2566. To uniformly label the 1 subunit with 
13C/15N, cells were grown in M9 minimal medium prepared with 99% (15NH4)2SO4 and 99% 
13C6-D-
glucose (Spectra Stable Isotopes). The fusion protein was overexpressed by growing the cells at 
37 oC until an OD600nm of 0.8 was reached, followed by induction of the protein synthesis with 1 
mM IPTG and subsequent incubation at 25 oC for 16 h. Cells were collected by centrifugation and 
disrupted by sonication in 20 mM HEPES buffer pH 6.9, containing 500 mM NaCl and 0.05 % 
Triton X-100 (Sigma-Aldrich). Following centrifugation, the supernatant was applied onto a Chitin 
bead column (NEB). The column was washed with 20 mM HEPES buffer pH 6.9, containing 500 
mM NaCl, followed by cleavage with 50 mM dithiothretiol (DTT) at room temperature over 16 
h, resulting in the release of the 1 subunit (93 amino acid) from the chitin bound intein tag. The 
1 subunit was further purified by dialysis in order to remove a 1.6 kDa peptide that occurred as 
a by-product from the cleavage reaction.  
Circular dichroism 
All experiments were recorded on a Jasco J-715 spectropolarimeter (Jasco Spectroscopic, Japan) 
in a 1 mm quartz cell at room temperature. Ellipticity was recorded in the 250 – 200 nm range 
with 5 increments per CD spectra. A spectrum of 20 M AIDA-β2 dissolved in 10 mM sodium 
phosphate pH 6 and either 0, 5, 10, 20, 40 or 80 M AIDA-β1. Spectra of 16 M AIDA-β1 in 10 
mM sodium phosphate pH 6 were also recorded and with the same conditions but in the 
presence of either 100 mM Ca2+, 50 mM DPC, 50 mM SDS or 30% TFE.  
NMR 
All NMR spectra were recorded at 310 K on a BRUKER DRX600 spectrometer operating at a field 
strength of 14.1 T, equipped with a TXI(H/C/N) probe. All spectra were processed using Topspin 
version 1.3. Analysis of all NMR spectra were performed using the program CARA version 
1.5.5[164] 
15N AIDA-β2 samples were prepared in, 0.5% oPOE, 50 mM DPC, 0.5% SDS and 100 M protein 
respectively. 1H,15N-HSQC spectra were recorded for each sample using standard pulse 
sequences taken from the Bruker Topspin pulse sequence library.  
A sample with selectively labeled 15N-Phe AIDA-β2 was prepared in 10 mM sodium phosphate, 
5% D2O, 0.05% NaN3, pH 6 with 0.5% oPOE to a final protein concentration of 35 M. 
A 2H15N AIDA-β2 sample was prepared in 10 mM sodium phosphate, 5% D2O, 0.05% NaN3, pH 6 
with 0.5% oPOE. TROSY 1H,15N-HSQC spectra were recorded. 
A 13C15N AIDA-β1 sample was prepared in 10 mM sodium phosphate, 5% D2O, 0.05% NaN3 to a 
final concentration of 0.84 mM. 1H13C HSQC, 1H15N HSQC, CBCA(CO)NH, CBCANH, 
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HBHA(CBCACO)NH, HBHANH, HNCA, HN(CA)CO, HNCO, HN(CO)CA and 1H15N TOCSY-HSQC were 
recorded. 90 mM d38-DPC were added and a second 1H15N HSQC were recorded. 
Crystallization 
Crystallization trials were performed using the sitting drop vapor diffusion method at 278, 293 
and 298 oK with a protein concentration of 1.4 mg/ml in 0.5% oPOE or 1.3 mg/ml in 50 mM DPC. 
Screening was conducted using 24 well plates, with a drop volume of 1 µl protein and either 1 or 
0.5 µl reservoir solution. The screening was conducted using Molecular Dimensions Structure 
Screen 1 and 2 (ww.moleculardimensions.com) and the drops were mixed by aspiration. 
Modeling 
Homology models of AIDA-β2 was produced with the β-domain crystal structures of the 
autotransporters NalP and EspP from E. coli (PDB ID: 1UYN and 2QOM) as a template using 
MODELLER 9v2.[165] The models were subsequently optimized with respect to the Discrete 
Optimized Potential Energy (DOPE) score using the looprefine module of MODELLER. 
The best AIDA-β2 homology model obtained was energy minimized using the program Gromacs 
3.3.1 [166] with the GROMOS96 force field [167] and done with the steepest descents method in 
steps of 1 femtoseconds with a cutoff for Vander Waals interactions of 1.4 nm. 
Results 
Purification of AIDA-β2  
AIDA β2 was successfully expressed in LB media, isotope labeled Spectra 9 and M9 minimal 
media and the inclusion bodies were essentially purified in accordance with the previously 
established purification protocol.[163] For refolding and preparation of samples for NMR studies it 
was necessary to optimize the refolding process with respect to the used amounts of detergent 
used for refolding. For screening many different detergent conditions optimal for NMR 
experiments the cost of detergents would rapidly increase to unacceptable levels when using 
other detergents than oPOE which have a relative low cost (180 EUR for 25 g) compared to 
detergents more suitable for NMR (e.g. DPC 1600 EUR for 25 g). Because the use of deuterated 
detergents reduces the relaxation of membrane proteins significantly it was desirable to find 
detergents which could be obtained in this state. However, the costs of deuterated detergents 
are considerable higher than non-deuterated (e.g. d38-DPC 25000 EUR for 25 g) emphasizing 
the need for a reduction of detergent in the refolding protocol.  
It has been shown that OMPs are generally resistant to the detergent SDS and that denaturation 
requires heat treatment. Consequently will protein in a boiled sample migrate slower on a SDS-
polyacrylamide gel compared to protein in a non-boiled sample due to the larger radius to mass 
ratio of denatured proteins. This phenomenon is called heat-modifiability.[168]  To see whether 
AIDA-β2 were folded correctly the folded protein were subjected to a heat-modifiability test 
after each refolding (see figure 13) 
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Although no systematic investigation of the required amount of detergent needed for correct 
folding of AIDA-β2 was carried out, it appears that at least 10 times the cmc values of the 
detergent were needed to get as much AIDA-β2 refolded into its correct state as possible. 
Attempts to reduce the amounts of detergents needed were carried out by reducing the buffer 
volume when AIDA-β2 was refolded to less than 10 mL/g of inclusion body pellet as described by 
Mogensen et al.[163] Unfortunately such a volume reduction causes the protein to precipitate into 
an insoluble white substance.  
Circular dichroism 
The far-UV CD spectrum of AIDA-β2 in oPOE showed a typical β-sheet signal with a single 
minimum at 220 nm as have been observed previously (see figure 14).[163] This is a clear 
indication that the protein is folded into a β-barrel structure as is seen for autotransporters in 
general and hence is considered to be the correct folded protein state for AIDA-β2. 
 
The far-UV CD spectrum of AIDA-β1 dissolved in buffer showed a typical random coil profile 
whereas the presence of 50 mM DPC or SDS induced and more typical α-helical pattern with 
minima at 208 and 222 nm (see figure 14) The addition of 30 % TFE appear to stimulate the α-
helix formation even further and was used as an control experiment to observed the maximal 
inducible α-helix. From the combined experiments it is clear that the presence of micelles 
Figur 14. Far-UV CD spectra of AIDA-β2 (left) and AIDA-β1 (right). AIDA-β1 were carried out with identical protein 
concentration and either 100 mM Ca
2+
, 50 mM DPC, 50 mM SDS or 30% (v/v) TFE. A clear shift from an unfolded 
state to a more α-helix state is observed for AIDA-β1 is solutions containing amphipathic molecules. 
Figur 13. AIDA-β2 purified in oPOE not subjected to heat-treatment (NB) or subjected to heat-treatments (B). A clear 
band shift is observed which is typical for correctly folded OMPs  
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stimulate a partial formation of α-helix in the part of the β-domain linking the β-barrel with the 
passenger domain located outside the membrane.   
NMR 
A 1H,15N-HSQC spectrum were recorded on AIDA-β2 dissolved in oPOE (see figure 15). The peaks 
in the spectrum were with few exceptions impossible to distinguish from each other and peaks 
with very high intensity were located in the 1H ppm range between 8 and 8.5 ppm. When 
dissolved in SDS micelles the 1H,15N-HSQC spectrum revealed a few more unambiguous peaks 
and there were especially a distinguishing difference in the 15N 108-111 ppm range which is 
often populated by glycine residues.[111] In DPC micelles further peaks were observable in a 
1H,15N-HSQC spectrum, however the best result was as expected obtained by recording a TROSY 
1H,15N-HSQC on a deuterated sample of AIDA-β2. Unfortunately the majority of the peaks were 
ambiguous with very broad line width and the sample could therefore not be used for recording 
of triple resonance spectra and subsequent assignment of the signals. 
 
In an attempt to assess whether the broad line width originated from part of the protein being 
unfolded we selectively labeled the 11 phenylalanines in the protein. We were however not able 
to obtain a high protein concentration (35 M) due to a low protein yield from the expression 
and consequently we could not detect any signals in the recorded 1H,15N-HSQC spectrum. 
A 1H,15N-HSQC spectrum were recorded on AIDA-β1 which showed a nicely resolved spectrum 
with ~120 peaks (see figure 16) of which 15 residues are expected to originate from a small 
cleavage peptide from the purification. The protein appears to be unfolded as all the peaks are 
located in a narrow 1H ppm range and this observation is confirmed by the CD-spectra which 
Figur 15. 
1
H,
15
N-HSQC spectra of AIDA-β2 dissolved in 0.5 % oPOE (A), 0.5 % SDS (B), 50 mM DPC (C). TROSY-
1
H,
15
N-
HSQC spectrum of AIDA-β2 dissolved in DPC  
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shows a typical random coil profile. After the addition of DPC the signals were still located in a 
narrow 1H ppm range and the addition of DPC did only cause minor changes in the spectra which 
are a clear indication that most of the protein remains unfolded. We did therefore not proceed 
with a structural determination of the protein despite have recorded a complete set of triple 
resonance spectra. 
 
Crystallization 
The wells were visually checked for crystals regularly for a period of over six month. Although a 
few instances of micro crystals were observed they did not evolve into larger crystals and there 
was no coherence between the salt types and concentrations in the reservoirs of the isolated 
instances. There were therefore no obvious derived experiments and we did not conduct further 
crystal screenings.  
Homology model 
A homology model of AIDA-β2 was calculated based on the β-domain crystal structure of the 
autotransporter NalP. The calculated AIDA-β2 structure contains 12 β-strands folded in an 
antiparallel β-barrel (see figure 17) with a α-helix located in the center of the barrel as is also 
seen in the structures of the four β-domains of autotransporters that have been solved. 
However, in contrast to the other β-domain structures the AIDA-β2 structure contains three long 
loops between residue 110-132, 151-168 and 207-222. The lengths of these loops are sufficiently 
long to form a β-strands and it is likely that they do so in nature. A topology model predicts 
between 12 and 15 β-strand (data not shown) and because the number of strands in all solved 
OMPs are even numbers[154] 13 and 15 strands can most likely be ruled out. Because the model is 
based on a 12 β-strand domain it can be speculated that the modeler program have mistaken 
two of the extra β-strands with loops and that the actual count is 14, however a tertiary 
structure must be solved to answer that question. 
Figur 16. 
1
H,
15
N-HSQC spectra of AIDA-β1 recorded without (left) or with (right) the presence of DPC micelles. The 
peaks are in both spectra clearly clustered in the 
1
H 8-8.5 ppm range indication that the protein is not folded into a 
globular fold. 
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Discussion 
The purpose of this part of the thesis is to preserve some knowledge about the experiments we 
have performed on AIDA-β2 and AIDA-β1 in case someone will reattempt to work on the β-
domain using NMR spectroscopy. As mentioned in the introduction, despite a major 
improvement of methods and hardware the structure of only 36 unique membrane proteins 
have been solved using NMR. Of these only one monomer have been more than 30 kDa (human 
VDAC-1[169]) like AIDA-β2 which clearly illustrates the tremendous tasks that lies ahead before 
solving NMR structures of membrane proteins become trivial. By using heat modifiability and 
CD-spectroscopy we were able to determine whether the AIDA-β2 protein was correctly folded 
after refolding. However, because none of these methods are residue specific we were not able 
to determine if (small) parts of the protein like a tail region were unfolded which is not unlikely 
as AIDA-β2 is merely a part of the complete AIDA autotransporter. Such an unfolded region 
would give rise to very strong signal located in the 1H 8-8.5 ppm as is seen in the AIDA-β2 HSQC 
spectra.  
Due to difficulties with bringing down the required amount of needed detergent for refolding we 
have not been able to screen a large number of detergents for optimal NMR conditions with 
respect to AIDA-β2 NMR spectra. Neither have we observed such promising spectra with the 
limited amount of detergents we have recorded in, that we could justify spending several 
thousand euro on deuterating the detergents. As expected we observed an increase in the 
unambiguous signals when recording a 1H15N HSQC on a perdeuterated AIDA-β2 sample. 
Nonetheless, we have as mentioned not been able to obtain highly resolved NMR spectra that 
would be adequate for structural studies.  
 
Figure 17. Homology model of AIDA-β2 based on the crystal structures of crystal structures of the autotransporters 
NalP and EspP from E. coli 
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Introduction
Considerable work has been put into the characterization and
understanding of the interactions of proteins and peptides
with biological membranes in order to further elucidate their
biological functions. [1–3] Because biological membrane lipids
are expensive, frequently ill-defined, and generally difficult to
work with, peptides are often embedded in membrane-mim-
icking environments such as surfactant micelles and bi-
celles.[1, 3, 4] Determination of the orientations and insertion
depths of proteins in lipid aggregates is also essential for un-
derstanding the mechanisms of the rapidly growing number of
identified antimicrobial peptides (AMPs). These peptides are
very promising candidates for alternative treatment of an in-
creasing number of microbial infections that cannot be treated
with conventional antibiotics as a consequence of growing re-
sistance. A wide variety of such peptides has been discovered
in a multitude of different organisms, and they display great
diversity in their primary sequences and tertiary structures.[5]
One large group of AMPs does not adopt secondary struc-
tures in the absence of lipid aggregates, but in the presence of
lipids they form small amphiphatic a helices. It has been sug-
gested that they disrupt the cell membranes of the target or-
ganisms either by forming pores (“toroidal” or “barrel-stave”)
or by binding to the surfaces of the microbes in a detergent-
like manner, leading to displacement of a part of the mem-
brane.[6] Often, a single mutation that does not change the
overall structure of a peptide can lead to large changes in anti-
microbial behavior. It is therefore desirable to have a tool for
obtaining detailed information on interactions between AMPs
and membranes/surfactants for the determination of the
mechanisms of action of the individual peptides.
Various optical spectroscopic techniques such as Fourier
transform infrared (FTIR), Raman, fluorescence, and oriented
circular dichroism have been used to characterize lipid-peptide
interactions at low resolution.[7] Computational biology meth-
ods such as molecular dynamics have provided valuable infor-
mation at atomic resolution.[8] A considerable amount of pro-
teins and peptides have been simulated in lipid bilayers to pro-
vide valuable spatial information concerning their arrange-
ments in membrane-mimicking environments. The results of
this effort have been made available in the “Orientation ofACHTUNGTRENNUNGProteins in Membranes” (OPM) Database.[9] However, many of
these simulations have not been validated by experimental
data, and there is therefore a need for the development of
new high-resolution techniques to probe lipid–peptide inter-ACHTUNGTRENNUNGactions. The most commonly used experimental methods for
studying membrane proteins and peptides at high resolution
include electron paramagnetic resonance (EPR),[10] solid-state
NMR[11] and solution-state NMR with the aid of chemical
shifts,[12] NOEs,[1] and the attachment of various paramagnetic
spin labels to the peptides.[13] In addition, 19F has been incor-
porated into peptides as an NMR probe. These various ap-
proaches have also been combined with measurement of the
paramagnetic effect of apolar oxygen to measure the immer-
sion depths of peptides in bicelles under high pressure.[14] Fur-
thermore, both the line-broadening effect and the reduced
signal intensity induced by titration with paramagnetic species
such as MnII in solution have been used to determine which
residues are facing the solution.[15, 16] It is, however, likely that
positively charged metal ions would to some degree be associ-
[a] M. Franzmann, Prof. Dr. R. Wimmer
Department of Biotechnology
Chemistry and Environmental Engineering, Aalborg University
Sohngaardsholmsvej 49, 9000 Aalborg (Denmark)
Fax: (+ 45) 98141808
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[b] Prof. Dr. D. Otzen
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Supporting information for this article is available on the WWW under
http ://dx.doi.org/10.1002/cbic.200900347.
We describe the background and implementation of a method
to determine, at atomic resolution, the insertion depths and
orientations of peptides embedded in micelles. A nonperturb-
ing paramagnetic agent—Gd ACHTUNGTRENNUNG(DTPA–BMA)—was used to in ACHTUNGTRENNUNGduce
paramagnetic relaxation enhancements (PREs) of peptide
atoms inside the micelle. By calibrating these PREs it was possi-
ble to translate them into distance restraints that could be
used for structure calculation. We demonstrate this here on
the antimicrobial peptides novicidin and novispirin. Characteri-
zation of the interactions between antimicrobial peptides and
membranes is important for understanding of their biological
activities and functions, and a further development of tools to
study these interactions is described.
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ated with the proteins or the micelles, especially when anionic
detergents such as SDS are used, and this specific association
can significantly bias the results obtained.
Studies of peptides in aligned media have also been exten-
sively used to yield information on their global orientations
and thereby also the orientations of peptides in membranes.[17]
These studies rely on hydrogen–nitrogen couplings, and 15N-
isotopically labeled peptides are therefore needed. These can
be very expensive, however, especially in the case of AMPs,
which, because of their very natures, often cannot be ex-
pressed in their active forms in bacterial and fungal expression
systems.
Chelated paramagnetic metals such as the electrically neu-
tral Gd ACHTUNGTRENNUNG(DTPA–BMA) are highly water soluble and do not
appear to interact either with phospholipids or with pro-
teins.[18,19] Because we have not observed any chemical shift
changes either in the peptide or in the DPC signals, but merely
attenuation of the signals upon addition of Gd ACHTUNGTRENNUNG(DTPA–BMA), we
have concluded that neither our peptides nor detergent inter-
act with this chelate. This is consistent with a previously pub-
lished observation that GdACHTUNGTRENNUNG(DTPA–BMA) does not interact with
lipid membranes[18] or with ubiquitin.[19] Gd ACHTUNGTRENNUNG(DTPA–BMA) is
more strongly paramagnetic than similarly used nitroxide
agents such as HyTEMPO, and smaller amounts are therefore
needed in the experiments; this further reduces chances of
binding.[19] In more recent years the role of GdACHTUNGTRENNUNG(DTPA–BMA) has
therefore been adapted from that of a contrast agent in MRI-
type experiments to investigation of the solvent exposure of
micelle-bound proteins, because it can be used in a nonper-
turbing manner.[19–21]
Relaxation enhancements caused by paramagnetic ions can
be described by inner-sphere, second-sphere, and outer-
sphere models. The inner-sphere model describes the relaxa-
tion of atoms within the same molecular framework as the par-
amagnetic center, the outer-sphere model describes the relaxa-
tion enhancement of atoms not bound and rotationally uncor-
related to the paramagnetic center, and the second-sphereACHTUNGTRENNUNGinteraction model describes an intermediate situation in which
there is no specific interaction between the molecule carrying
the paramagnetic center and the molecule carrying the nu-
cleus in which the relaxation is enhanced, but the two mole-
cules are still rotationally correlated.[22]
Relaxation enhancement arises from modulation of the dipo-
lar interaction between the electron and nuclear spins. In the
inner-sphere model, this modulation is caused by the rotation-
al diffusion of the molecular framework containing both the
paramagnetic center and the nuclear spin. In the outer-sphere
model, this modulation is caused by translational diffusion of
the molecule containing the paramagnetic center and the mol-
ecule containing the nuclear spin.[23] In the second-sphere in-
teraction model, both rotational and translational diffusion
enter into the equations.
Although one would intuitively expect the relaxation en-
hancement of proteins in solution by a Gd complex in solution
to follow an outer-sphere model, it has been shown that the
relaxation enhancements caused by Gd ACHTUNGTRENNUNG(DTPA–BMA) can be
more accurately described by a “second-sphere interaction”
model, which gives a highly distance-dependent paramagnetic
effect[19] [Equation (1)]:
1
T 1
¼ 2
15

m0
4p
2 g2HðgJmBÞ2JðJ þ 1Þ
r6

3tC
1þ w2Ht2C
þ 7tC
1þ w2St2C

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where J is the electronic spin, tC is a correlation time depen-
dent on the T1 of the electron spin and the rotational and dif-
fusional correlation times of the molecules in question,[19] r is
the distance between the electron and 1H spin, T1 is the longi-
tudinal relaxation time, m0 is the induction constant, gH the
1H
gyromagnetic ratio, gJ the Land factor, mB the Bohr magneton,
r the distance between the electron and the 1H spin, and wH
and wS the Larmor frequencies of the
1H and electron spin,ACHTUNGTRENNUNGrespectively.
However, this relationship holds only for the interaction be-
tween fixed nuclear and electron spins. If the moiety carrying
the electron spin is free to move, the interactions need to be
integrated over the volume in which the electron spin can be
located.[21, 24] This leads to a dependence of the PRE on theACHTUNGTRENNUNGinverse third power of the distance between nuclear and elec-
tron spin.
To the best of our knowledge, chelated paramagnetic
agents and other paramagnetic agents in solution have until
recently only been used in a qualitative manner, only providing
relative comparisons of different parts of the peptide. Al-
though it is possible to estimate a peptide’s orientation in a
micelle, no absolute information about immersion depths
could be obtained. Zangger and co-workers developed a
method to measure the orientations and immersion depths of
small helical peptides in micelles and bicelles with the aid of
paramagnetic agents in solution.[21, 25] This technique relies on
quantitative use of PRE values to calculate the tilt and azimuth
angles of a straight-helical peptide without the need for iso-
tope labeling of the protein. In a recent paper, a method that
allowed peptides of any structure to be oriented in a micelle
by a least-squares fitting of observed versus calculated PREs
was proposed.[25]
Here we present a different method for obtaining informa-
tion relating to immersion depths and orientations of all types
of secondary and tertiary structures of proteins at atomic reso-
lution. Our method is readily implemented in existing structure
calculation programs, and allows the straightforward incorpo-
ration of PREs into the structure calculation as experimental
data equal to NOEs and dihedral angles. From GdACHTUNGTRENNUNG(DTPA–BMA)
titration experiments we have determined the PREs for the
atoms of interest in our model peptides—novicidin and novi-
spirin—in [D38]dodecylphosphocholine (DPC) micelles. To con-
vert these PREs into quantitative distance information, we
have calibrated PRE data for DPC in micelles with distances ob-
tained from simulated DPC micelles. We were thus able to con-
vert the PRE values of our model peptides into detailed infor-
mation on the distances between the centers of the micelles
and the atoms in the peptides. Because this PRE/distance cor-
relation is completely independent of the structural properties
of the molecules, this method should be directly applicable for
all types of micelle-embedded peptides and proteins, for
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which it can provide accurate orientation and immersion
depth information at atomic resolution.
Results and Discussion
Calibration of micelle distances from PRE values
From a 1D NMR spectrum we have identified six unambiguous
proton signals (H1–3, H5, H6, H12, H13, and H23; see
Scheme 1) of DPC micelles in solution. To obtain distance infor-
mation for atoms in micelles, we titrated DPC micelles with Gd-ACHTUNGTRENNUNG(DTPA–BMA), which is known not to interact with peptides and
micelles.[19, 21] The PRE values of an atom depend on the inverse
of the sixth power of the distance between the affected nu-
cleus and a fixed paramagnetic center.[26] However, for a nucle-
ar spin surrounded by a mobile, noninteracting paramagnetic
probe the relaxation depends on the inverse of the third
power between the atoms.[21, 24]
The PRE values for the atoms of DPC are given in Table 1.
Scheme 1 shows the DPC molecule with the numbering used.
To convert the PRE values into distance information, the PRE
values were correlated with distances obtained from an MD-
simulated micelle. For each DPC atom we measured the dis-
tance of the atom from the center of mass of the micelle to
which it belonged until the average distances became stable.
This part of the simulation was considered an equilibration
phase and was discarded for the subsequent calculations. We
then continued the simulation of the micelle and averaged
over the DPC atoms in all molecules in all the snapshots. As ex-
pected, this shows that the methyl protons of the DPC choline
group are located furthest away from the micelle center,
whereas the methyl groups of the acyl chain are closest to the
center, despite the carbon chains being bent and flexible,
which can be seen in the average distance of 10.75  between
the micelle center and the DPC H23 atoms. The PRE values for
the DPC protons identified in the NMR spectra were plotted
against the calculated average distances of the corresponding
atoms and the values were fitted to Equation (2) (see Figure 1):
PRE ¼ aþ k  ðgþ RrÞ3 ð2Þ
where Equation (1) has been integrated as described previous-
ly,[21] and all constants have been combined into the single
constant k. The distance between the electron and the 1H spin
is split into three distances, where g is the average distance of
a Gd atom from the surface of the micelle, R is the micelle
radius, and r is the distance between the atom in question and
the center of the micelle.
It had previously been estimated that the Gd ACHTUNGTRENNUNG(DTPA–BMA)
complex has to diffuse approximately 10  away from theACHTUNGTRENNUNGinteracting partner in order not to contribute to relaxation.[19]
Our g value of 80.9  lies between this value and the radius
Scheme 1. A) Chemical structure of DPC showing the (arbitrary) numbering
used in the text. B) Chemical structure of Gd ACHTUNGTRENNUNG(DTPA–BMA).[19]
Table 1. Distances between the hydrogen atoms of DPC and the micelle
center.
Atom(s) Average PRE value Average distance to centerACHTUNGTRENNUNG[s1 mm1]  sd []
H1–3 0.550.032 22.550.25
H5 0.450.029 21.860.21
H6 0.400.046 21.640.19
H12 0.210.0018 18.400.17
H13 0.150.0085 17.190.19
H14 – 16.470.17
H15 – 15.420.20
H16 – 14.700.18
H17 – 13.850.18
H18 – 13.200.17
H19 – 12.480.16
H20 – 12.010.14
H21 – 11.430.17
H22 – 11.120.18
H23 0.0910.0057 10.750.20
Calculated distances between the hydrogen atoms of DPC and the center
of the micelle. For the distinguishable atoms the PRE values are listed.
Figure 1. PRE values for well-resolved DPC protons plotted against distance
information relating to the corresponding atoms in a MD-simulated micelle.
The values were fitted to Equation (2), giving an “a” value of 0.057
0.017 s1 mm1, a g + R value of 30.50.9  [with the maximum distance
from the center of the DPC micelles obtained in the MD simulation (R =
22.55 ); this yields a “g” value of 7.98 ], and a k value of 253.1
91.95 s1 mm1 3. d corresponds to the distance to the center of the DPC
micelle.
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of the Gd complex making up the distance of closest ap-
proach, so it seems realistic.
We furthermore had to introduce the constant “a” into
Equation (2), because the measured PREs do not tend towards
zero with decreasing distances to the micelle center. This is
probably due to the fact that the DPC molecules in this system
exist in equilibrium between a monomeric form in solution
and the aggregated form in the micelle, because DPC has a
critical micelle concentration (cmc) of 1.1 mm,[27] which means
that 1.1 mm of the total 90 mm DPC molecules are at any time
located outside the micelle, where they experience a greater
relaxation enhancement than inside the micelle. Exchange be-
tween these two states is fast on the NMR timescale, as shown
by the fact that no sharp signals for DPC can be seen in the
NMR spectrum of a micellar solution–-only the broad signals
from micellar DPC.
Structure calculation
The proton signals of the 18-residue peptides novicidin and
novispirin in DPC micelles were assigned with the aid of stan-
dard sets of homonuclear 2D spectra, and the Ca and Cb shifts
of the residues were assigned with the aid of 1H,13C HSQC
spectra. A set of 80 structures was calculated for each peptide,
and the 20 structures with the lowest residual target functions
can be seen in Figure 2.
Key values from the structure calculations are listed in
Table 2. As can be seen from Figure 2, both novicidin and novi-
spirin form highly similar slightly curved a helices that are
clearly amphiphatic, because the hydrophobic residues Leu3,
Ile6, -7, -11, -13, and -14, and Tyr17 are located on one side
whereas Arg4, -5, and -8, Lys9, -15, and -16, and His12 are lo-
cated on the opposite side. This has also been reported previ-
ously for novispirin and for the highly similar peptide ovispirin
in other lipidic environments.[16, 28]
Qualitative interpretation of PRE values—paramagneticACHTUNGTRENNUNGrelaxation wave
Figure 3 shows a plot of the PRE values of the Ha atoms of
novicidin and novispirin against the residue numbers of the
peptides; it features wavelike patterns with wavelengths of
either three or four residues between the maxima of the PRE
curves. These patterns are characteristic for a helices lying par-
allel to the surfaces of the micelles, as previously described.[21]
The maximum PREs of novicidin are experienced by the resi-
dues Asn2, Arg5, Lys9, His12, and Lys16, all located on theACHTUNGTRENNUNGhydrophilic side of the amphipathic helix. For novispirin the
maxima are located at residues Asn2, Arg5, Lys9, His12, and
Tyr17, showing a slight deviation in the C-terminal part of the
peptide, where the mutation is located. Because the GdACHTUNGTRENNUNG(DTPA–
BMA) is located in the solution surrounding the micelles, the
relatively high PRE values confirm that the hydrophilic sides of
the helices are facing the outsides of the micelles, as would be
expected. The PRE values for novispirin residues 2–13 are very
similar to the values for novicidin, but for residues 14, 15, 17,
and 18 the values for novispirin are noticeably higher (see
Figure 2. Overlay of novicidin (black) and novispirin (gray) structures in the
presence of DPC. The bundles of the 20 structures with the lowest residual
target functions are shown, with N, C’, and Ca from residues 2–17 aligned.
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Figure 3). Because the Gly to Phe mutation from novispirin to
novicidin is located at the C-terminal ends of the peptides, it is
possible to observe this mutation and hence to distinguish the
two peptides by their PRE values. Because the PRE values for
residues 14, 15, 17, and 18 are higher in novispirin than in the
corresponding novicidin residues it is most likely that the more
hydrophobic Phe pulls the C-terminal part of novicidin into the
micelle and further away from the Gd-containing buffer than is
the case in novispirin.
Quantitative use of PRE values
In order to use PRE values quantitatively for determining the
positioning of a peptide in a micelle, we need to convert them
into distances from the center or the surface of the micelle.
The center of a micelle represents a single point in space,
whereas the surface of the micelle represents a multitude of
points. Structure calculation programs routinely accept distan-
ces between points in space as constraints for structure calcu-
lations, whereas the distance between a point in space and a
spherical surface is not straightforward to implement. For that
reason we sought to convert the PRE values into distances be-
tween the atoms in question and the centers of the micelles.
This requires knowledge of the micellar radii, which has been
reported in the literature both from experiments[27, 29] and from
MD simulations.[30, 31] Simulations have shown that the shapes
of the micelles are dependent on the DPC concentration, with
high concentrations (460 mm) giving rodlike micelles and bilay-
ers whereas lower concentrations (120 mm) give spherical mi-
celles.[31] Because all our experiments are conducted at 90 mm,
we can safely assume a spherical micelle shape with minor
fluctuations. The method presented here is based on knowl-
edge of the micellar radii. If the peptides and proteins investi-
gated are so large that they start to influence the micellar radii
significantly, the radii of the peptide-loaded micelles have to
be determined independently. The method can still be used,
however, but the R value in Equation (3) has to be adjustedACHTUNGTRENNUNGaccordingly.
Conversion of PRE values into distances is fairly straightfor-
ward with the calibration curve obtained from the titration of
DPC. As mentioned above, a nonzero offset in the r3 depend-
ence of the PRE on the distance of an atom from the micelle
center is caused by the presence of monomeric DPC molecules
in the aqueous phase in equilibrium with DPC in the micelle.
This offset does not have to be taken into account for peptide
data, because the equilibrium between free and micelle-bound
peptide is shifted strongly towards the micelle-bound form.
This was substantiated by NMR spin diffusion measurements.
The observed diffusion coefficient of 90 mm DPC is 1.07 
1010 m2 s1 and the diffusion coefficient of novicidin in the
presence of 90 mm DPC is 0.97  1010 m2 s1, whereas the dif-
fusion constant of novicidin in aqueous solution without deter-
gents was measured as 1.98  1010 m2 s1. Therefore, in order
to use the calibration curve obtained from DPC on the peptide
atoms, the start value “a” can be eliminated from the calibra-
tion curve [see Eq. (2)] , allowing us to calculate the distance
from the PRE with Eq. (3):
r ¼ ðgþ RÞ

PRE
k
1=3
ð3Þ
Peptide PRE values can thus be converted into average dis-
tances between the atoms in question and the centers of the
micelles. In order to account for experimental uncertainties,
distances are allowed to vary within a range of two standard
deviations from the value determined from the calibration
curve. The distances thus calculated for novicidin and novispir-
in atoms can be seen in the Supporting Information.
It is crucial for the validity of this approach that the peptide
is bound strongly to the micelle with only one conformation.
Weak binding to the micelle would lead to significant fractions
of the peptide in the bulk solution, in which it is in close con-
tact with the paramagnetic center. This would yield too-high
PRE values, and consequently too-low distances from the mi-
Table 2. Quality criteria for the calculated novicidin structures.
Novicidin Novispirin
number of distance constraints 210 211
– of which intraresidual 130 135
– of which sequential 42 41
– of which medium-range (2Dres4) 38 35
number of angle constraints[a] 26 26
– of which f 13 13
– of which y 13 13
CYANA residual target function [2] 0.740.05 0.600.04
distance restraints violated by more than
0.2 
0 0
angle restraints violated by more than 58[b] 0 0
rmsd residues 2–17 [][c] 0.170.08 0.130.05
% of residues in Ramachandran plot[d]
– in most favored regions 86.6 89.7
– less favored regions 13.4 9.0
– generously allowed regions 0 1.0
– disallowed regions 0 0.3
[a] Only those derived from Talos. [b] Per molecule. [c] For backbone
atoms C’, Ca, and N, as calculated by CYANA from the pairwise rmsd
values of each of the 20 structures against a mean structure. [d] As calcu-
lated by PROCHECK_NMR.
Figure 3. PRE values for Ha nuclei of novicidin (&, black) and novispirinACHTUNGTRENNUNG(*, gray) as a function of residue number. Error bars indicate variations in
PRE values obtained from fitting several peaks.
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cellar surface. Conformational flexibility will likewise lead to an
averaging of PRE values.
For the calculations, a range of linker residues consisting
only of pseudoatoms was attached to the C terminus of the
peptide. At the end of the chain of linker residues, the center
of the micelle was attached as a pseudoatom. This approach
builds on a previously described technique for introducingACHTUNGTRENNUNGdistance constraints obtained from metal ions in metallopro-
teins.[32] In CYANA, lower distance limits and upper distance
limits were introduced for the distances between the pseudo-ACHTUNGTRENNUNGatom defining the center of the micelle and every Ha atom for
which PRE data were available (here all of them except Lys1).
In cases of high PRE values that would suggest distances
from the micelle center larger than the radius of the micelle, it
would be advantageous only to apply a lower distance limit
corresponding to the micelle radius. Conversely, in the case of
very low PREs with large experimental uncertainties only an
upper distance limit should be applied.
In our samples, this only applies to the Ha3 atom of Gly10 in
novicidin. Because this PRE is based on only one peak, it
seemed impossible to estimate the experimental uncertainty,
and the PRE was excluded from further calculations. For all
other atoms we used both lower and upper distance limitsACHTUNGTRENNUNGdefined by the average calculated distance to the center
minus/plus one standard deviation obtained by calculating the
distance from multiple Ha peak volumes (see the Supporting
Information).
Structure calculation was then repeated with all experimen-
tal constraints (TALOS-derived angle constraints, NOESY cross
peak intensities, and PRE-derived distance constraints) present
in the calculation. The PRE-derived distance constraints were
weighted by only 10 % relative to the weighting for NOE-
derived distance constraints in the calculation of the residual
target function, in order not to allow PRE-derived distance
limits to influence the structure of the peptide itself, but
merely to position it correctly with respect to the center of the
micelle. In cases in which PRE data are available only for a lim-
ited number of amino acids, increasing the weight of the PRE-
derived distance constraints should be considered.
Figure 4 shows the PRE-derived distance limits from each Ha
atom to the center of the micelle, together with the ranges of
distances for the calculated ensemble of structures.
As can be seen from Figure 4, the distance constraints posi-
tioning the peptide in the micelle derived from PRE values are
mostly fulfilled, and for those that are not fulfilled the viola-
tions are negligible. Increasing the acceptable deviation of the
distance between a specific Ha and the center of the micelle
has no influence on the overall positioning and orientation of
the peptide, but reduces or eliminates the violations. The
result of the simultaneous structure/positioning calculation can
be seen in Figure 5.
The structures and positioning of both novicidin and novi-
spirin in DPC show that the charged groups of the sidechains
of the hydrophilic residues (Lys1, Asn2, Arg4, Arg5, Lys9, His12,
Lys15, and Lys16), together with the N and C termini, are locat-
ed at the DPC/solution interface, whereas the hydrophobic
side chains of Ile7, Ile11, and Ile14 are further away from the
surface of the micelle. Novicidin appears to be more deeply
buried in the sphere than novispirin, as would be expected
from the lower PRE values. Furthermore, novispirin is rotated
approximately 208 around the helix axis in relation to novici-
din, in order to best accommodate the PRE restraints (see
Figure 5).
Conclusions
PREs have been used here in a quantitative manner in combi-
nation with distance information from MD simulations to pro-
vide valuable long-range distance restraints to determine the
insertion depths and orientations of small micelle-embedded a
helices. In contrast with previous studies that used paramag-
netic agents or oxygen for determining immersion depths, this
method provides information with atomic resolution. For this
study we have used PRE values of Ha atoms, because these
provide the least flexible protons in the peptide backbone that
are not affected by solvent exchange (as is the case with the
HN atoms). Dynamic light scattering (DLS) measurements on
DPC micelles show no detectable size increase upon addition
Figure 4. Black lines show the calculated distances between Ha atoms from the 20 structures with the lowest residual target function and the center of the
micelle. The gray area defines the range between the upper and lower distance restraints, based on the PRE values of the Ha atoms. A) Restraints are ob-
tained from the average PRE values one standard deviation of the multiple novicidin peaks. B) The same values for novispirin. d corresponds to the distance
to the micelle center.
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of the peptide (data not shown), but if the technique were to
be applied on larger systems or even membrane proteins this
should be taken into consideration.
The only strictly quantitative approach for utilizing PREs so
far was published very recently.[25] Our method has several ad-
vantages over that method. Firstly, our protocol is readily ap-
plicable in standard structure calculation protocols and does
not need a separate fitting routine. Secondly, our method
allows simultaneous determination of structure and lipid im-
mersion. Incompatibilities between NOE data and PRE data will
show up immediately and can be corrected during structure
calculation. Thirdly, our protocol treats PRE data individually
for each atom of the protein, instead of accumulating all PRE
data for the whole peptide into one sum of squared errors
function.
It is believed that precise orientations of some antimicrobial
peptides in biological membranes are of vital importance for
the antimicrobial action and to the absence/presence of cyto-
toxicity. The ability to determine
precise orientations is therefore
a key technique for understand-
ing of the modes of action of
some of these peptides. The
technique demonstrated here on
two highly similar peptides pro-
vides this capability in a straight-
forward, generally applicable,
and ready-to-implement way.
Experimental Section
Materials : DPC was purchased
from Avanti Polar Lipids (Alabaster,
AL, USA) and DPC-d38 from Cam-
bridge Isotope Laboratories, Inc.
(Andover, MA, USA). Novicidin (se-
quence: KNLRRIIRKGIHIIKKYF) and
novispirin (sequence: KNLRRIIRKGI-
HIIKKYG) were generously provid-
ed by Novozymes A/S, and Gd-
(DTPA–BMA) was generously pro-
vided by Klaus Zangger.
NMR recording : All NMR spectra
were recorded at 310 K on a
BRUKER DRX 600 spectrometer op-
erating at a field strength of 14.1 T,
fitted with a TXIACHTUNGTRENNUNG(H/C/N) probe with
triple-axis gradients. Either novici-
din or novispirin (2 mm) was dis-
solved in [D38]DPC (90 mm, Cam-
bridge Isotope Laboratories), phos-
phate buffer (10 mm), sodium
azide (0.05 %), and D2O (5 %) at
pH 6 to a final volume of 500 mL.
For structural determination of
novicidin and novispirin in DPC mi-
celles, the following spectra were
recorded: 2D NOESY spectra with
80 ms mixing times were recorded with Watergate water suppres-
sion,[33] [1H,1H] TOCSY spectra with 50 and 80 ms mixing times
were recorded by use of a clean TOCSY pulse sequence with a
15 kHz spin-lock and Watergate water suppression.[34] 2QF COSY
and [1H,13C] HSQC in the aromatic and aliphatic regions were re-
corded by use of standard sequences taken from the Bruker Top-
spin pulse sequence library. All spectra were processed with Top-
spin version 1.3. Assignments of all NMR spectra were achieved by
use of the program CARA version 1.5.5[35] and NOE cross-peaks
were subsequently integrated by use of CARA’s NEASY subrou-
tine.[36] Backbone torsion angle restraints were obtained from
chemical shift values by use of the program TALOS,[37] and the
CALIBA[38] subroutine in CYANA was used to convert integrated
cross-peak intensities from the NOESY spectra into distance con-
straints. These combined constraints provided the input for struc-
ture calculation with the torsion angle dynamics program
CYANA.[39] Structure calculations were started from 80 conformers
with random torsion angle values and the 20 structures with the
lowest CYANA target functions were collected and analyzed with
the aid of Pymol.[40]
Figure 5. The bundles of A) the 20 novicidin and B) the 20 novispirin structures with the lowest residual target
functions are shown with N, C’, and Ca from residues 2–17 aligned. The structures are calculated with PRE con-
straints between the micelle center and the Ha atoms. A 45.2  diameter sphere is shown to illustrate the approx-
imate size of the DPC micelle. Note that the micelle in solution is not a perfect sphere but a mobile, continuously
changing shape. However, on average, the micellar shape will be close to spherical, so the micelle is represented
here in its simplest form as a sphere. Below are the structures of C) novicidin and D) novispirin with the lowest re-
sidual target functions and with visible side chain atoms.
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PRE measurements : For the PRE measurements on novicidin and
novispirin, samples identical to those used for structural determina-
tion were titrated with Gd ACHTUNGTRENNUNG(DTPA–BMA) to give final concentrations
of 2, 5, and 10 mm. Eight inversion recovery NOESY spectra with
recovery delay times of 1, 50, 150, 400, 700, 1200, 2600, and
4000 ms were recorded for each titration point in order to obtain
the T1 relaxation time. For calibration, samples were prepared with
DPC (90 mm) dissolved in D2O (5 %), phosphate buffer (10 mm),
and sodium azide (0.05 %) at pH 6. As above, the samples were ti-
trated with Gd ACHTUNGTRENNUNG(DTPA–BMA) and eight 1D inversion recovery spectra
with recovery delay times of 1, 50, 150, 400, 700, 1200, 2600, and
4000 ms were recorded for each titration point (including a set
before the start of the titration). T1 relaxation times were analyzed
by use of TOPSPIN version 1.3. Relaxation rates (1/T1) were plotted
against the concentration of the Gd complex, and linear regression
yielded the PRE values as the slope of the regression line. AllACHTUNGTRENNUNGmolecular visualizations were made with Pymol.[40]
Diffusion measurements : Diffusion measurements on novicidin
were recorded with novicidin (2 mm), DPC-d38 (90 mm), phosphate
buffer (10 mm), and sodium azide (0.05 %) dissolved in D2O (100 %)
at pH 6, and also on an otherwise identical sample without
[D38]DPC. The diffusion constants were also measured on a sample
containing only DPC (90 mm), phosphate buffer (10 mm), and
sodium azide (0.05 %) dissolved in D2O (100 %) at pH 6. Diffusion
coefficients were determined by use of a double stimulated echo
pulse sequence.[41] A total of 32 spectra were recorded, with in-
creasing gradient strengths ranging from 7.1 to 40 G cm1. Novici-
din or DPC signals were integrated at each gradient strength and
diffusion constants were obtained by fitting to Equation (4) by use
of Bruker TopSpin version 1.3.
I ¼ I0 expðDtð2pgdGÞ2  ðDd=3Þ  104Þ ð4Þ
with d= 4 ms, D= 140 ms, and G being the gradient strength.[42]
Molecular dynamics simulations : The initial DPC micelle coordi-
nates were taken from the homepage of Professor Peter Tieleman
at the University of Calgary (http://moose.bio.ucalgary.ca).[30] The
micelle was put into an 88  80  80 nm-sized box, extending 2 nm
from the micelle along all three axes. The box was filled with
19405 TIP3P water, and sodium ions were iteratively placed at the
coordinates with the lowest electrostatic potential by the YASARA
MD protocol.[43] Simulation temperatures were 310 K, water densi-
ties 1003 g L1, and the pH was 6. The van der Waals pairs cutoff
distance was 7.86  and particle mesh Ewald (PME) long-range
electrostatics were employed.[44] The time steps chosen were
1.25 fs for bond, angle, dihedral, and planarity forces and 2.5 fs for
the intermolecular forces. Simulations were started with a steepest
descent minimization (until atom speed <2200 m s1), followed by
500 steps of simulated annealing of the solvent to equilibrate the
system. MD simulations were conducted with YASARA 8.9.11[43]
with use of the YASARA MD protocol and the AMBER99 force-
field[45] at constant pressure (NPT ensemble). The MD simulations
ran for 3.345 ns with a snapshot taken every 7.5 fs; this gave 446
micelle states. During the first ns the micelle expanded slightly, so
this part of the simulation was considered an equilibration phase
and these snapshots were discarded for the subsequent calcula-
tions.
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Table S1. Novicidin PRE values. 
Residue 
number 
PRE               
[s-1mM-1] 
Dist. to micelle 
center [Å] 
Dist standard 
diviation [Å] 
Lower distance 
restraints [Å] 
Upper distance 
restraints [Å] 
2 0.75 23.54 0.57 22.96 24.11 
3 0.10 16.97 1.15 15.82 18.12 
4 0.09 15.68 2.35 13.33 18.03 
5 0.27 20.69 0.65 20.04 21.33 
6 0.09 16.13 0.66 15.47 16.79 
7 0.04 11.73 0.61 11.12 12.34 
8 0.09 16.41 1.54 14.87 17.95 
9 0.18 19.05 1.60 17.45 20.64 
10(2HA) 0.05 13.89 0.98 12.91 14.87 
10(3HA) 0.02   6.83 0.98   5.86 7.81 
11 0.04 11.69 0.98 10.72 12.67 
12 0.21 19.80 0.26 19.54 20.06 
13 0.10 16.76 0.47 16.29 17.23 
14 0.06 14.60 0.95 13.64 15.55 
15 0.09 16.05 1.43 14.62 17.49 
16 0.54 22.49 1.29 21.20 23.78 
17 0.19 19.48 0.16 19.32 19.63 
18 0.14 18.29 0.98 17.31 19.27 
Average values of PRE values from multiple Hα peaks and average calculated distances between the 
Hα atoms and the center of the micelle. As only one distance has been obtained from residue 10(2HA), 
10(3HA), 11 and 18 an average of the remaining standard deviations have been used.  
Table S2. Novispirin PRE values. 
Residue 
number 
PRE 
[s-1mM-1] 
Dist. to micelle 
center [Å] 
Dist standard 
diviation [Å] 
Lower distance 
restraints [Å] 
Upper distance 
restraints [Å] 
2 0.72 23.47 1.06 22.41 24.53 
3 0.098 16.82 0.01 16.81 16.83 
4 0.14 18.45 1.06 17.39 19.51 
5 0.29 20.93 1.06 19.87 21.99 
6 0.09 16.25 1.61 14.63 17.86 
7 0.05 13.51 1.06 12.45 14.56 
8 0.13 17.95 0.61 17.34 18.56 
9 0.20 19.45 1.42 18.04 20.87 
10(2HA) 0.076 15.59 1.06 14.53 16.65 
10(3HA) 0.064 14.73 1.06 13.67 15.79 
11 0.11 17.22 1.06 16.16 18.28 
12 0.25 20.20 1.49 18.71 21.69 
13 0.11 17.25 1.06 16.19 18.31 
14 0.098 16.68 1.17 15.51 17.85 
15 0.20 19.66 1.06 18.60 20.72 
16 0.29 20.91 1.00 19.91 21.91 
17 0.46 22.15 1.16 20.99 23.31 
18(2HA) 0.41 22.01 1.06 20.95 23.07 
18(3HA) 0.33 21.37 1.06 20.31 22.43 
Average values of PRE values from multiple Hα peaks and average calculated distances between the 
Hα atoms and the center of the micelle. As only one distance has been obtained from residue 2, 4, 5, 
7, 10(2HA), 10(3HA), 11, 13, 15, 18(2HA), 18(3HA) an average of the remaining standard deviations 
have been used.  
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Peptide acylationMany small cationic peptides, which are unstructured in aqueous solution, have antimicrobial properties.
These properties are assumed to be linked to their ability to permeabilize bacterial membranes, accompanied
by the transition to an α-helical folding state. Here we show that there is no direct link between folding of
the antimicrobial peptide Novicidin (Nc) and its membrane permeabilization. N-terminal acylation with C8–
C16 alkyl chains and the inclusion of anionic lipids both increase Nc's ability to form α-helical structure in
the presence of vesicles. Nevertheless, both acylation and anionic lipids reduce the extent of permeabiliza-
tion of these vesicles and lead to slower permeabilization kinetics. Furthermore, acylation significantly
decreases antimicrobial activity. Although acyl chains of increasing length also increase the tendency of the
peptides to aggregate in solution, this cannot rationalize our results since permeabilization and antimicrobial
activities are observed well below concentrations where aggregation occurs. This suggests that significant
induction of α-helical structure is not a prerequisite for membrane perturbation in this class of antimicrobial
peptides. Our data suggests that for Nc, induction of α-helical structure may inhibit rather than facilitate
membrane disruption, and that a more peripheral interaction may be the most efficient permeabilization
mechanism. Furthermore, acylation leads to a deeper embedding in the membrane, which could lead to an
anti-permeabilizing “plugging” effect.ular dichroism; Nc, Novicidin;
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Over the past two decades, more than 800 antimicrobial peptides
(AMPs) have been reported from sources as diverse as animals, plants,
insects, and fungi [1–4]. As parts of the innate immune system in
vertebrates, AMPs are often the first line of defence against an
invading organism, and thus show activity against a broad range of
targets. Microorganisms do not easily evolve resistance to them,
making them of great interest as alternatives to small-moleculeantibiotics. Over the recent few years significant resources have been
directed towards their commercialization. So far, only a few products
have succeeded, while several promising candidates have been halted
because of adverse effects or effects similar to existing antibiotics [5].
The lack of success most likely reflects limited understanding of
their mechanism of action and microbial specificity. At present the
common procedure is to search for naturally occurring AMPs and then
subsequently mutate them to change their specificity [6–10]. More
detailed insight into AMP activity may ultimately allow design in silico
[11].
Many AMPs are understood to target the bacterial plasma
membrane directly rather than through receptors (though there are
a growing number of exceptions such as lantibiotic peptides that
target lipids in the bacterial septum and thus inhibit cell division [12]
and defensins with viral targets [13]). They do so in a variety of ways,
including a barrel-stave model, a carpet model, and a toroidal-pore
model [14]. In the barrel-stave model, the peptides completely
traverse the membrane by pore formation, quickly ruining the
807B. Vad et al. / Biochimica et Biophysica Acta 1804 (2010) 806–820electrochemical gradient and killing the cell [15]. This mode of action
is mostly driven by hydrophobic interactions between an amphipathic
peptide and the lipid's acyl chains and is therefore less specific
towards membranes of different lipid compositions [15]. A minimum
of 22 and 8 amino acids is necessary to straddle the bacterial
membrane for anα-helical- and a β-sheet peptide, respectively. In the
carpet model, the positively charged peptides cover the membrane
surface in a carpet-like fashion until they reach a concentration where
they permeabilize the cell by disrupting the membrane curvature
[16]. As opposed to the barrel-stave model, the peptide does not need
to assume a specific oligomeric structure and the peptides are always
in contact with the lipid headgroups at the interface with the acyl
chains. This mode of action is more sensitive to the lipid headgroup
charge, explaining why it is more specific towards the negatively
charged surface of bacteria [17–19]. Finally, the toroidal-poremodel is
a mixture between the carpet model and the barrel-stave model.
Defined pores are formed as in the barrel-stave model but the
peptides lie in the lipid headgroup-acyl chain interface. This is
possible because the peptides induce a sharp bending of the lipids so
that lipid headgroups can line the interior of the pore.
It may be possible to modulate the mode of antimicrobial action,
and thus the spectrum of applications, by modifying the AMPs with
acyl chains, since this modification will increase AMP hydrophobicity
and potentially also its membrane affinity. This has been studied in
two different approaches: Makovitzki et al. [20] synthesized tetra-
peptides with acyl chains of length 8–16 (number carbons in the acyl
chain) and found that the tetrapeptides conferred bacterial species
specificity while their aggressiveness correlated with acyl chain
length. The same group also showed that conjugation of the AMP
magainin with acyl chains of length 7, 11, and 16 had important
effects on magainin activity, with the membrane permeabilizing
ability increasing uniformly with chain length [21]. Furthermore, the
attachment of the acyl chains also resulted in a change of the
secondary structure of magainin-C11 and magainin-C16 (magainin
with acyl chains of lengths 11 and 16, respectively) in solution from
that of the wildtype magainin. While magainin-C7, like the wild type,
was disordered and monomeric in solution, both magainin-C11
and magainin-C16 adopted α-helical structure. Magainin-C11 was
only α-helical above a threshold concentration indicating detergent-
like properties in which the protein assumed an α-helical structure in
the micellar state. In contrast, magainin-C16 remained α-helical at all
investigated concentrations, suggesting that the longer acyl chain was
able to sequester the hydrophobic residues in the folded magainin at
the monomer level. C-terminal modification with biotin through a
single or tandemly coupled caproyl group had no significant effect on
gramidicin structure or function [22], and modification with a
palmitoyl only group slightly reduces the gramicidin's lipid-perturb-
ing properties, consistent with the peptide's high tendency to
associate with the lipid even in the unacylated form [23].
For non-acylated peptides that are unstructured in solution,
membrane binding is generally accompanied by the formation of α-
helical structure in order to satisfy hydrogen-bonding requirements in
a less hydrophilic environment [24]. One might therefore expect that
membrane-binding properties and thus antimicrobial properties
should correlate with the ability to form α-helical structures in a
membrane environment. However, it has been shown for designed
antimicrobial peptides composed of a mixture of α- and β-amino
acids [25] (but not for peptides containing β-amino acids alone [26])
that there is no correlation between helical propensity and antimi-
crobial activity.
To explore in greater detail how acylation canmodulatemembrane-
binding properties, and whether helical propensities of peptides with
α-amino acids correlate with membrane permeabilization, we report
here a detailed study on the effect of acylation on the AMP Novicidin
(Nc) [7,27–30]. This AMP is a variant of the 18-residue Ovispirin, which
in turn is derived from the N-terminal region of the cathelicidinpeptide SMAP-29 from sheep. Ovispirin showed unacceptably high
haemolytic activity, but the mutation Ile10→Gly (Novispirin) reduced
this to more appropriate levels. Subsequently, the C-terminal mutation
Gly18→Phe (giving the peptide Novicidin, abbreviated Nc, sequence
KNLRR IIRKG IHIIK KYF) led to improved efficacy towards microorgan-
isms (personal communication, Hans Henrik Kristensen). Novispirin
and Nc are unstructured in solution but readily adopt α-helical
structures in the presence of anionic lipids and detergents, as well as to
a smaller extent in the presence of cationic and zwitterionic detergents
[31], in agreement with its amphipathic character (Fig. 1A). We focus
on the structural and vesicle-disruptive properties of Nc (denoted Nc
wt in its unmodified form), its N-terminally acylated derivatives and a
Dansyl-labelled version of Nc. Surprisingly, we find that the induction
of measurable amounts of α-helical structure is not a prerequisite for
membrane permeabilizing properties and that acylation actually
reduces permeabilization efficiency. We suggest that a more peripheral
membrane contact may be the most productive mode of action for at
least some AMPs.
2. Materials and methods
2.1. Chemicals
DMPC (1,2-di-myristoyl-sn-glycero-3-phosphocholine), DHPC
(1,2-di-hexanoyl-sn-glycero-3-phosphocholine), DMPG (1,2-di-myr-
istoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]), DOPC (1,2-di-
oleoyl-sn-glycero-3-phosphocholine) and DOPG (1,2-di-oleoyl-sn-
glycero-3-[phospho-rac-(1-glycerol)]) were from Avanti Polar Lipids
(Alabaster, AL). Protected amino acids, 1,2-ethane dithiole (EDT),
triisopropylsylane (TIPS), di-chloromethane (DCM), dimethylforma-
mide (DMF), N,N-diisopropylethylamine (DIPEA), 1H-benzotriazolyl)-
1,1,3,3-tetramethyl-uronium hexafluorophosphate (HBTU), octanoic,
dodecanoic- and hexadecanoic acid, and O-(7-azabenzotriazol-1-yl)-N,
N,N′,N′-tetramethyl-uronium hexafluorophosphate (HATU) were from
Iris Biotech (Marktredwitz, Germany). Acetonitrile chromasolv gradient
grade, trifluoroacetic acid (TFA), sucrose 99.5% purity andD (+) glucose
99.5% purity were from Sigma (St. Louis, MO). DiIC18(3), Alexa-488
hydrazide (Alexa488), Alexa-633 hydrazide (Alexa633) and BL21(DE3)
were from Invitrogen (Carlsbad, California). Calcein disodium salt was
from Fluka (Buchs, Switzerland). Deuterated dodecylphosphocholine
(DPC-d38) was from Cambridge Isotope Laboratories Inc. (Andover,
MA). Gd-(DTPA-BMA) was generously provided by Klaus Zangger.
Recombinant Ncwt peptide (prepared as described [31] and used for all
experiments that involved non-derivatized Nc) was generously pro-
vided by Dr. Hans Henrik Kristensen.
2.2. Peptide synthesis, acylation and purification
Synthesis of the acylated Nc peptides was carried out in two steps.
Firstly, the 18-residue Nc peptide was synthesized on an automatic
CEM liberty microwave assisted peptide synthesizer (Matthews,
North Carolina) by solid-phase synthesis using standard Fmoc
chemistry on Wang resin. Secondly, the fatty acid was attached to
the N-terminus of the resin-bound peptide also using Fmoc chemistry.
To prepare dansyl-Nc, Nc was manually acylated with the dansyl
moiety. Further synthesis and purification details are provided in the
Supplementary information.
2.2.1. Preparation of LUV liposomes
LUVs (large unilamellar vesicles) containing calceinwere prepared
from stock solutions of lipids dissolved in methanol and dried
overnight in a Heto VR-1 centrifuge vacuum drier. Lipids were then
resuspended by vortexing in 20 mMTris HCl, pH7.5 containing 40 mM
calcein sodium salt, to a final concentration of 10 g/l (∼14 mM),
exposed to at least seven cycles of freezing in liquid nitrogen, followed
by thawing in a 50 °C water bath, before extrusion through a 200 nm
Fig. 1. Sequence of Novicidin and a helical projection highlighting its amphipathic character.
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Lipids, Vancouver, Canada). The lipid solutions were run on a PD10
column pre-equilibrated with 20 mM Tris HCl, pH 7.5. Eluent fractions
were gathered and tested by fluorescence measurements with and
without the addition of Triton X-100 to test for calcein release. Those
with the highest signal-to-background ratio were selected for further
use. All extruded vesicles were used on the same day that they were
made.
2.2.2. GUV liposomes and laser confocal microscopy measurements
GUVs (giant unilamellar vesicles) were prepared by the electro-
formationmethod originally described by Angelova and Dimitrov [32]
and observed with a LSM 510 scanning confocal microscope (Zeiss
GmbH, Jena, Germany). Further details are provided in the Supple-
mentary information.
2.3. Manual calcein release assay
All fluorescence measurements were conducted on an LS55
fluorimeter essentially as described [33]. Further details are provided
in the Supplementary information.
2.4. Stopped-flow measurements
Kinetic experiments were carried out on an Applied Photophysics
SX-18MV reaction analyzer (Applied Photophysics, Leatherhead,
Surrey) in fluorescence detection mode. For the calcein release
measurements, the solution was excited at 490 nm and a 510-nm
glass filter was used to measure emission intensity. The calcein
vesicles and peptides were mixed in 10:1 volume ratio and at least
three measurements were averaged for each concentration. Final
concentrations of lipid were around 50 µM while final peptide
concentrations varied from 0.2 µM to 72 µM. In measurements using
Dansyl-Nc, the samples were excited at 335 nm and a 530-nm glass
filter was used. The lipid concentration was held constant at 20 µM
while the peptide concentration was varied from 1 to 10 µM.
2.5. Secondary structural changes measured by CD spectroscopy
Circular dichroism studies were performed on a Jasco J-810
spectropolarimeter (Jasco Spectroscopic Co., Hachioji City, Japan)
with a Jasco PTC-348W1 temperature control unit. Scan speed was setto 100 nm/min, slit width 2 nm. All experiments were carried out in
20 mM Tris–HCl pH 7.5, at 25 °C using a 1 mm quartz cuvette. The
measurements were conducted as one-pot titrations with an initial
peptide concentration of 200 µM and stepwise addition of lipids. After
the addition of each new lipid aliquot, the sample was allowed to
equilibrate for at least 1 min before a spectrumwas recorded. Samples
at each concentration were measured in three scans and averaged to
yield the final spectrum. Background spectra without peptide were
subtracted and the CD signal was corrected for dilution.
2.6. Differential scanning calorimetry (DSC)
LUVs for use in DSC experiments were prepared by dissolving and
mixing appropriate amounts of DMPC and DMPG yielding pure DMPC
and 80:20 w/w% DMPC:DMPG in 1:1 chloroform:methanol, respec-
tively. 10 mg lipid was transferred to a glass vial and solvent was
removed under a stream of nitrogen gas followed overnight incubation
in a vacuum desiccator (p<60mbar) to remove trace amounts of
solvent. Lipids were rehydrated in 10 mM sodium phosphate pH 8.0 to
produce a 10 mg/ml lipid solution and LUVswere subsequently formed
by extrusion through 100-nm polycarbonate filter by 15 passages
through a MiniExtruder (Avanti Polar Lipids, Alabaster, CA). The phase
behavior of LVUs was studied using a Microcal VP-DSC scanning
microcalorimeter (Northampton, MA, USA). Samples were prepared by
mixing peptide and buffer in appropriate ratios followed by addition of
pre-formed LUVs to obtain a lipid concentration of 1 mg/ml and varying
peptide content from pure lipid to 1:20 Nc:lipid (molar ratios). Heating
and cooling scans were performed between 5 and 45 °C at a scan rate of
60 °C/h and prescan thermal equilibration for 15 min using 10 mM
sodium phosphate buffer pH 8.0 as the reference sample. The high
feedbackmodewasused to ensure correct recording of sharp peaks. The
DSC cell was pressurized to ∼30 psi throughout the experiment.
2.7. Peptide lipid binding measured by fluorescence anisotropy
The excitation was set to 335 nm and emission was measured at
515 nm in a 200 µl Hellma quartz cuvette. Slit width was set to 7.5 nm
for both the vertical and horizontal filters. For each sample the
G-Factor was measured before measuring the anisotropy. Dansyl-Nc
concentration was held constant at 25 µM and increasing amounts of
lipid was added. The samples were mixed by pipetting and allowed to
equilibrate for 2 min before measuring anisotropy.
Fig. 2. (A) CD spectra of Nc and acylated derivatives in 20 mM Tris–Cl pH 7.5: 40 µM Nc
wt, 40 µM Nc-C8, 40 µM Nc-C12, 200 µM Nc-C12, 40 µM Nc-C16, 40 µM Novicidin in
80DOPC:20DOPG vesicles and 40 µM Nc-C8 in pure DOPC vesicles. Development of CD
spectra at 208 nm with the addition of increasing concentrations of (B) DOPC and
(C) 80DOPC:20DOPG to Nc wt, Nc-C8, Nc-C12 and Nc-C16.
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Cell permeabilization assays and minimal inhibitory concentration
(MIC) assayswere performed essentially as described [34,35] but with
modifications described in the Supplementary information.
2.9. Solution-state NMR experiments
NMR samples containing 1 mM Nc-C16 or 2 mM Nc were dissolved
in 90 mM DPC-d38, 10 mM phosphate buffer, 0.05% sodium azide, 5%
D2O, pH 6 to a final volume of 500 μl. All NMR measurements were
conducted at 37 °C on a Bruker DRX600 spectrometer (Bruker BioSpin,
Rheinstetten, Germany) operating at a field strength of 14.1 T, equipped
with a TXI(H/C/N) probe with triple-axis gradients. The PRE measure-
ments of Nc-C16 were performed as previously described in detail [36].
Further details are provided in the Supplementary information.
2.10. Solid-state NMR
TheNMRbicelle samplesweremade fromDMPC,DHPC, andDMPG.
All experiments were performed on a Bruker Avance 400 spectrome-
ter operating at 9.4 T corresponding to 400 MHz for protons. Further
details are provided in the Supplementary information.
3. Results
3.1. Interaction of Nc and acyl derivatives with lipids
We start by analyzing the degree to which zwitterionic (DOPC)
and mixed, partially anionic (80DOPC:20DOPG) lipid vesicles induce
structure in the different Nc variants. These vesicles were used as
simple mimics of the mammalian plasma membrane (predominantly
zwitterionic) and the outer leaflet of the bacterial cell membrane (at
least 25% anionic lipid in E. coli). The secondary structure of Nc and
the acylated derivatives (termed Nc-CX, where X refers to the number
of carbon atoms in the acyl chain) was monitored by far-UV CD.
Fig. 2A shows the CD spectra of Nc, Nc-C8, Nc-C12, and Nc-C16. Nc, Nc-
C8, and low concentrations (40 µM) of Nc-C12 display CD spectra
characteristic of a random coil. At high concentrations (200 µM), the
CD spectrum of Nc-C12 changes to a distinct α-helical profile with
minima at 209 and 222 nm. Nc wt and Nc-C8 remain unstructured at
200 µM (data not shown). The CD spectrum of Nc-C16 is primarily α-
helical over the entire accessible concentration range (20–200 µM).
In the presence of 0–2 mg/ml DOPC, Nc shows only a slight change
in its CD spectrum, retaining the features of a random coil structure
(data not shown) though there is a small increase in ellipticity
between 0 and 2 mg/ml lipid (Fig. 2B). This agrees with the
observation that high (several hundred mM) concentrations of non-
ionic and zwitterionic surfactant are required to induce helical
structure in the closely related peptide Novispirin [31]. In contrast,
Nc-C8 and Nc-C12 both change from random coil to α-helical
structure with increasing concentrations of lipid over the range
probed (the spectrum for Nc-C8 shown in Fig. 2A). In the presence of
80DOPC:20DOPG vesicles, the spectra of Nc, Nc-C8, and Nc-C12
changed dramatically from random coil to α-helix (representative
spectra shown in Fig. 2A, summarized in Fig. 2C). The ellipticity at
208 nm, which is indicative of α-helical structure, shows a reasonably
linear increase with lipid concentration, apart from a more hyperbolic
behavior for Nc-C12 in DOPC (Fig. 2B). As we have previously reported
for Novispirin [31], this slope most likely represents the initial linear
stage of a hyperbolic binding curve, whose slope (summarized in
Table 1) is directly proportional to the lipid binding affinity. To avoid
artifacts from light scattering, we did not record data at higher lipid
concentrations.
For both lipid compositions, Nc wt shows the lowest lipid affinity
of all the peptides (measured in terms of α-helix induction), although
Fig. 3. (A) Typical timeprofile of calcein release byNc andderivatives. Signalnormalised relative
of Nc and acylated derivatives to calcein-loaded vesicles three distinct calcein release patterns
curvedisplaying secondorder characteristics (■), a fast releasewith afluorescence increasebetw
decreases to 100% (▲). Injection occurs in all cases at 50 s. (B and C)Nc and the acylatedderivati
(data for Nc in DOPC included for comparison). The normalised maximum fluorescence was p
calcein release (R50) from DOPC vesicles and 80DOPC:20DOPG vesicles and the ratio between
Table 1
Increase in ellipticity at 208 nm of Nc peptides as a function of lipid concentration
(units of molar ellipticity per mg/ml lipid×10−3).a,b
Peptide DOPC 80DOPC:20DOPG
Nc wt −1.21 −8.98
Nc-C8 −6.56 −29.56
Nc-C12 −8.84c −11.87
Nc-C16 −0.58 −1.15
a All data carried out in 20 mM Tris–HCl pH 7.5 at 25 °C. Fits based on data shown in
Fig. 2.
b These values are not actual affinity constants (since the ellipticity generally increases
linearly and does not level off to a plateau level over the concentration range tested) but
serve to illustrate the degree towhich different lipids can increase the secondary structure
of the Nc peptides over the experimentally accessible concentration range.
c Data have been fitted to a parabolic equation to derive the slope at zero molar lipid.
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(corresponding to the binding affinity) is ∼7 times higher. Nc-C12 has
slightly greater affinity for DOPC than Nc-C8, but the switch to
80DOPC:20DOPG vesicles only increases Nc-C12 affinity by around
30% while that of Nc-C8 increases 5-fold. The CD spectra of Nc-C16
remained essentially unchanged by the addition of both lipid types.
The reduced effect of anionic lipids likely reflects the increased
propensity of the acylated peptides to form α-helical structures on
their own (see Discussion).
3.2. Acylation leads to a marked decrease in the efficiency of lipid
permeabilization
We now turn to a functional analysis of the Nc peptides, i.e. their
ability to permeabilize vesicles, using a manual calcein release assay.to signal upon the addition of TritonX-100 (seeMaterials andmethods).With the addition
are observed in steady-state fluorescence measurements. A slow release leading with the
een0- and100% (□), andfinally a fast releasewith anovershootwhichafter∼1 min reach
veswere added to calcein-loaded vesicles composed of (B) DOPC and (C) 80DOPC:20DOPG
lotted as a function of protein concentration. (D) Peptide concentrations needed for 50%
these two values. Errors based on duplicate measurements.
Fig. 4. (A) Degree of release of β-galactosidase from E. coli by different concentrations
of Nc and acylated variants hereof. Errors in individual measurements ∼7% based on
duplicate measurements. (B) MIC assay performed on E. coli using different con-
centrations of Nc and acylated variants hereof. Errors in individual measurements ∼15%
based on duplicate measurements. Clearly Nc wt is the most effective at reducing E. coli
growth while Nc-C12 and Nc-C16 hardly have any effect at all.
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which calcein fluorescence is self-quenched, and measured the
release of calcein as function of peptide concentration, using the
addition of Triton X-100 to obtain the fluorescence level associated
with 100% release. The presence of calcein did not affect the ability of
lipids to induce structural changes in the peptides (data not shown),
nor did Triton X-100 influence the fluorescence of calcein (data not
shown).
Three distinct calcein release patterns were observed (Fig. 3A):
(i) instantaneous (<10 s) calcein release, followed by a steady base-
line (mainly seen for acylated Nc), (ii) relatively rapid release of
calcein which could be described by first order kinetics with a plateau
being reached after a few minutes (mainly seen for wt Nc), or
(iii) rapid overshoot of fluorescence to a value well above that of free
calcein, followed by a decrease to a signal corresponding to roughly
100% calcein release (seen at high concentrations of all 4 peptides)The
fraction of calcein released as a function of peptide concentration in
the two different lipid compositions is illustrated in Fig. 3B–C. The
efficacy of release is quantified by the amount of peptide needed to
effectuate 50% calcein release (R50). In all cases, very high concentra-
tions of peptide lead to a drop in calcein release (data not shown),
possibly due to vesicle aggregation (vide infra).
The ranking order of the lipolytic effect of the peptides is as follows
(summarized in Fig. 3D): Nc>Nc-C8>Nc-C16>Nc-C12. For all of the
peptides, it was apparent that R50 increased in 80DOPC:20DOPG
vesicles. The ratio R50DOPC:DOPG/R50DOPC (the higher this ratio, the greater
the preference for DOPC) decreased in the order Nc>Nc-C8>Nc-
C12∼Nc-C16, reaching a plateau of around 3 for Nc-C12 and Nc-C16.
This indicates that the more hydrophobic the peptide, the lower the
preference for DOPC vesicles. For Nc-C8 and Nc-C12 these permea-
bilization data contrast with the structural data provided by CD, which
reveal that acylation decreases the preference for 80DOPC:20DOPG
vesicles in terms of inducing α-helicity.
3.3. Exposure of E. coli to Nc variants shows that acylation reduces the
efficacy of Nc as an antimicrobial peptide
To compare the data on synthetic vesicles with Nc's biological
targets, i.e. bacteria, we measured the lysis of E. coli at different
concentrations of the Nc variants. Lysis was measured by the release
of cytosolic β-galactosidase, monitored by the hydrolysis of the
chromogenic substrate o-nitrophenyl galactose. All peptides lead
to the same level of release at concentrations around 20–40 µM
(Fig. 4A), but differ at lower concentrations. When we quantify this as
[Nc-X]50%, the concentration of Nc at which release is 50% of the
maximal value, we obtain a value of ∼1 µM for Nc wt and values of
5–7 µM for all 3 acylated peptides. An even clearer picture emerges
from MIC (minimal inhibitory concentration) assays (Fig. 4B), which
reveal that Nc-C8 has a ∼3-fold reduction in efficacy compared to
Nc wt, while Nc-C12 and Nc-C16 hardly have any inhibitory effect at
all. Thus, both in calcein assays and biological assays, unacylated Nc
permeabilizes membranes more efficiently than acylated Nc. This
membrane-lysing activity does not have any unwanted side effect,
since hemolysis assays do not reveal any of the Nc peptides to have
lytic activities against red blood cells at concentrations up to several
mM (data not shown).
3.4. Fluorescence anisotropy measurements show that Nc mobility is
decreased upon mixing with DOPC and 80DOPC:20DOPG vesicles
The calcein release measurements indicate that Nc binds to and
permeabilizes both neutral and partially anionic vesicles, although CD
titration data show that α-helical structure is only induced in the
partially anionic vesicles. This suggests that induction of α-helix
structure in peptides that are unstructured in solution is not a
prerequisite for AMP action. To monitor binding independent offolding, we used a Dansyl-labelled variant of unacylated Nc (Dansyl-
Nc) to measure how the fluorescence anisotropy of the dansyl group
changes as lipid is added. Immobilization of the peptide on the vesicle
surface is expected to lead to a significant increase in anisotropy.
Upon increasing the concentrations of lipid, we observe a hyperbolic
binding curve which for both DOPC and 80DOPC:20DOPG vesicles
reaches a plateau at a lipid:protein molar ratio of ∼250 (Fig. 5A).
Lipids were added stepwise to a single Dansyl-Nc solution. We were
able to probe higher lipid:peptide ratios than in the CD experiments
because of the low concentrations of Dansyl-Nc required for these
experiments. To obtain reproducible results, we had to let the system
equilibrate for a fewminutes before recording anisotropy, particularly
at the lower concentrations. This is most likely due to reorganization
of the lipids into micellar-like structures as we can see from our
calcein release measurements that the binding happens on a much
Fig. 5. (A) Anisotropy measurements of Dansyl-Nc in increasing concentrations of pure DOPC and 80DOPC:20DOPG. The vesicles were allowed to equillibrate for 1 min before each
measurement. (B) DSC scans of DMPC and 80DMPC:20DMPG at different peptide–lipid ratios. Legend indicates Nc wt:lipid ratio (molar ratio).
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anisotropy for the DOPC vesicles. This could tentatively be interpreted
as increased propensity to aggregate and thus permeabilize these
vesicles compared to 80DOPC:20DOPG vesicles (cf. Fig. 3D). Alterna-
tively, the peptide could be localized in a deeper and more ordered
part of the bilayer in the DOPC vesicles, leading to a more pronounced
effect on the lipid transition (see below).
3.5. DSC experiments reveal Nc interactions with both lipid types
Further evidence for the strong interaction of Nc with zwitterionic
as well as partially anionic vesicles comes from differential scanning
calorimetry experiments, where we monitor the phase transition
temperature tm in the presence of different concentrations of Nc. Here
we use DMPC and 80DMPC:20DMPG where the transition tempera-
ture (23 °C in the absence of peptide) is experimentally accessible.
Even at P:L ratios as low as 1:500, Nc wt has a marked effect on the
transition (Fig. 5B) but the details are different for the two lipids: for
DMPC, tm declines by a few degrees as we go from 1:500 to 1:250 P:L
and is replaced by amuch broader transition at 1:100 and 1:25 P:L. For
80DMPC:20DMPG, there is a rise in tm at the two lowest P:L ratiosfollowed by a decline; the broad transition is only observed at the
highest P:L.
3.6. Dansyl-labelled Nc highlights differences in peptide insertion into
different lipids
We combined the time-resolution of stopped-flow kinetics with the
environmental sensitivity of a Dansyl fluorophor, attached to the N-
terminus of unacylated Nc, to investigate the coupling between peptide
binding and calcein release. The Dansyl probe increases the hydropho-
bicity of Nc and this might be expected to lead to an increased
partitioning into the membrane. Accordingly, Dansyl-Nc shows a ∼3-
fold higher affinity towards DOPC and 80DOPC:20DOPG vesicles
compared to Nc wt, measured in terms of increased α-helicity (data
not shown). However, Dansyl-Nc shows the same 6–7 fold preference
for 80DOPC:20DOPG over DOPC as Nc wt does (Table 1), making it a
valid probe for measuring binding to different membrane types. When
Dansyl-Nc is mixed with DOPC vesicles, we observe a slight increase in
Dansyl fluorescence prior to vesicle disruption (indicated by the
increase in calcein fluorescence), indicating a modest degree of peptide
interaction with the membrane before disruption (Fig. 6A). However,
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fold higher increase in Dansyl fluorescence (compared to DOPC), which
also precedes vesicle disruption (Fig. 6B). This increased Dansyl
fluorescence in 80DOPC:20DOPG vesicles compared to DOPC vesicles
indicates that Novicidin undergoes a greater change in environmental
polarity when it inserts into 80DOPC:20DOPG vesicles. This suggests
that Nc inserts more deeply into the 80DOPC:20DOPG membrane than
into the pure DOPC membrane. We also observe an additional increase
in Dansyl fluorescence during the process of calcein release from
80DOPC:20DOPG vesicles, suggesting a further rearrangement of
Dansyl-Nc in the 80DOPC:20DOPG membrane upon vesicle disruption.
3.7. Nc peptides cause vesicle leakage, aggregation and lysis
Confocal laser scanning microscopy (CLSM) with giant unilamel-
lar vesicles (GUVs) provides an alternative way of elucidating theFig. 6. Stopped-flow analysis of Nc interactions with lipids. Upon the addition of Dansyl-
Nc we observe an increase for the dansyl fluorescence for both vesicles composed of
DOPC (A) and 80DOPC:20DOPG (B) before an increase in the calcein fluorescence. In
DOPC vesicles, there is a small increase in dansyl fluorescence due to binding (up to
0.1 s) followed by release of vesicle contents over 0.1–10 s. For the 80DOPC:20DOPG
vesicles, there is a large fluorescence increase from the dansyl probe up to ∼0.1 s and an
additional slower increase up to 100 s (possibly due to lipid rearrangements) while
calcein release occurs over the period 1–100 s.mechanism of action of the different peptides, since we can focus on
individual vesicles rather than measuring ensemble changes. The
GUVs contained a lipid fluorophor (DiIC18) and were loaded with
membrane impermeable water-soluble fluorophors (Alexa488 for
80DOPC:20DOPG vesicles and Alexa633 for DOPC vesicles), allowing
us to monitor changes in both membrane integrity and permeability.
The increased imaging facilities come at the expense of kinetic
resolution, because diffusion limitation led to typical lag times of 10–
15 min until the added peptide reached the field of vision, which
makes it unrealistic to compare with the time profile provided by
stopped-flow experiments. As illustrated in Fig. 7 and summarized in
Table 2, the interactions between peptide and vesicle could be
classified into three groups: (i) slow leakage that led to complete
release of the vesicle content over 5–10 min, leaving an empty but
intact vesicle behind; (ii) vesicle aggregation where the vesicles
clump together, without necessarily facilitating the release of trapped
fluorophor and (iii) vesicle lysis, causing immediate release of the
vesicle content and complete loss of vesicle structure. Within the
framework of current models for AMP action, (i) is most simply
interpreted as pore formation and (iii) as the carpet model for
membrane lysis, whereas (ii) represents an alternative class of
interactions which do not occur in the absence of Nc and which to
our knowledge has not been described before using CLSM. Images
recorded at different stages of the process are provided in the
Supplementary material.
Nc wt added to DOPC vesicles caused both vesicle lysis and
aggregation (Table 2). The fused vesicles seemed partially stabilized,
as they were the last to rupture and little to no leakage was observed.
For Nc, it was clear that there was a higher degree of vesicle
aggregation when the vesicles contained 20% DOPG. The aggregation
of both vesicle types caused partial entrapment of the water-soluble
probe and leads to larger particles with greater light-scattering
properties. This could very well explain the overshoot in steady-state
measurements at high concentrations that was more prominent
with 80DOPC:20DOPG vesicles. For both vesicle types, both lysis of
the vesicles and slow leakage was observed during and after the
aggregation of the vesicles. The increase in vesicle aggregation
observed with 80DOPC:20DOPG vesicles might be explained by
favorable electrostatic interactions between adsorbed (cationic) Nc
and neighbouring (anionic) vesicles. We have also observed aggre-
gation of the related peptide Novispirin in the presence of different
concentrations of SDS [31].
The addition of Nc-C8 to either DOPC vesicles or 80DOPC:20DOPG
vesicles did not cause vesicle aggregation to any observable degree,
but we did observe vesicle lysis. Vesicle leakage was only evident for
80DOPC:20DOPG vesicles. The leaky vesicles retained their structural
integrity despite the fact that they did not aggregate, in contrast to
observations with Nc. Nc-C12 did not cause slow leakage from neither
DOPC nor 80DOPC:20DOPG vesicles but resulted in vesicle lysis, and,
in contrast to Nc-C8, also led to vesicle aggregation. Thus, vesicle
aggregation seems to be independent of whether the peptide causes
lysis or leakage. For Nc-C16 the vesicle leakage behavior was
comparable to that of Nc for both DOPC and 80DOPC:20DOPG vesicles
but Nc-C16 caused an equally high degree of aggregation of vesicles
irrespective of their lipid composition.
We also investigated the behavior of Nc when presented with a
mixed population of different vesicles. In the presence of both DOPC
and 80DOPC:20DOPG vesicles, we see a clear preference for the
vesicles containing DOPG. We distinguish between the two vesicle
types by filling them separately with different water-soluble
fluorophores (Alexa488 for DOPC versus Alexa633 for 80DOPC:20-
DOPG). While the 80DOPC:20DOPG vesicles behave more or less in
the vesicle mixture as we have observed for neat 80DOPC:20DOPG
vesicles (both aggregation, lysis and leakage are observed), we only
observe rupturing of a few of the DOPC vesicles in the mixture. This
indicates that the 80DOPC:20DOPG vesicles compete effectively
Fig. 7. Representative multicolour fluorescence images of Alexa488 (green colour) loaded lipid vesicles with DiIC18 (red colour) incorporated in the membrane obtained by confocal
laser scanningmicroscopy. In the presence of Nc and acylated derivatives,we observe three distinctmodes of action, namely (A) vesicle leakage, (B) vesicle aggregation and (C) vesicle
lysis. The relative preferences for the three modes of action are summarized in Table 2. The arrows represent the flow of time, but the length of time is not specified due to different
kinetics with different peptides and lipids.
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material).
3.8. Nc-C16 is more deeply embedded in micelles than Nc wt
In order to analyze the effect of acylation on Nc's anchoring in
amphiphilic environments, we have used solution-state NMR to
determine the structure and extent of insertion of Nc-C16 in
zwitterionic (DPC) micelles. The structure was determined with
traditional homonuclear 2D-spectra for the proton shift assignment
and 1H–13C-HSQC natural abundance spectra for the Cα and Cβ shift
assignment. Key values of the structure calculation are listed in
Table 3. The structure of Nc-C16 consists of a single slightly bent
amphipathic α-helix with the acyl chain attached to the N-terminalTable 2
Summary of confocal laser scanning microscopy experiments with Nc and acylated
derivatives, indicating the propensities of the peptides for three different kinds of
vesicle interactions (illustrated in Fig. 7).a
Peptide DOPC vesicles 80DOPC:20DOPG vesicles
Vesicle leakage
Nc wt + +++
Nc-C8 − +
Nc-C12 − −
Nc-C16 + +++
Vesicle aggregation
Nc wt + +++
Nc-C8 − −
Nc-C12 ++ +
Nc-C16 +++ +++
Vesicle lysis
Nc wt ++ +
Nc-C8 +++ ++
Nc-C12 +++ +++
Nc-C16 ++ +
a For practical reasons, all experiments were performed at pH 6 and at 15 °C. The
degree of leakage, aggregation and lysis was based on a relative comparison between
the different samples.part of the peptide (Fig. 8A). Similar structures have been reported for
the homologous peptides Ovispirin and Novispirin in SDS micelles
[37–39]. The only NOE cross peaks between the peptide and the
attached acyl group that could be assigned were the correlation
between the HN of residues 1–3 and the protons located on the
fatty acid α-carbon atom. In the calculated structures the acyl chain
therefore appears highly flexible without this necessarily being
correct.
To determine the relative insertion depths of Nc and Nc-C16 in
DPC micelles, samples with the micelle bound peptides were titrated
with the paramagnetic agent Gd(DTPA-BMA) that is known not to
interact with peptides and micelles [36,40]. T1 relaxation values for
the Hα protons in the peptides were calculated from peak volumes of
cross peaks with the Hα atom appearing in the indirect dimension of
inversion-recovery weighted NOESY spectra. The R1 relaxation rates
of the Hα atoms measured at different concentration of Gd(DTPA-Table 3
Quality criteria for the calculated Nc-C16 structures.
Number of distance constraints 271
Of which intraresidual 136
Of which sequential 69
Of which medium-range (2≤Δres≤4) 66
Number of angle constraintsa 26
Of which φ 13
Of which ψ 13
CYANA residual target function 0.89±0.04 Å2
Distance restraints violated by more than 0.2 Å 0
Angle restraints violated more than 5°b 0
rmsd residues 2–17c 0.13±0.08 Å
% of residues in Ramachandran plotd
In most favored regions 91.5
Less favored regions 7.6
Generously allowed regions 0.9
Disallowed allowed regions 0
a Only those derived from TALOS.
b Per molecule.
c For backbone atoms C′, Cα and N, as calculated by CYANA from the pairwise rmsd
values of each of the 20 structures against a mean structure.
d As calculated by PROCHECK_NMR.
Fig. 8. (A) Structure of Nc-C16 in the presence of DPC. Superposition of the 20 backbone
conformers with the lowest cyana target function representing the 3D NMR structure.
The bundle is obtained by superimposing the backbone Cα, C, and N atoms of resi-
dues 2–17. The carbon atoms of the acyl chain are clearly seen extending from the
N-terminal part of the peptide. (B) PRE values of Hα nuclei of Nc (▲) andNc-C16 (■) as a
function of residue numbers. Error bars indicate variations in PRE values obtained from
fitting several peaks.
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paramagnetic agents giving the paramagnetic relaxation enhance-
ment (PRE) values of the atoms.
In Fig. 8B the Hα PRE values of Nc and Nc-C16 can be seen as a
function of the residue numbers. The PRE curves of both peptides give
a wavelike pattern with a wavelength of either 3 or 4 residues
between the maxima of the PRE curves which for both peptides are
located at the residues Asn-2, Arg-5, Lys-9, His-12 and Lys-16
corresponding to the hydrophilic side of the amphipathic helix.
As the PRE values depend on the inverse of the sixth power of the
distance between the hydrogen and the paramagnetic atom [40], the
results shows that the hydrophilic side of the helix is facing the
outside of the micelle as expected. The PRE values of the Nc atoms are
significantly larger than the corresponding atoms in Nc-C16 which
clearly indicates that the acylated variant of Novicidin is burieddeeper into the micelles. This difference is most pronounced for Asn2
in the N-terminal part of the peptides where the acyl chain of Nc-C16
is attached, which suggests that the hydrophobic acyl chain of Nc-C16
is pulling the N-terminus of the peptide towards the hydrophobic core
of the micelle. This increased immersion then appears to be
transmitted along the helix backbone to the rest of the peptide all
the way to the C-terminus, probably reflecting an overall increase in
the membrane partitioning coefficient.
3.9. Solid-state NMR experiments reveal stronger interactions of acylated
Nc with lipids
We now turn from Nc–detergent to Nc–lipid interactions using
oriented-sample solid-state NMR spectroscopy. Atomic-resolution
details on the insertion of the different variants of Nc into different
phospholipids may be obtained by recording 1H–13C PISEMA spectra
[41] of natural abundance samples with the peptides reconstituted
into bicelles (formed by DMPC:DMPG:DHPC lipids at different ratios)
produce bicelles with the right size and charge properties. Note that
DMPC:DMPG based membranes was chosen instead of DOPC:DOPG
membranes to follow known recipes [42] for production of stable
bicelles. To the best of our knowledge, such recipes are not established
for DOPC/DOPG membranes. Accordingly, direct comparison of
biophysical and solid-state NMR data has to be conducted under the
precaution that lipid chain-length and saturation may influence
details of the membrane–peptide interactions. The DMPC:DMPG:
DHPC bicelles orient in a strongmagnetic field with the bicelle normal
perpendicular to the field direction, enabling measurement of
anisotropic (i.e., orientation-dependent) chemical shift and dipole–
dipole coupling interactions for the various CHn groups in the lipids.
Accordingly, the 1H–13C PISEMA experiments may be used correlate
orientation-dependent 13C chemical shifts with 1H–13C dipole–dipole
couplings for the abundant lipid molecules as demonstrated previ-
ously for other systems by Ramamoorthy and coworkers [43,44]. By
monitoring the positions and lineshapes of the resonances for various
lipid carbons in 2D PISEMA spectra, it is possible to probe small
differences in local dynamics and orientation of the lipid functional
groups and thereby get information about the influence of the
peptides on the various parts of the lipids. This is illustrated in Fig. 9,
with Fig. 9A showing a representative full 2D PISEMA spectrum of
DMPC:DHPC bicelles containing Nc wt (molar ratios Nc wt:DMPC:
DHPC 1:57:18), Fig. 9B the molecular structure of DMPC with
indication of three representative functional groups, and Fig. 9C–H
excerpts for these functional groups from 2D PISEMA spectra recorded
using different lipid:peptide systems. The full PISEMA spectrum
demonstrates correlation between 1H–13C dipole–dipole couplings
(giving rise to multiplets/splittings in the horizontal direction) and
13C chemical shifts for the highly abundant lipid CHn groups.
Variations in the orientation-dependent dipole–dipole coupling and
chemical shifts upon mixing in peptides to the membranes will probe
peptide:lipid interactions with spatial resolution through observation
of distinct signals for the various lipid carbons.
The PISEMA spectrum excerpts (Fig. 9C–H) originate from samples
with pure lipid (red line), lipid and Ncwt (green line), lipid and Nc-C8
(blue line), and lipid and Nc-C16 (magenta line) with the lipids
being either pure zwitterionic bicelles (DMPC together with DHPC,
Fig. 9C–E) or a mixtures of zwitterionic and anionic bicelles (molar
ratios Nc:DMPC:DMPG:DHPC 1:46:10.6:17.7, Fig. 9F–H). The spectra
report the perturbation of headgroup (Cα), a central carbon (C3), and a
terminal acyl carbon (C14) according to the structural model given in
Fig. 9B. In addition to contour plots from relevant parts of the 2D
PISEMA spectra for the four different samples, the individual panels
also contain sum projections (left and top) onto the 13C chemical shift
axis (vertical) and the 1H–13C dipolar axis (horizontal). The individual
panels also contain (right and bottom) the corresponding traces taken
through the maximum point of the 2D spectra for the peptide-free
Fig. 9. Solid-state NMR spectra of Novicidin and acetylated variants in pure and mixed lipids. (A) Full 1H–13C dipole–dipole couplings versus 13C chemical shift correlated PISEMA
spectrum of DMPC:DHPC bicelles including Nc wt (molar ratios Nc:DMPC:DHPC of 1:57:18). (B) Molecular model of DMPC with indication of the Cα, C3, and C14 carbons through
which excerpts of PISEMA spectra (C–H) are taken. (C–H) Each panel describes four different bicelle samples containing either; pure lipid bicelle (red), lipid and Nc wt (green), lipid
and Nc-C8 (blue) and lipid with Nc-C16 (magenta). Each panel consists of an excerpt from 2D 1H–13C PISEMA spectra of DMPC:DHPC or DMPC:DMPG:DHPC bicelles as well as sum
projections and traces along the position of the pure bicelle for both the 1H dimension and the 13C dimension. (C–E) describe the spectral changes observed for zwitterionic bicelles.
(F–H) describe the spectral changes observed for a mixture of zwitterionic and anionic bicelles (molar ratios Nc:DMPC:DMPG:DHPC 1:46:10.6:17.7). The focus is on three
representative regions describing the lipid head group (C, F), the central part of the lipid molecule (D, G), and the lipid tail region (E, H).
Table 4
Summary of peptide induced-perturbation of CHn groups in the headgroup (Cα), central
(C3), and tail (C14) regions of zwitterionic (DMPC) and mixed zwitterionic and anionic
(DMPC:DMPG) bicelles.a
Peptide DMPC DMPC:DMPG (4:1)
Headgroup (Cα) Nc ++ +
Nc-C8 +++ ++
Nc-C16 +++ ++
Central (C3) Nc ++ −
Nc-C8 ++ +
Nc-C16 ++ ++
Tail (C14) Nc − −
Nc-C8 − −
Nc-C16 +++ +
a See labelling of lipid functional groups in Fig. 9B.
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tion and time averaged dynamics) may be monitored from the 2D
contours as well as the projections, it is evident that most sensitivity
towards minor changes in peak positions will be probed through the
traces. Note that all samples were prepared with approximately the
same peptide concentration. Furthermore, the calcein release data
(Fig. 3) suggest that Nc will display stronger interactions with
zwitterionic vesicles than with the mixed zwitterionic and anionic
vesicles. However, the CD data (Fig. 2) suggest that 80DOPC:20DOPG
vesicles bind Nc more strongly.
From the upper panels in Fig. 9C–H, it becomes evident that Nc as
well as the acylated Nc variants interact with the headgroup of both
types of lipids. This is seen from the position and shape of the
contours, and very clearly from the traces taken at the position of the
resonance in the pure lipid spectra. A closer inspection of the spectra
provides a more diverse set of observations for a deeper penetration
of the peptides into the various lipids. From Fig. 9C–E column, it is
seen that Nc-C16 interacts with all carbon sites of the zwitterionic
lipids and thereby may adapt a transmembrane (or transiently
transmembrane) configuration with significant effect on the carbons
on the central region of the lipids. Note that in the absence of NMR
signals from the peptide, we cannot determine whether it is the acyl
chain or the peptide backbone that is transmembrane. In contrast, it
appears that largely only the headgroup region (Cα and C3 carbons)
are affected by the peptides with shorter or no acylation. Turning to
the DMPC:DMPG:DHPC lipid bicelles (Fig. 9F–H column), it appearsthat the perturbing effect from the various peptides on the local
environment of the lipids are somewhat less pronounced (weaker
interactions) and to a large extend only influence the headgroup
region. For the Nc wt sample only a slight shift in the resonance
position is observed for the α and β (not shown) carbons, indicating a
relatively weak perturbation as compared to the interaction with the
pure bicelles.
The observed changes (summarized in Table 4) overall indicate
that Novicidin and its acylated variants mainly interact with the
surface of bicelles composed of zwitterionic and anionic lipids, while
more pronounced interactions are observed for the pure zwitterionic
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accelerates the interaction with perturbation of the inner parts of
the membrane for the Nc-C16 acylation. We note that the 1H–13C
PISEMA experiments do not provide information on whether this
transmembrane perturbation is caused by the formation of ion
channels (barrel stave) or static/transient incorporation of mono-
mer/oligomers of acylated peptides. We note that, in full consistency
with the NMR observations, the biophysical measurements report the
strongest membrane perturbation for the DOPC vesicles, with the
requirement of less peptide to penetrate/perturb the vesicles relative
to the 80DOPC:20DOPG vesicles— although this appears to occur with
very little induction of secondary structure.
4. Discussion
4.1. Acylation promotes higher-order assemblies and α-helical structure
The CD spectra of Nc and the acylated derivatives in buffered
solution clearly show that the C12 and C16 acyl chains changed the
peptide structure. Nc-C12 is random coil at 40 µM but α-helical at
200 µM, whereas Nc-C16 was α-helical at all measured concentra-
tions (10–100 µM). For Nc-C12, this can be explained by the peptides
arranging in a surfactant like fashion (aided by the acyl chain's desire
to avoid an aqueous environment) with a critical micelle concentra-
tion (CMC) between 40 and 200 µM. Micelle formation results in an
α-helical structure, as described by Makovitzki et al. [20]. For Nc-C16,
the CMC is either below the peptide concentration tested in this study
(i.e. <10 µM) or the structure is stabilized in a different fashion,
possibly existing only as amonomer. Solution-state NMR experiments
on pure samples of Nc-C12 and Nc-C16 in the absence of lipids
showed that both derivatives at ∼1 mM in aqueous buffer formed
aggregates that did not yield any useful NMR signals (M. F. and R. W.,
unpublished data). However, when dispersed in DPC, Nc-C16 yielded
well-defined NMR spectra. In addition, Dufour et al. [45] have studied
linearized versions of the lipopeptide surfactin and found that C10,
C14, and C18 surfactin had CMC values of 1113, 301, and 8 µM
respectively. These values are consistent with our own observations
and also support the Nc-C16 micellization. In principle, the acyl chain
could also pack against the peptide at the monomer level provided a
suitably hydrophobic binding surface was available as suggested by
Makovitzki et al. [20]. A helix projection of Nc (Fig. 1) highlights a
perfectly amphipathic helix with a sharp distinction between a
hydrophobic face (only interrupted by Gly10) and a cationic face,
where the acyl chain is attached to first residue placed in themiddle of
the cationic face. Nevertheless, Nc-C16's apparent micellization
suggests that the C16 chain engages in inter- rather than intra-
molecular packing. It is likely that the precise site of attachment of the
acyl chain will dictate whether it is more favorable for the chain to
dock against the peptide, engage with other acyl chains in an
intermolecular micellar arrangement, or even combine the two
types to form small micelles that also incorporate the peptide, as
suggested for the lipopeptides elegantly developed by Privé et al. [46].
It is worth considering how these aggregative tendencies may
influence subsequent vesicle interactions:We have a systemwith two
defined states, one monomeric where the peptide has a random
conformation, the other most likely multimeric where the peptide has
an α-helical structure. Let us assume that the peptide initially inserts
as a monomer into the lipid bilayer (even if it binds as a multimer it is
likely to rearrange its higher-order arrangement in the bilayer, and
possibly monomerize, due to the change in environment). In that case
binding will need to be preceded by micelle dissociation above the
CMC of the lipopeptide micelle (which is <10 µM for Nc-C16 and
between 40 and 200 µM for Nc-C12). Detergent micellar dynamics
typically involve two relaxation processes, namely the dissociation of
monomer from micelles (on the µs scale) and micelle break-up (on
the minute scale depending on the biophysical properties of thedetergent) [47]. Thus, we do not consider it likely that monomer
dissociation frommicelles is rate-limiting for the kinetics of binding of
acylated Nc to membranes.
Furthermore, we do not expect the acylated peptides' aggregation
tendencies to play significant roles in their membrane permeabilizing
and antimicrobial properties for three reasons: Firstly, these activities
are measured at very low concentrations where aggregation in
solution is very insignificant for Nc-C8 and Nc-C12 and likely also
very low for Nc-C16. Secondly, there is no difference between Nc-C12
and Nc-C16's permeabilizing and antimicrobial activities despite
significant differences in aggregation potential. Thirdly, Nc-C8 can
be considered a non-aggregating peptide under all our measured
conditions and its permeabilizing and antimicrobial activities lie
neatly between the unacylated Nc wt and the Nc-C12 and Nc-C16
peptides.
Any changes in membrane disruption kinetics are therefore most
likely to reflect changes in the binding to the membrane and/or
structural rearrangements in this environment. Let us address these
issues.
4.2. Changes in secondary structure caused by the addition of lipids
Nc folding in vesicles is strongly dependent on the lipid head-
group. Nc remains largely random coil in DOPC, but 80DOPC:20DOPG
vesicles induce α-helical structure. However, the increase in second-
ary structure does not in itself favor permeabilization butmakes it less
efficient. These data can be interpreted in twoways: either Nc binds to
a smaller extent to DOPC than to 80DOPC:20DOPG vesicles but
the peptide molecules that do bind are much more efficient at
permeabilizing DOPC than 80DOPC:20DOPG. Alternatively, Nc binds
to DOPC vesicles but in a disordered conformation. We favor the latter
interpretation, since we know from three independent techniques
(calcein release, fluorescence anisotropy and DSC) that Nc binds at
least as well to DOPC vesicles as to 80DOPC:20DOPG vesicles. The
differences in structure may reflect different arrangements on the
vesicle surface and/or membrane traversion, as suggested also by the
different DSC profiles towards zwitterionic versus partially anionic
vesicles. One scenario could be that Nc is loosely attached to DOPC
vesicles, allowing it to remain relatively unstructured and thus cover a
larger surface on the vesicle, while in 80DOPC:20DOPG vesicles Nc is
buried at the headgroup-acyl chain interface, favoring an amphipathic
α-helix structure. This is consistent with our stopped-flow experi-
ments with Dansyl-Nc where we observe a higher degree of
interaction with 80DOPC:20DOPG vesicles both prior to and after
vesicle disruption. Our solid-state NMR observations also show that
Nc mainly interacts with the lipid headgroups. Previously we
observed that the closely related peptide Novispirin was able to
bind to the positively charged surfactant LTAC to a more superficial
extent than to the complementary SDSmicelles, highlighting different
levels of interaction [31]. Other studies also indicate that binding and
permeabilization can be separate processes, and that binding alone is
not sufficient for membrane permeabilization. For example, the
amyloid-β peptide can bind to both crystalline and liquid disordered
phases but only permeabilize the liquid disordered state [48].
Acylated peptides are α-helical in the presence of zwitterionic
vesicles, suggesting that the acyl chain causes the peptides to adsorb
to the vesicles in a manner that facilitates the formation of α-helix.
One could imagine that the acyl chains work as “anchors” that pull the
peptides into the headgroup-acyl chain interface where it then folds
into an α-helix, supported by our PRE-data which indicate deeper
penetration into micelles by Nc-C16 than Nc wt (Fig. 8B). This
anchoring effect may also explain our solid-state NMR observation
where we not only observe perturbation of the lipid head groups but
also effects in the central and tail parts of the lipids—where α-helical
secondary structure would support membrane penetration (static or
transient). Graham and Phillips [49] reported that adsorption of rigid
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pressure compared to flexible molecules. Thus increased peptide
rigidity induced by α-helix formation (in combination with “plug-
ging” effects mentioned below) could explain the decreased tendency
to disrupt vesicles. In addition, the increased submersion into the lipid
bilayer will make the acylated peptides less sensitive to the nature of
the headgroup and will thus decrease the preference for zwitterionic
lipids shown by Nc.
4.3. Changes in lipid specificity caused by acylation
In the steady-state fluorescence measurements of vesicle disrup-
tion, we observe that Nc causes calcein release from DOPC vesicles at
7-fold lower concentration than those needed for disruption of
80DOPC:20DOPG vesicles. Solid-state NMR data also reveal a stronger
interaction between the peptide and the DMPC membranes than the
DMPC:DMPG membranes. Peptide acylation increases the concen-
trations needed for vesicle disruption, and leads to a decreased
preference for zwitterionic vesicles compared to partially anionic
vesicles (Fig. 3D). However, this decreased functional efficiency does
not reflect a lower degree of overall binding to vesicles, as we need
less lipid to induce changes in secondary structure for both Nc-C8 and
Nc-C12 compared to Nc. To explain this apparent discrepancy, we
speculate that the peptide's N-terminal acyl chain to some degree is
able to counteract membrane disruption. The observed faster release
rates for acylated peptides could then could then be explained by
the higher surface concentration of peptide that has been able toFig. 10. A schematic model to illustrate why much less Nc wt is required compared to the
attaches peripherally to DOPC vesicles since there is no significant change in the secondary
DOPG, Nc is submergedmore extensively in the bilayer, most likely at the acyl chain headgrou
the dansyl-labelled Nc prior to vesicle disruption. The acylation of Nc (acyl chain in pink
Nevertheless the insertion is different from that in 80DOPC:20DOPG vesicles, since there are
two types of vesicles. The acyl chain helps to counteract the vesicle destabilizing effect of the
irrespective of the lipids used.accumulate up to this level without disrupting themembrane because
of the “plugging” effects of the acyl chainwhich help retainmembrane
integrity (see model in Fig. 10). The “plugging” effect could very well
be what we observe in the solid-state NMR spectra. It is clear that Nc-
C16 interacts with central parts of the lipid bilayer as seen in Fig. 9E
and H. We note that from the present NMR data, we cannot
distinguish whether it is the peptide itself or it is its acyl chains that
interact with the central parts of the lipids. Data which could be
interpreted in the same light have been observed for the lipopeptide
surfactin where an increase in acyl chain length lowers the surface
pressure of vesicles [50]. In vivo these effects would presumably lead
to a decrease in the haemolytic activity of the peptide as the outer
leaflet of red blood cell is primarily composed of the zwitterionic
phosphatidylcholine and phosphatidylethanolamine [51].
The decreased preference of acylated Nc for zwitterionic lipids
differs significantly from the work of Dathe et al. [52] and Wieprecht
et al. [53], who report an increased affinity towards zwitterionic
vesicles as a result of increased hydrophobicity. However, in their
studies they have made point mutations in order to increase the
hydrophobicity, rather than acylating the peptide. As with the
acylated variants, this emphasizes the separation of folding and
function.
4.4. Vesicle aggregation
The overshoot observed in our calcein release assay is presum-
ably a scattering effect caused by vesicle aggregation. Apparently theacylated versions to cause the same degree of vesicle permeabilization. Nc wt (blue)
structure upon binding although we still observe vesicle disruption. In the presence of
p interface, leading to increasedα-helix structure and an increase in the fluorescence of
) pulls the peptide deeper into the DOPC vesicles as we have formation of α-helix.
still clear differences in the vesicle disruption kinetics and concentrations needed for the
peptide, leading to the need for higher concentrations of peptides to disrupt the vesicles,
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overshoot to decrease over time. This is confirmed in our CLSM
experiments where we in some cases clearly observe vesicle
aggregation followed by vesicle disruption. Peptide induced aggrega-
tion of vesicles has been reported previously for antimicrobial
peptides such as Cryptidin-4 and polylysine, measured by FRET and
dynamic light scattering [54–56]. The aggregation is believed to be
driven primarily by preferential electrostatic interactions, bilayer
deformation, and lipid head group dehydration [56,57]. We do
observe a link between the aggregation and the acylation, since
increasing chain lengths increase the aggregation (though Nc-C8 has
reduced aggregation capability compared to non-acylated Nc). One
explanation could be that the previously suggested plugging effect, in
combination with exposure of cationic side-chains on the surface
which can attract neighbouring anionic vesicles, gives the peptide–
lipid complexes time to interact and subsequently aggregate.
Our working model for the effect of Novicidin on membranes is
summarized in Fig. 10.
4.5. In a mixed population of vesicles charge interactions are the
governing forces of peptide–lipid interactions
Confocal laser scanning microscopy experiments on the mixed
populations of purely zwitterionic and zwitterionic-anionic vesicles
(Supplementary material) reveal that peptides show a marked
preference towards the (partially) negatively charged DOPC:DOPG
vesicles over the zwitterionicDOPCvesicles. This preferencediffers from
our calcein releasemeasurements but does not contradict them. Rather,
they simply reveal that long-range interactions in solution,mediated by
electrostatics, can be sufficient to trap peptides on or close to a
membrane surface for subsequent folding and membrane interactions.
Although the visualization of vesicle contents release by peptides and
small molecules has been reported previously [58–61], to our
knowledge this is the first example of the microscope-based analysis
of mixed vesicle populations. This allows us to compare the affinity of
wildtype and modified peptides for a specific lipid composition in the
presence of competing lipids, and thus ultimatelymodel complex in vivo
systems, such as the human digestive tract, where the antimicrobial
peptides are exposed to a diverse range of possible targets [62,63].
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FULL PAPERS 
Structural Studies of Amphibian Antimicrobial 
Peptides in Micelle and Bicelle Phospholipid 
Environments 
Magnus Franzmann[a], Kirstine Lykke Christensen[a], Daniel Otzen[b] and Reinhard 
Wimmer *[a] 
 
In this study, we describe the insertion depth and orientation of two 
antimicrobial peptides Maculatin 1.1 and Citropin 1.1 from Australian 
tree frogs in different membrane mimicking environments. Soluble 
paramagnetic species were used to induce paramagnetic relaxation 
enhancements (PREs) from which the orientation and insertion depth 
in micelles and bicelles were determined.  Our data suggest that 
Citropin 1.1 is positioned parallel to the surface of the membrane 
whereas the interaction of Maculatin 1.1 with the membranes 
dependents on the charge of the lipid/detergent head groups. 
 
Introduction 
Secretion of small peptides with antibiotic properties has been 
shown to be a vital part of the innate immune system of many 
organisms. They are typically secreted in tissues that are 
continuously exposed to the environment like epithelia cells 
where they act as a first line of defense against microbes. 
Antimicrobial peptides (AMPs) have attracted considerable 
amounts of interest for treatment of a rapidly increasing number 
of microbes with multiresistance phenotypes to traditional 
antibiotics and they are considered promising candidates as 
alternative antibiotic agents.[1] Since the characterization of 
Bombinis by Csordas and Michl in 1969[2, 3] the skin of 
amphibians like toads and frogs have become one of the riches 
sources of AMPs with several hundred natural peptides 
isolated.[4] These peptides are typically cationic peptides 
consisting of less than 50 amino acids and most of them are 
unstructured in solution but adopt an α-helical structure in the 
presence of lipids or other amphipathic molecules.[5] Two overall 
methods of action for peptides with these characteristic can be 
described using the Shai-Matsuzaki-Huang model.[6] This 
postulates that small cationic peptides can either disrupt the cell 
membrane of the target organisms by forming pores (toroidal or 
barrel-stave model) or by binding to the surfaces of the microbes 
in a detergent like manner, leading to displacement of a part of 
the membrane (carpet model). 
The work presented here describes the study of two model 
peptides that presumably act upon the microbial membranes by 
either the pore model or the carpet model. The protein groups 
Citropins and Maculatins consist of amphiphatic α-helix peptides 
found in the skin secretions of members of the Australian tree 
frog family.[7] Maculatin 1.1 (hereafter only referred to as 
maculatin) is a cationic 21 amino acid peptide which has been 
extracted from the dorsal glands of the frog Litoria genimacula 
and has been shown to have an AMP effect mainly on Gram 
negative bacteria.[8, 9] It is unstructured in solution but adapts an 
α-helical structure in TFE/water mixtures or in the presence of 
membrane mimicking detergents or lipids.[9] The structural studies  
 
 
 
 
 
in 50% TFE and DPC micelles reveal a slight kink at Pro15 in an 
approximately 30 Å α-helix which has the length to span the 
widthof bacterial membranes and to form pores.[9] Citropin 1.1  
(hereafter only referred to as citropin) is a 16 amino acid cationic 
AMP secreted found in the skin secretions of the frog Litoria 
citropa. It shares N-terminal sequential homology with maculatin 
(see table 1) and is also a peptide that adopts an α-helical 
structure in membrane mimicking environments.[10] The solution 
structure of citropin determined in 50% TFE by NMR shows a 
straight α-helix but the length of this is as opposed to maculatin 
not sufficiently long to span the bacterial membranes which could 
indicate a carpet model mode of action.  
Direct visualization of leakage of different sized fluorophores 
from zwitterionic giant unilamellar vesicles (GUVs) upon addition 
of maculatin or citropin points towards different membrane 
permeabilizing mechanisms for the two peptides.[11] As maculatin 
allows passage of small but not large fluorophores these studies 
suggests that maculatin forms pores in the vesicles. In contrast is 
the overall structure of membranes exposed to citropin 
completely destroyed when a critical peptide concentration is 
reached whereas both small and large fluorophores are retained 
below this threshold concentration.[11] This indicates that citropin 
disrupts the membrane through the carpet model. Based upon 
interpretations of line broadening effect in 2H and 31P solid state 
NMR spectra it has been suggested that that maculatin inserts 
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deep into the core of anionic bilayers as opposed to zwitterionic 
bilayers where the peptide binding mostly affects the surface 
atoms.[12, 13] In contrast does citropins placement near the 
phosphate head groups appear to be independent of the lipid 
charge. These finding are supported by surface plasmon 
resonance (SPR) and Langmuir-monolayer technique studies that 
like the solid state NMR studies suggest different modes of action 
for maculatin dependent of the membrane charge.[14] Additional 
studies by differential scanning calorimetry (DSC) and fourier 
transform infrared spectroscopy (FTIR) shows a preferred 
interaction between both maculatin and citropin and bilayers 
containing 1,2-dimyristoyl-sn-glycero-3-phospho-(1'-rac-
glycerol)(sodium salt)(DMPG) compared to bilayers with only 
zwitterionic lipids like 1,2-dimyristoyl-sn-glycero-3-
phosphatidylcholine (DMPC) or 1,2-ditetradecanoyl-sn-glycero-3-
phosphoethanolamine (DMPE).[3, 15] Somehow ambiguous to 
these combined results are the solid state NMR study of 
maculatins impact of the phospholipid membranes of live E. coli 
cells. The appearance of isotropic peaks upon addition of 
maculatin indicates a formation of small micelle structures 
originating from the disintegration of the cell membrane which 
corresponds to a carpet model mode of action.[3] Likewise is a 
considerable disruption of the overall structure of the bacteria S. 
aureus observed by electron microscopy when maculatin are 
added to the cells.[16] Although these later two examples could be 
caused by extreme amount of toroidal pores it is apparent that 
further studies are needed to fully elucidate the membrane 
disrupting mechanisms of citropin and especially maculatin.  
Previous NMR studies have in order to analyze the 
membrane interaction of maculatin and citropin relied on line 
broadening effects and chemical shift changes observed on the 
lipid resonance signals.[12, 13, 17] Although this provides valuable 
information whether the peptide is surface bound or inserted into 
the membrane it is due to spectral overlap not possible to 
unambiguously identify all atoms in the lipid acyl chains hence 
determining the insertion depth with even low levels of precision. 
The accuracy is further worsened by the mobility of the lipids 
where especially the tail regions of the lipids are highly mobile.[18]  
Here we present an atomic resolution solution study of 
citropin and maculatin inserted into detergent micelles and both 
anionic and zwitterionic phospholipid bicelles. Besides a 
widespread use in alignment media bicelles are also used as 
membrane mimicking systems because they presumably 
provides a more native like lipid environment compared to 
micelles due to the more planar shape of the bilayers.[19] However, 
because micelles are considerable smaller and easier to handle 
than disc shaped bicelles, micelles are more frequently used to 
study membrane associated proteins and peptides. Questions 
regarding the biological relevance when studying protein and 
peptides in detergent micelles have been raised and we therefore 
compare data from both micelle and bicelles solutions to seen 
whether the orientation and the immersion depth differs in the two 
membrane mimicking systems.[19] From distance restrains 
obtained from NOESY and dihedral angles obtained from HSQC 
spectra we were able to determine high resolution structures of 
the peptides incorporated into the membrane mimicking systems. 
From titrating lipid or detergent bound maculatin and citropin with 
the water soluble paramagnetic agents Gd(DTPA-BMA) and a 
polylysine dendrimeric form of 24 Gd(DOTA) complexes 
(24Gd(DOTA)) we have determined PREs from peptide atoms of 
interest. The PRE values provided distance information between 
the free floating paramagnetic centers and the peptide protons. 
Because the peptide atoms to different degrees were embedded 
into the lipids/detergent and thereby inaccessible by the water 
soluble Gd complexes we have combined the calculated 
structures with the PRE data to obtain information concerning the 
orientation and immersion depth of the peptides. To gain a 
deeper insight into the membrane disrupting mechanisms of the 
two peptides we have compared the PRE values obtained by the 
relative small Gd(DTPA-BMA) which presumably are capable of 
entering any transmembrane pores and the much larger 
24Gd(DOTA) polymer which on the other hand is very unlikely to 
do so. 
 
Table 1 
Peptide Sequence 
Maculatin 1.1 GLFGVLAKVAAHVVPAIAEHF-NH2 
Citropin 1.1 GLFDVIKKVASVIGGL-NH2 
Results and Discussion 
Structure calculations.  
The proton signals of the two peptides citopin and maculatin in 
the presents of DPC detergent micelles were assigned with the 
aid of sets of homonuclear DQF-COSY, TOCSY and NOESY 
spectra and the carbon signals were assigned with the aid of 
1H,13C-HSQC spectra recorded at natural abundance. For each 
peptide 80 structures were calculated based on distance 
restraints derived from NOE integrals and dihedral angle 
restraints obtained from the chemical shift values using the 
software program TALOS.[20] The 20 structures with the lowest 
residual target function were collected for both citropin and  
Figure 1 A) Overlay of maculatin structures in the presence of DPC micelles 
(magenta) or DMPC/DHPC  bicelles (cyan). B) Overlay of citropin structures 
in the presence of DPC micelles (green) and DMPC/DHPC bicelles (yellow). 
All bundles show the 20 structures with the lowest residual target functions, 
with N, C’ and C
α
 from residues 2-20 and 2-12 aligned for maculatin and 
citropin respectively. 
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maculatin and least squared fits are shown in figure 1. Key values 
of the structure calculations are listed in table 2. Neither the 
reported structure of citropin[10] nor maculatin[9] have been 
submitted to the  Biological Magnetic Resonance Data Bank  
(www.bmrb.wisc.edu/) and it is therefore not possible to compare 
them in details to our structure. However, roughly based on the 
published figures our calculated structures appear to be highly 
similar to both citropin dissolved in 50% TFE[10] and maculatin 
dissolved in 50% TFE and DPC[9]. Maculatin forms a slightly 
curved and clearly amphiphatic α-helix with the hydrophilic 
residues Gly1, Gly4, Lys8, Ala11, His12, Gly15, Ala16, Glu19, 
His20 located on one side of the helix. Citropin is likewise an 
amphipathic α-helix with the hydrophilic Gly1, Asp4, Lys7, Lys8, 
Gly14, Gly15 located on one side of the helix, however, the α-
helical axis of citropin is more straight compared to maculatin.   
Bicelles solutions with lipid concentrations of 15% (w/v) and a 
long chained lipid to short chain lipid ratio of 0.5 e.g. 
([DMPG]+[DMPC])/[DHPC]=0.5 have been shown to be highly 
suitable for NMR studies of membrane associated proteins and 
peptides.[19, 21] They form approximately discoid lipid bilayers with 
a diameter of 80-100 Å and a thickness of 50 Å consisting of 
long chained lipids which are rimmed by short chained lipids thus 
shielding the hydrophobic tails of the lipids from the surrounding 
water and thereby stabilizing the overall structure.[19, 21, 22] The 
relaxation properties of proton coherences are very fast in 
bicelles which makes it very difficult to observe any J coupling 
hence any signals in COSY, TOCSY or HSQC type spectra.[23] 
However, dipole-dipole interactions observed in NOESY type 
spectra were clearly observable although due to the size of the 
DMPC/DHPC bicelles the line width of the maculatin and citropin  
 
signals were considerable broadened when studied in bicelles 
compared to the in the much smaller DPC micelles. DMPC and 
DMPG are to our knowledge not commercially available in fully 
deuterated forms but merely as partly deuterated where only the 
hydrogens of the lipid tails are replaced by deuterium. By using 
these partly deuterated lipids and applying a selective pulse and 
transverse signal cancellation using pulsed field gradient we were 
able to suppress most of the very strong and disturbing lipid 
signals. Only minor chemical shift differences were observed 
between citropin and maculatin dissolved in DPC and bicelle 
solutions. The assignments of the NOESY peaks from the 
peptides in DPC solutions were therefore used as basis for the 
assignment of citropin and maculatin in bicelle solutions, although 
due to broader peptide signals in bicelles solutions a lower 
amount of signals were observed. Similar to the structure 
determination of citropin and maculatin in DPC solutions the 
reduced numbers of distance restraints in bicelles solutions 
obtained from NOEs and dihedral angle constrains obtained from 
chemical shifts (although merely from proton chemical shifts) 
were used as input for the structure calculation program. From 80 
calculated structures the 20 with the lowest residual target 
function were collected (see figure 1). The RMSD between 
maculatin dissolved in DPC and DMPC/DHPC solutions is 1.36 Å 
and between citropin in DPC and DMPG/DMPC/DHPC solutions 
it is 0.86 Å. Key values of the structure calculations are listed in 
table 2. 
Paramagnetic relaxation enhancements 
PRE values of the Hα atoms of citropin and maculatin in DPC 
micelles have been obtained by titrating the samples with  
Table 2. Quality Criteria for the Calculated Structures 
 
Maculatin 
(DPC) 
Citropin 
(DPC) 
Maculatin 
(DMPC/DHPC) 
Citropin 
(DMPG/DMPC/DHPC) 
number of distance constraints 200 153 112 152 
 - of which intraresidual 119 97 60 83 
 - of which sequential 48 30 39 52 
 - of which medium-range (2 ≤ Δres ≤ 4) 33 26 13 17 
number of angle constraints
a
 22 20 22 20 
 - of which φ 11 10 11 10 
 - of which ψ 11 10 11 10 
CYANA residual target function 0.21 ± 0.02 Å
2
 0.097 ± 0.002 Å
2
 0.16 ± 0.028 Å
2
 0.54 ± 0.036 Å
2 
distance restraints violated by more than 0.2Å 0 0 0 0 
angle restraints violated more than 5
o b
 0 0 0 0 
rmsd residues 2-20 (mac) or 2-15 (cit)
c
 0.04 ± 0.03 Å 0.21 ± 0.01 Å 0.30 ± 0.11 Å
2
 0.74 ± 0.19 Å
2 
% of residues in Ramachandran plot 
d
     
 - in most favored regions 98.2 100 96.5 91.7 
 - less favored regions 1.8 0 3.2 8.3 
 - generously allowed regions 0 0 0.3 0 
 - disallowed regions 0 0 0 0 
(a) Only those derived from TALOS, (b) Per molecule, (c) For backbone atoms C', C
α
 and N, as calculated by CYANA from the pair wise rmsd values of each of 
the 20 structures against a mean structure, (d) as calculated by PROCHECK_NMR 
 4 
 
Gd(DTPA-BMA) and the values plotted as a function of the  
residue numbers (see figure 2). For both peptides a wavelike 
pattern with a wavelength between 3-4 residues are observed 
spanning the entire length of the peptides which is characteristic 
for α-helices lying parallel to the surface of micelles as previously 
described.[24, 25] The PRE maxima of maculatin are observed for 
Gly4, Lys8, His12, Gly15, Glu19, His20 and Phe21 which 
corresponds to the hydrophilic side of the structure with exception 
of the C-terminal phenylalanine. The PRE values of protons 
depend on the inverse of the third power of the distance between 
the measured nuclei and the paramagnetic center when using a 
free-floating noninvasive paramagnetic agent like Gd(DTPA-
BMA).[24, 25, 26] It can therefore be assumed that when comparing 
PRE values relative to each other, the ones with the highest PRE 
values must be located nearer towards the paramagnetic agent 
and hence towards the solution. It is therefore clear that the  
 
hydrophilic side of the peptide is facing the outside of the 
micelles as would be expected. The PRE values with the 
highest values observed for citropin are Asp4, Lys8, Ser11 and 
Gly15 which like maculatin is located on the hydrophilic side of 
the peptide. 
 
PRE values and hence the calculated distances between the 
peptide atoms and micelles center are dependent of the 
dynamical properties of the molecules as can be seen from eq. 3 
and 4.[27] Therefore, it is not straightforward to calibrate PRE 
values on one system with known distances and then to apply 
this calibration on a different molecular system with potentially 
different dynamic behavior. There, we have investigated the 
dynamic properties of DPC,  maculatin and citropin in micelles 
and maculatin in bicelles. Residue specific T1 and T2 relaxation 
times were obtained for selected 15N labeled amino acids in the 
Table 3 
Citropin  Val5 Ala10 Gly14 Gly15 Leu16  
Citropin (DPC) T1 (s
-1
) 0.60 ± 0.011 0.55 ± 0.005 0.60 ± 0.010 0.71 ± 0.037 0.70 ± 0.025  
 T2(s
-1
) 0.12 ± 0.006 0.17 ± 0.012 0.15 ± 0.009 0.16 ± 0.012 0.13 ± 0.007  
        
Maculatin  Leu2 Val9 Ala11 Val13 Gly15 Phe21 
Maculatin (DPC) T1 (s
-1
)  1.08 ± 0.34 8.18 ± 0.094 1.27 ± 0.54 0.97 ± 0.26 1.43 ± 0.60 
 T2(s
-1
)  0.095 ± 0.0047 0.097 ± 0.012 0.096 ± 0.0048 0.095 ± 0.0030 0.13 ± 0.0063 
Maculatin 
(DMPG/DMPC/DHPC) 
T1 (s
-1
) 0.94 ± 0.007 0.79 ± 0.172 0.86 ± 0.016 0.86 ± 0.014 0.95 ± 0.024 0.84 ± 0.011 
 T2(s
-1
) 0.036 ± 0.0013 0.053 ± 0.013 0.035 ± 0.0012 0.035 ± 0.0012 0.044 ± 0.0011 0.034 ± 0.0004 
Figure 2 PRE values for Hα nuclei of (A) maculatin in DPC titrated with Gd(DTPA-BMA), (B) maculatin in DMPC/DHPC titrated with Gd(DTPA-BMA), (C) 
maculatin in DMPC/DHPC titrated with 24Gd(DOTA), (D) citropin in DPC titrated with Gd(DTPA-BMA) and (E) citropin in DMPC/DHPC titrated with 
Gd(DTPA-BMA). Error bars indicate variations in PRE values obtained from fitting several peaks.  
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two peptides dissolved in DPC micelles or maculatin in 
DMPG/DMPC/DHPC bicelles and the values are listed in table 
3.[28] From the average values of T1/T2 we have calculated the 
correlation times (τr) of the peptides as described previously by 
Clore et al. to 1.01 * 10-8 s, 1.55 * 10-8 s, and 5.9 * 10-9 s for 
maculatin in micelles, maculatin in bicelles and citropin in micelles, 
respectively.[29] For DPC we have calculated a correlation time 
based on correlation times obtained from Beswick et al.[30] They 
measure L (correlation time characterizing the internal motion) to 
80 ps at 285 K and 50 ps at 298 K from which we have 
extrapolated L to be 33.8 ps at 310 K. The overall correlation 
time for the micelle was calculated from the equations[31]: 
   
 
where  is the viscosity, r is the radius of the micelle, k the 
Boltzmann constant, T the temperature and D is the diffusion 
constant. We have measured the diffusion constant for a DPC 
micelle to 1 * 10-10 m2/s at 310 K and by assuming a micelle 
radius of 22.5 Å we have calculated m to 1.13 * 10
-8 s. The 
effective correlation time is given by: 
 
  
  
where S2 is the order parameter, m is the correlation time of 
overall ensemble motion and L is the correlation time of the 
internal motions. By inserting the order parameters, the 
extrapolated L from Beswick et al.
[30] and the calculated m we 
have calculate the effective correlation time for micelle bound 
DPC to 4.22 * 10-11 s.  
To be able to compare the obtained R values impact on R1 
relaxation (PREs) we have plotted the proton relaxation rates as 
a function of the correlation time as calculated from eq. 3 and 4 
(see figure 3):  
             
 
 
where J is the electronic spin, r the distance between the electron 
and 1H spin, μ0 is the magnetic susceptibility in vacuum, H the 
1H 
gyromagnetic ratio, gJ the Landé factor, μB the Bohr magneton 
and ωH and ωS the Larmor frequencies of the 
1H and electron 
spin, respectively, M is the lifetime of the intermolecular adducts 
(estimated to 2.4 ns based on c and R values from
[25, 27]), r the 
correlation time of the molecules in question and T1e the electron 
relaxation time (1 * 10-8).[27, 32] 
Eq. 3 and 4 are only valid when both the paramagnetic 
species and the nuclear spin whose PRE is observed, are 
attached to the same rigid molecular framework. If the 
paramagnetic species floats freely, the PRE only depends on the 
inverse 3rd power of r[24, 25]: 
 
The effective correlation time of DPC give a PRE value of 63 s-1 
compared to 62, 66 and 73 s-1 for maculatin in bicelles, maculatin 
in micelles and citropin in micelles, respectively (the values are 
plotted in figure 3). It therefore turns out that, despite large 
differences in correlation times between DPC and peptide atoms, 
the correlation time dependent term of eq. 3 and 4 are most 
fortunately very similar for  DPC and for citropin and maculatin. It 
is therefore possible to calibrate the distance dependence of 
PREs on DPC and use the calibration on PREs measured for the 
peptides embedded in the micelles.[24] Taken into consideration 
that the calculated distances are dependent on the inverse third 
power of the PREs (eq. 5) an error in PRE calibration due to 
differences in correlation times translates to a mere cubic root of 
this error in determined distance. For citropin in micelles, which is 
the value with the largest c difference from DPC, the error in 
distance is approximately 5%. 
Hα PRE values of citropin and maculatin have been converted 
into distances to their respective micelle centers. The distances 
are plotted in figure 4. These distances have then been converted 
to distance restraints and used as input for the structure 
calculation program alongside the distance restraints derived 
from NOEs and chemical shifts as described previously.[24] From 
is seen that both citropin and maculatin are positioned near the 
surface of the micelles and that the hydrophilic side chains 
together with the N and C termini of both citropin and maculatin 
are located in the DPC/solution interface.  
PRE values of Hα atoms of maculatin in DMPC/DHPC bicelles 
have been obtained by titrating the bicelles with Gd(DTPA-BMA) 
and the values have been plotted as a function of the residue 
Figure 4 Black lines show the calculated distances between H
α
 atoms of the 20 
structures with the lowest residual target function and the center of the micelle. 
The gray area defines the range between the upper and lower distance 
restraints, based on the PRE values of the H
α
 atoms. Restraints are obtained 
from the average PRE values of maculatin (A) and citropin (B) ± 1 Å. d 
corresponds to the distance to the micelle center. 
Figure 3 PRE plotted as a function of R. Correlation times for DPC(▼), 
maculatin in DPC micelles (▲), maculatin in DMPG/DMPC/DHPC bicelles (■) 
and citropin in DPC micelles(●) 
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numbers (see figure 2). Despite difficulties obtaining high quality 
data due to increased signal line width, it is possible to observe 
tendencies in the PRE curves. The PRE maxima of the maculatin  
Hα atoms titrated with Gd(DTPA-BMA) are observed for Leu2, 
Gly4, Lys8, His12 and Glu19 which is identical with the PRE 
maxima of maculatin in DPC micelles except from Leu2, the 
absence of Gly15 and lower values of the C-terminal residues 
His20 and Phe21. These data clearly points to maculatin as 
positioned at the surface of the zwitterionic bicelles. However, if 
maculatin were forming toroidal pores with a internal diameter 
large enough for the passage of Gd(DTPA-BMA) molecules with 
a diameter of 7 Å[27] the hydrophilic residues would still be facing 
the solution hence the paramagnetic agent and a wavelike 
pattern would still be observed. We therefore titrated 
DMPC/DHPC bicelles with 24Gd(DOTA) which is very unlikely to 
travel through pores due to the much larger size.[11] The resulting 
PRE values gave somehow ambiguous data (see figure 2). 
Although it is difficult to determine the maximum values of the 
PRE curve due to missing data the residues Gly1, His12, Gly15 
and His20 appear to be peak values. This would correspond well 
to the maxima of maculatin in DPC micelles which also had 
maximum values at His12, Gly15, His20 in addition to Gly4, Lys8, 
Glu19 and Phe21. More worrying is the fact that some of the 
PREs have negative values which should not be possible. One 
should obviously be careful drawing conclusions based on these 
data however there are indications that maculatin remains to be 
positioned near the head groups of the bicelles lipids like it is 
seen in DPC micelles.  
Despite great interest (and efforts) we have not been 
successful in acquiring useful PRE values for maculatin in anionic 
DMPG/DMPC/DHPC bicelles. As has been observed by Marcotte 
et al.[13] the bicelles are disrupted by insertion of amphibian AMPs 
over the relative long acquisition time (> 1 day) for the NMR 
experiments. The disruption causes a visible milky precipitate in 
the NMR tube and the signals are consequently broadened 
beyond detection due to the size of the aggregates. Interestingly  
does maculatin cause precipitation in the anionic bicelles much 
faster (<1 day) compared to in zwitterionic bicelles where the 
solution stays clear for well over a week. As has been observed 
by several other groups this is a clear indication that maculatins 
affinity and likely also its mode of action is different in anionic 
lipids compared to in zwitterionic lipids.[12, 13] 
Citropin in DMPG/DMPC/DHPC bicelles did not precipitate 
over time as observed for the maculatin sample and we were 
therefore able obtain PRE values by titrating the sample with 
Gd(DTPA-BMA). The values have been plotted as a function of 
the residue numbers (see figure 2), and the PRE maxima of the 
citropin Hα atoms are observed for Gly1, Asp4/Val5, Lys8, Ser11, 
Gly15 which is identical to the PRE maxima observed in micelles 
except that a data point for Gly1 H  can be obtained, because 
Leu2 HN is observable in the bicelles sample. Combined with 
knowledge of citropin’s mode of action from previously published 
studies[11] this clearly indicates that citropin acts by the carpet 
model due to its apparent position at the solution/lipid interface of 
the bicelles. 
Conclusion 
We have used PRE values of Hα atoms in both a qualitative and 
quantitative manner to obtain information concerning the 
orientation and immersion depth into membrane mimicking 
environments of the two model AMPs citropin and maculatin. 
Compared to previously published studies of citropin’s and 
maculatin’s interaction with lipids and detergents at low 
resolutions[3, 11, 12, 13, 14, 15, 17], our data provides results at atomic 
resolution in micelles and bicelles from where conclusions can be 
drawn to their antimicrobial mode of action. In agreement with 
these previously studies our data shows that both citropin and 
maculatin forms amphipathic α-helical structure in the presents of 
detergent or lipids, and that both peptides are located in at the 
water/detergent interface near the head groups of the zwitterionic 
Figure 5 The structures of maculatin (A) and citropin (B) with the calculated distances to the micelles centers depicted as dotted lines. Spheres of 45.2 Å 
diameters are shown to illustrate the approximate size of DPC micelles. 
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DPC micelles. Furthermore does our data suggest that citropin 
and maculatin are likewise positioned at the surface of 
DMPG/DMPC/DHPC and DMPC/DHPC bicelles, respectively, 
which is also in agreement with previous publications.[12, 13] As the 
data obtained in micelles are highly similar to the data obtained in 
bicelles (and therefore also likely at bacterial membranes), our 
data suggests that simple micelle systems are well suited to 
determine the structure and position of membrane associated 
peptides and at least AMPs positioned parallel to the surface of 
the membrane. Because we were unable to measure PRE values 
of maculatin in anionic bicelles due to significantly reduced 
stability of the samples we have been unable to measure whether 
maculatin forms transmembrane pores under these lipid 
conditions. However, the altered bicelles stability properties 
induced by the addition of maculatin clearly indicated that the 
peptide interacts differently with the anionic lipids however it is 
not possible based on these observations to conclude if there is 
any changes in its mode of action. Further studies of maculatin 
are clearly needed in order to fully elucidate the membrane 
penetrating mechanism of the peptide.  
Experimental Section 
Materials. DPC, DHPC, DMPC and DMPG were purchased from 
Avanti Polar Lipids (USA) and DPC-d38, DMPC-d54, DMPG-d54 and 
DHPC-d22 as well as 
15
N labeled FMOC Leu, Val, Ala, Phe and Gly 
were purchased from Cambridge Isotope Laboratories Inc. (USA). 
Gadomer17 (24Gd(DOTA)) were purchased from InvivoContrast 
(Germany) and Omniscan (Gd(DTPA-BMA)) was generously provided 
by Aalborg Hospital. Wang resins and Rink-Amide MBHA resin were 
obtained from Iris Biotech GmbH (Germany) and Fmoc-L-amino acids 
from Advanced ChemTech (USA).  
Solid Phase Synthesis. Both partially 
15
N labeled and unlabeled 
maculatin and citropin were synthesized by solid phase peptide 
synthesis on an Activo-P11 Automated Peptide Synthesizer 
(Activotec, Cambridge, UK). Wang resins were preloaded with Rink-
Amide MBHA resin. 25% piperidine in dimethyldformamide (DMF) 
was used for FMOC deprotection of all resins and amino acids, and 
0.5 M HOBt/HBTU in DMF were used for activation of the amino acids. 
The amino acid couplings were performed using 1 M 
diisopropylethylamine (DIPEA) in DMF under nitrogen atmosphere 
with coupling times of 60 min. Dichloromethane (DCM) was used for 
final washing and the peptides were cleaved from the resin using 2 
mL 95:2.5:2.5 (v/v/v) mixture of trifluoroacetic 
acid/triisopropylsilane/H2O with a cleaving time of 60 min. The 
peptides were precipitated with 10 mL cold diethyl ether and 
centrifuged at 300 g for 10 min (4 
o
C). The supernatant was removed 
and the pellet containing the peptide was washed twice with cold 
diethyl ether before lyophilizing.  
Reverse phase HPLC purification of the peptides were performed on 
a UltiMate 3000 LC system (Dionex, USA) with a C18 semi-
preparative column (Luna 5u C18(2), Phenomenex). The solid phase 
synthesis product were dissolved in a small amount of DMSO and 
subsequently diluted with 0.1% TFE in H2O and applied to the column. 
Purification was achieved using a linear gradient from 20 to 100 % of 
eluant A acetonitrile. 0.1% TFA was always present. The flow rate of 
5 mL/min over 30 min. Fractions of interest were collected and pooled 
before dilution with H2O and lyophilizing.  
MALDI-TOF Mass spectrometry was used for verification of the 
synthesis product. Peptides were dissolved in 5% (v/v) formic acid in 
H2O and mixed 1:1, 1:2 and 1:3 with saturated sinapinic acid (SA) 
followed by sonication and centrifugation. 1 L of the solutions was 
dried on a MALDI-TOF target plate and data were recorded using a 
Bruker Reflex III spectrometer (Bruker-Daltronics, Germany).  
NMR samples. Both 2 mM maculatin and 2 mM citropin were 
dissolved in 90 mM DPC-d38, 10 mM phosphate buffer, 0.05% (w/v) 
NaN3, 5% (v/v) D2O, pH 6 to final volumes of 500 L. Furthermore 
were either 2 mM maculatin or 2 mM citropin mixed with 1,2-
dimyristoyl(d54)-sn-glycero-3-phosphatidylcholine (DMPC) and if 
stated 1,2-dimyristoyl(d54)-sn-glycero-3-phospho-(1'-rac-
glycerol)(sodium salt) (DMPG) both dissolved in 10 mM phosphate 
buffer, 0.05% (w/v) NaN3, 5% (v/v) D2O, pH 6. The solutions were 
subjected to a series of heat/cold/vortex cycles before mixing with 
1,2-dihexanoyl(d22)-sn-glycero-3-phosphocholine in 10 mM 
phosphate buffer, 0.05% (w/v) NaN3, 5% (v/v) D2O, pH 6 to give final 
volumes of 300 L and lipid concentrations of 15 % (w/v) with a 
long/short lipid ratio (q) of 0.5. Peptide samples with selectively 
15
N 
labeled amino acids (Leu2, Val9, Ala11, Val13, Gly15, Phe21 in 
maculatin and Leu2, Val5, Ala10, Gly14, Gly15, Leu16 in citropin) 
were prepared in DPC-d38 solutions as described above. Selectively 
labeled maculatin was furthermore prepared in a 
2
H-
DMPG/DMPC/DHPC solution as described above.  
NMR recording. All NMR spectra were recorded at 310 K on a 
BRUKER DRX600 spectrometer operating at a field strength of 14.1 T, 
equipped with a TXI(H/C/N) probe with triple-axis gradients. NOESY, 
TOCSY, DQF-COSY and 
1
H,
13
C-HSQC spectra were recorded for 
maculatin and citropin samples dissolved in DPC as described 
previously.
[24]
 NOESY spectra were recorded for maculatin and 
citropin dissolved in lipid mixtures. Assignment of all NMR spectra 
was performed using the program CARA version 1.5.5.
[33]
 NOE cross 
peaks were subsequently integrated using the NEASY subroutine of 
CARA
[34]
. Backbone torsion angle restraints were obtained from 
chemical shift values using the program TALOS
[20]
 and the CALIBA
[35]
 
subroutine in CYANA was used to convert integrated cross-peak 
intensities from the NOESY spectra into distance constraints. These 
combined constraints provided the input for the structure calculation 
using the torsion angle dynamics program CYANA
[36]
. Structure 
calculations were started from 80 conformers with random torsion 
angle values and the 20 structures with the lowest CYANA target 
function were collected and analyzed using Pymol.
[37]
 
For the PRE measurement, the samples were titrated with either 
Gd(DTPA-BMA) to final concentrations of 2, 5 and 10 mM or with 
24Gd(DOTA) to final concentrations of 0.1 and 0.2 mM. For the two 
samples containing either maculatin or citropin in the presence of 
DPC eight inversion recovery NOESY spectra with recovery delay 
times of 1, 50, 150, 400, 700, 1200, 2600 and 4000 ms were recorded 
on the samples without paramagnetic agents and for each titration 
point in order to obtain the T1 relaxation time. For the two samples 
containing maculatin and citropin in the presence of lipid mixtures six 
inversion recovery NOESY spectra with recovery delay times of 1, 
150, 400, 700, 1200 and 2600 ms were recorded on the samples 
without paramagnetic agents and for each titration point in order to 
obtain the T1 relaxation time. T1 and T2 relaxation times of the NH 
groups at the selectively labeled amino acids of maculatin and citropin 
were obtained using pulse sequences described by Kay et al.
[28]
 For 
T1 experiments relaxation delays of 1, 200, 400, 800, 1600, 5000 ms 
were used and for T2 experiments relaxation delays of 0, 16, 31, 63, 
130, 250 ms were used. All spectra were processed using Topspin 
version 1.3. Assignment of all NMR spectra were performed using the 
program CARA version 1.5.5
[33]
 and cross peaks were subsequently 
integrated using the NEASY subroutine of CARA.
[34]
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We report a new NMR method for determining the stereospecific assignment of prochiral protons in proteins based on the 
structures of the peptide in simulated water environments and differences in paramagnetic relaxation enhancement exerted 
by a non-perturbing water soluble paramagnetic agent. Paramagnetic relaxation enhancements of peptide atoms provide 
information concerning the relative orientation of prochiral protons towards the solvent. Together with a preliminary 
structure, this information can be used to stereospecifically assign prochiral protons.  This information can then be used to 
improve the structure calculation.  
 
1 
Introduction 
NMR structure determination of proteins and peptides is mainly based on NOESY 
spectra, where cross peak intensities are used to derive upper distance 
constraints(Wuthrich 2003). This requires knowledge of which two atoms, nearly 
exclusively hydrogen atoms (in NMR often referred to as “protons”), are 
responsible for the cross peak. Such knowledge is typically referred to as the NOE 
assignment. It is usually not possible to stereospecifically assign resonances from 
chemically nonequivalent, diastereotopic, protons, e.g. the diastereotopic protons 
in CH2 groups or the two non-equivalent methyl groups in isopropyl moieties. 
However, NOEs to these groups are a vital source of structural information, and 
discarding them would significantly reduce the quality of the obtained structures. 
In an attempt to retain the use of NOEs involving protons whose stereospecific 
assignment is not known, pseudoatoms were introduced.(Guntert 1998)  
Pseudoatoms are artificial atoms fixed to the molecular framework at a location at 
the center of mass of a group of protons. NOEs observed to any member of this 
group are then in the structure calculation treated as NOEs to these pseudoatoms. 
However, the actual distance of an atom outside the group to the pseudoatom is 
only rarely the same as the distance to the single members of the group. This is 
accounted for by introducing a pseudoatom correction, where the upper distance 
limit between the affected atoms is increased by the distance between the 
pseudoatom and the members of the group, which is the maximum possible error 
introduced. While this ensures that no additional constraint violations are 
introduced by the introduction of the pseudoatoms, it constitutes a loss of 
information, as the introduced error in most cases is much lower than the 
pseudoatom correction accounts for. This loss of information leads to more 
loosely defined structures. To avoid this problem and to improve the quality of the 
calculated structures, various methods have been developed to stereospecifically 
assign diastereotopic groups in proteins, thus eliminating the need for introduction 
of pseudoatoms. Nonrandom, fractional labeling of proteins with 13C(Neri and 
others 1989; Senn and others 1989) or 2H(Curley and others 1994; Ostler and 
others 1993) valine, leucine and glycine can be used to stereospecifically assign 
diastereotopic groups using scalar couplings. Chemical shift calculations can 
reveal stereospecific assignments, if the chemical shift differences are more than 
0.3 ppm(Williamson and Asakura 1992). 3Jαβ couplings in combination with Hα-
2 
Hβ distances obtained from NOEs can be used for assignments of β-methylene 
protons (Hyberts and others 1987; Xu and others 1992; Zuiderweg and others 
1985) which also has been combined with grid searches in X-ray structure 
databases.(Nilges and others 1990) Furthermore, C,H and H,H dipolar couplings 
can be used for determining the stereospecificity of CH2 groups provided that 
additional structural information is known.(Carlomagno and others 2000) 
The extensively used software program HABAS (Guntert and others 1989) 
calculates proton stereospecific assignments based on scalar couplings and the 
intraresidual and sequential NOEs. The program GLOMSA (Guntert and others 
1991) provides additional assignments of diastereotopic substituents based on 
distance restraints and calculated structures.  
Here we use paramagnetic relaxation enhancements (PREs) for stereospecific 
assignment. PREs have previously been used to map protein surfaces (Pintacuda 
and Otting 2002), refine protein NMR structures (Madl and others 2009; Madl 
and others 2006) and determine the position and orientation of peptides in 
micelles (Franzmann and others 2009; Respondek and others 2007; Zangger and 
others 2009). We calculate the structure of a peptide by standard methods and 
determine the PREs for a maximum possible number of diastereotopic protons. 
Subsequently, we compare the obtained PREs with the distances of individual 
atoms from the solution in our first structure. If there is a consistent correlation 
between the observed PREs and distances, we define a stereospecific assignment. 
Finally, we repeat the structure calculation with the stereospecific assignments. 
We used Omniscan (Gd(DTPA-BMA)) as a paramagnetic relaxation enhancement 
agent, as it has been shown not to interact specifically with proteins (Pintacuda 
and Otting 2002). 
As model system we used the 40 residue peptide Plectasin, an antimicrobial 
peptide from a fungus with known structure.(Mygind and others 2005)  
 
Materials and methods 
Materials: Plectasin was generously provided by Novozymes A/S and Omniscan 
(Gd(DTPA-BMA)) was generously provided by Aalborg Hospital. 
NMR recording: All NMR spectra were recorded at 300 K on a BRUKER DRX 
600 spectrometer operating at a field strength of 14.1 T, fitted with a TXI (H/C/N) 
probe with triple-axis gradients. A NMR sample containing 1 mM Plectasin, 30 
3 
mM acetic acid, 5% D2O, 0.05% azide at pH 3.8 was prepared. A 2D NOESY 
spectrum with 50 ms mixing time was recorded with a WATERGATE water 
suppression.(Piotto and others 1992) [1H, 1H]-TOCSY spectra with 50 ms mixing 
time were recorded using a clean-TOCSY pulse sequence with a 15 kHz spin-lock 
and excitation sculpting water suppression.(Griesinger and others 1988; Hwang 
and Shaka 1995) 2QF-COSY and [1H-13C]-HSQC spectra were recorded using 
standard pulse sequences taken from the Bruker Topspin pulse sequence library. 
All spectra were processed using Topspin version 1.3. Assignment of all NMR 
spectra were based on previously published resonance frequencies by Mygind et 
al.(Mygind and others 2005) and performed using the program CARA version 
1.5.5(Keller). NOE cross peaks were integrated using the NEASY subroutine of 
CARA(Bartels and others 1995), and the CALIBA(Guntert and others 1991) 
subroutine in CYANA was used to convert integrated cross-peak intensities from 
the NOESY spectra into distance constraints. These combined constraints 
provided the input for the structure calculation using the torsion angle dynamics 
program CYANA(Guntert and others 1997). Structure calculations were started 
from 80 conformers with random torsion angle values and the 20 structures with 
the lowest CYANA target function were collected and analyzed using 
Pymol(DeLano 2002).  
 
For proton PRE measurements of Plectasin the sample was titrated to 2, 5 and 10 
mM final concentration of Gd(DTPA-BMA). 8 inversion recovery [1H-13C]-
HSQC spectra with recovery delay times of 1, 50, 120, 250, 700, 1000, 2000, 
3000 ms were recorded with 0 mM Gd(DTPA-BMA) present and for each 
titration point in order to obtain the T1 relaxation time. Relaxation rates (1/T1) 
were plotted against the concentration of the Gd-complex, a linear regression 
yielded the PRE values as the slope of the regression line.  
 
Water simulation: calculated peptide structures were placed in simulation boxes, 
extending 1.5 nm from the peptide along all three axes. The boxes were filled with 
TIP3P water and sodium ions were iteratively placed at the coordinates with the 
lowest electrostatic potential. Simulations were started with a steepest descent 
minimization (until atom speed <2200 m/s) and followed by 500 steps of 
simulated annealing using the YASARA 8.9.11 MD protocol.(Krieger and others 
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2004) Water atoms were removed from the PDB files using the program 
pymol(DeLano 2002) 
 
Results and discussion 
The proton signals were assigned using a standard set of homonuclear 2D-spectra, 
and the carbon shifts of the residues were assigned using a 1H-13C-HSQC 
spectrum. From an inversion recovery [1H-13C]-HSQC spectrum we identified 24 
prochiral proton pairs for which we could determine the PRE values by measuring 
the T1 relaxation times at increasing concentrations of relaxation agent. Due to a 
higher spectral overlap in the lower 1H-ppm range, the identified protons pairs 
were mainly bound to Cα (5) and Cβ (15) carbons of their respective amino acids 
while only a few pairs were bound to Cδ (1) or Cγ (3) carbons. The PRE values of 
protons depend on the inverse of the third power of the distance between the 
measured nuclei and the paramagnetic center when using a free-floating 
noninvasive paramagnetic agent like Gd(DTPA-BMA).(Franzmann and others 
2009; Luz and Meiboom 1964a; Luz and Meiboom 1964b; Respondek and others 
2007) It can therefore be assumed that when comparing the PRE values of two 
atoms relative to each other, the one with the highest PRE value must be located 
nearest towards the paramagnetic agent and hence towards the solution. The PRE 
values of the 24 measured prochiral proton pairs are listed in table 1. 
 
A set of 80 structures was calculated and the 20 structures with the lowest residual 
target functions were collected. The HABAS program was used in the structure 
calculation and yielded 14 stereospecifically assigned pairs out of 50 possible. 
The structure contains an α-helix and two antiparallel β-strands in an αβ-defensin 
motif and is cross-linked by three disulfide bridges. Key values of the structure 
calculations are listed in table 2. The structure of Plectasin has previously been 
published(Mygind and others 2005) (pdb code 1zfu) and our structure is, as 
expected, practically identical with the previously published structure (see figure 
1a) with a backbone RMSD of 0.795 Å between the two structures. To obtain 
information concerning the relative orientation of the Plectasin proton pairs 
towards the surrounding water, the distances between the peptide and water atoms 
were measured for all atoms in each of the 20 calculated peptide structures in 
water simulated boxes. Distances below 5.9 Å were discarded as it is not possible 
5 
e 
for the paramagnetic center to come closer to the peptide surfaces than this due to 
the 3.5 Å radius of the chelate(Pintacuda and Otting 2002) plus two hydrogen van 
der Waals radii. Minimum distances between peptide atoms and water were 
collected for the 24 prochiral proton pairs with measurable PRE values. If the 
same proton (of the two protons in the group) was situated closer to the surface in 
≥90% of the structures, we assumed it to be safe to assign this proton to the NMR 
resonance showing the higher PRE. This was the case in 15 out of the 24 proton 
pairs with measurable PREs. As this is synonymous with being closer to the 
paramagnetic atoms we can for the 15 stereo pairs combine this information with 
the PRE values and thereby stereospecifically assign the proton resonances.  
15 stereo specific proton pair assignments obtained from the interpretation of PRE 
data were introduced into the structure calculation protocol and the structure was 
recalculated. The HABAS protocol yielded further stereospecific assignments for 
12 proton pairs. The convergence of the 20 structures with the lowest CYANA 
residual target function was significantly improved from 0.64 ± 0.2 Å to 0.37 ± 
0.09 Å (see figure 1b and 1c respectively). The introduction of the restraints only 
gave rise to two distance violations in the new structure calculation. These 
violations were at the residue 14 Hβ2/ Hβ3 stereo pair. We cannot explain these 
violations and excluded this particular stereospecific assignment from the 
structure calculation.  
We have been using inversion recovery edited [1H-13C]-HSQC spectra for the 
measurement of T1 but, any type of experiment that measures T1 relaxation can 
be used. The method presented here is limited to protons not too distant from th
protein surface, which shows measurably different PREs. However, this will not 
likely be a practical limitation: of the protons from which we have obtained PRE 
values usable for stereospecific assignment, Cys 15 Hβ2/Hβ3 have the largest 
distance to the protein surface, 7.2  and 6.5 Å, respectively.  Although 
paramagnetic effects of chelated Gd3+ have been observed at distances up to 30 
Å(Vlasie and others 2007) let us assume that our method in principle only can 
assign diastereotopic protons that are no more than 7Å away from the protein 
surface. Globular protein molecules of 20-25 kDa usually have a radius of 10-13 
Å on the shortest axis. Approximating the protein as a perfect sphere with a radius 
of 13Å, (133-(13-7)3)/133 = 90% of the volume of the protein and hence the amino 
6 
acid residues will be within 7 Å from the surface and thus accessible for the 
proposed method for stereospecific assignment. 
The improvement in RMSD observed here is in agreement with several previous 
publications which have reported that the precision of NMR structures is 
improved when using stereospecific assignments of side chain atoms compared to 
structures calculated without them.(Driscoll and others 1989; Guntert and others 
1989; Nilges and others 1990) In contrast to many of the previously published 
methods, our method does not require any expensive labeling schemes and it is 
easy to implement in preexisting structure determination routines. At the same 
time, it yields a higher number of stereospecific assignments than the widely 
employed, purely computational HABAS method. 
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Figure legends 
 
Fig 1 a) Comparison of the previously published Plectasin structure (red) with the structure 
calculated by us without PRE based stereo specific assignments (blue). b) The bundle of 
20 Plectasin structures with the lowest residual target function calculated without PRE 
based stereo specific assignments. c) As “b” but calculated with PRE based stereo 
specific restraints. Table 2 gives the quality criteria for the two structures shown in b) and 
c) 
 
Table 1. Pairs of prochiral protons in Plectasin for which it was possible to measure the PRE 
values. Protons with the relative highest PRE values are marked in gray.  
 
Table 2. Quality criteria for the calculated Plectasin structures. (a) Distance restraint obtained from 
NOE's without including distance restraints from disulfide bonds. (b) Per molecule, (c) For backbone atoms 
C', Cα and N, as calculated by CYANA from the pairwise rmsd values of each of the 20 structures against a 
mean structure (d) As calculated by PROCHECK_NMR 
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Residue Atom type PRE 
G3 HA2 1.75± 0.255 
G3 HA3 0.70 ± 0.077 
C4 HB2 0.39 ± 0.034 
C4 HB3 0.40 ± 0.029 
G6 HA2 0.92 ± 0.023 
G6 HA3 1. 03 ± 0.065 
P7 HD2 1.40 ± 0.024 
P7 HD3 1.12 ± 0.037 
P7 HG2 2.02 ± 0.067 
P7 HG3 1.11 ± 0.318 
D9 HB2 1.29 ± 0.306 
D9 HB3 1.97 ± 0.352 
E10 HB2 0.89 ± 0.167 
E10 HB3 0.98 ± 0.164 
Q14 HB2 0.49 ± 0.210 
Q14 HB3 1.18 ± 0.222 
Q14 HG2 1.96 ± 0.108 
Q14 HG3 1.28 ± 0.097 
C15 HB2 0.42 ± 0.080 
C15 HB3 0.29 ± 0.020 
H16 HB2 0.75 ± 0.015 
H16 HB3 1.22 ± 0.186 
H18 HB2 0.58 ± 0.023 
H18 HB3 0.48 ± 0.009 
S21 HB2 2.04 ± 0.126 
S21 HB3 1.24 ± 0.176 
I22 HG12 1.67 ± 0.073 
I22 HG13 1.09 ± 0.037 
K23 HB2 2.11 ± 0.084 
K23 HB3 2.68 ± 0.097 
Y25 HB2 0.74 ± 0.015 
Y25 HB3 0.97 ± 0.162 
K26 HB2 1.71 ± 0.127 
K26 HB3 1.21 ± 0.267 
G28 HA2 0.54 ± 0.039 
G28 HA3 1.54 ± 0.293 
C30 HB2 0.39 ± 0.064 
C30 HB3 0.75 ± 0.112 
G33 HA2 4.34 ± 0.163 
G33 HA3 2.67 ± 0.066 
G34 HA2 0.71± 0.110 
G34 HA3 0.89 ± 0.087 
C37 HB2 0.57 ± 0.055 
C37 HB3 0.49 ± 0.024 
K38 HB2 0.88 ± 0.088 
K38 HB3 1.12 ± 0.066 
C39 HB2 1.65 ± 0.308 
C39 HB3 0.56 ± 0.019 
 
Table 1 
 
without stereospecific 
assignment with stereospecific assignment 
number of distance constraints a  356 360 
 - of which intraresidual 172 172 
 - of which sequential 105 107 
 - of which medium-range (2 ≤ Δres ≤ 4) 35 37 
 -of which long-range (>4) 44 44 
CYANA residual target function 0.59 ± 0.08 Å2  0.70 ± 0.11 Å2  
distance restraints violated by more than 0.2Å 0 0 
angle restraints violated more than 5o b  0 0 
rmsd residues 2-39 c  0.63 ± 0.2 Å 0.37 ± 0.09 Å 
% of residues in Ramachandran plot d  
 - in most favored regions 80.7 81.3 
 - less favored regions 19 18.7 
 - generously allowed regions 0.3 0 
 - disallowed regions 0 0 
% of diastereotopic groups stereospecifically assigned  28  52  
 
Table 2 
